#version 2.4
## 
## Oncotator v1.8.0.0 | Flat File Reference hg19 | GENCODE v19 EFFECT | UniProt_AAxform 2014_12 | ClinVar 12.03.20 | ESP 6500SI-V2 | ORegAnno UCSC Track | dbSNP build 142 | CCLE_By_GP 09292010 | COSMIC v62_291112 | 1000gp3 20130502 | UniProt_AA 2014_12 | dbNSFP v2.4 | ESP 6500SI-V2 | COSMIC_FusionGenes v62_291112 | gencode_xref_refseq metadata_v19 | CCLE_By_Gene 09292010 | ACHILLES_Lineage_Results 110303 | CGC full_2012-03-15 | UniProt 2014_12 | HumanDNARepairGenes 20110905 | HGNC Sept172014 | COSMIC_Tissue 291112 | Familial_Cancer_Genes 20110905 | TUMORScape 20100104 | Ensembl ICGC MUCOPA | TCGAScape 110405 | MutSig Published Results 20110905 
Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000gp3_AA	i_1000gp3_AC	i_1000gp3_AF	i_1000gp3_AFR_AF	i_1000gp3_AMR_AF	i_1000gp3_AN	i_1000gp3_CIEND	i_1000gp3_CIPOS	i_1000gp3_CS	i_1000gp3_DP	i_1000gp3_EAS_AF	i_1000gp3_END	i_1000gp3_EUR_AF	i_1000gp3_IMPRECISE	i_1000gp3_MC	i_1000gp3_MEINFO	i_1000gp3_MEND	i_1000gp3_MLEN	i_1000gp3_MSTART	i_1000gp3_NS	i_1000gp3_SAS_AF	i_1000gp3_SVLEN	i_1000gp3_SVTYPE	i_1000gp3_TSD	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_Cancer Germline Mut	i_CGC_Cancer Molecular Genetics	i_CGC_Cancer Somatic Mut	i_CGC_Cancer Syndrome	i_CGC_Chr	i_CGC_Chr Band	i_CGC_GeneID	i_CGC_Name	i_CGC_Other Germline Mut	i_CGC_Tissue Type	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Entrez_Gene_Id	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_Accession Numbers	i_HGNC_CCDS IDs	i_HGNC_Chromosome	i_HGNC_Date Modified	i_HGNC_Date Name Changed	i_HGNC_Date Symbol Changed	i_HGNC_Ensembl Gene ID	i_HGNC_Ensembl ID(supplied by Ensembl)	i_HGNC_Enzyme IDs	i_HGNC_Gene family description	i_HGNC_HGNC ID	i_HGNC_Locus Group	i_HGNC_Locus Type	i_HGNC_Name Synonyms	i_HGNC_OMIM ID(supplied by NCBI)	i_HGNC_Previous Names	i_HGNC_Previous Symbols	i_HGNC_Primary IDs	i_HGNC_Pubmed IDs	i_HGNC_Record Type	i_HGNC_RefSeq(supplied by NCBI)	i_HGNC_Secondary IDs	i_HGNC_Status	i_HGNC_Synonyms	i_HGNC_UCSC ID(supplied by UCSC)	i_HGNC_UniProt ID(supplied by UniProt)	i_HGNC_VEGA IDs	i_HGVS_coding_DNA_change	i_HGVS_genomic_change	i_HGVS_protein_change	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_Variant_Classification	i_Variant_Type	i_amino_acid_change	i_annotation_transcript	i_build	i_ccds_id	i_condel	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP++_NR	i_dbNSFP_GERP++_RS	i_dbNSFP_GERP++_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_fold-degenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos(1-coor)	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_domain	i_entrez_gene_id	i_gc_content_full	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_type	i_havana_transcript	i_normal_depth	i_normal_vaf	i_polyphen	i_refseq_mrna_id	i_rna_depth	i_rna_vaf	i_secondary_variant_classification	i_sift	i_strand	i_transcript_name	i_transcript_status	i_tumor_depth	i_tumor_vaf	i_ucsc_cons
CHD5	26038	genome.wustl.edu	37	1	6194862	6194862	+	Silent	SNP	G	G	A	rs377324742		TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr1:6194862G>A	ENST00000262450.3	-	19	3027	c.2928C>T	c.(2926-2928)ggC>ggT	p.G976G	CHD5_ENST00000378021.1_5'UTR	NM_015557.2	NP_056372.1	O00258	WRB_HUMAN	chromodomain helicase DNA binding protein 5	0					tail-anchored membrane protein insertion into ER membrane (GO:0071816)	endoplasmic reticulum (GO:0005783)|integral component of membrane (GO:0016021)|nucleus (GO:0005634)		p.G976G(1)		breast(3)|central_nervous_system(3)|liver(1)|lung(1)|ovary(4)|pancreas(1)|skin(1)|upper_aerodigestive_tract(2)	16	Ovarian(185;0.0634)	all_cancers(23;5.36e-32)|all_epithelial(116;2.32e-17)|all_neural(13;3.68e-06)|all_lung(118;3.94e-06)|all_hematologic(16;2.39e-05)|Lung NSC(185;5.33e-05)|Acute lymphoblastic leukemia(12;0.000372)|Glioma(11;0.00127)|Renal(390;0.00188)|Colorectal(325;0.00342)|Breast(487;0.00373)|Hepatocellular(190;0.0218)|Myeloproliferative disorder(586;0.0393)|Ovarian(437;0.15)		Epithelial(90;3.08e-37)|GBM - Glioblastoma multiforme(13;1.36e-31)|OV - Ovarian serous cystadenocarcinoma(86;7.7e-19)|Colorectal(212;9.97e-08)|COAD - Colon adenocarcinoma(227;1.07e-05)|Kidney(185;6.16e-05)|KIRC - Kidney renal clear cell carcinoma(229;0.00109)|BRCA - Breast invasive adenocarcinoma(365;0.0012)|STAD - Stomach adenocarcinoma(132;0.00346)|READ - Rectum adenocarcinoma(331;0.0649)|Lung(427;0.193)		CTTGGTTCCCGCCCCCCTTGG	0.582																																																1	Substitution - coding silent(1)	endometrium(1)						G		1,4405	2.1+/-5.4	0,1,2202	268.0	268.0	268.0		2928	-4.0	1.0	1		268	0,8600		0,0,4300	no	coding-synonymous	CHD5	NM_015557.2		0,1,6502	AA,AG,GG		0.0,0.0227,0.0077		976/1955	6194862	1,13005	2203	4300	6503	SO:0001819	synonymous_variant	26038			AF425231	CCDS57.1	1p36.3	2013-01-28			ENSG00000116254	ENSG00000116254		"""Zinc fingers, PHD-type"""	16816	protein-coding gene	gene with protein product		610771				11889561, 12592387	Standard	NM_015557		Approved		uc001amb.2	Q8TDI0	OTTHUMG00000000952	ENST00000262450.3:c.2928C>T	1.37:g.6194862G>A			A8KAP8|A8MQ44|D3DSH9|O60740	Silent	SNP	p.G976	ENST00000262450.3	37	CCDS57.1	-																																																																																			HMMPfam_SNF2_N		0.582	CHD5-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000002823.2	260	0%	-	NM_015557	0	-		-	-1	NM_015557.1	provisional	175	10.3%	0.547
PTCHD2	57540	genome.wustl.edu	37	1	11580754	11580754	+	Silent	SNP	C	C	A			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr1:11580754C>A	ENST00000294484.6	+	10	2349	c.2211C>A	c.(2209-2211)gtC>gtA	p.V737V	PTCHD2_ENST00000389575.3_Silent_p.V737V	NM_020780.1	NP_065831.1	Q9P2K9	PTHD2_HUMAN	patched domain containing 2	737					cholesterol homeostasis (GO:0042632)|regulation of lipid transport (GO:0032368)|smoothened signaling pathway (GO:0007224)	endoplasmic reticulum (GO:0005783)|integral component of membrane (GO:0016021)|nuclear membrane (GO:0031965)	hedgehog receptor activity (GO:0008158)	p.V954V(1)		NS(3)|breast(2)|endometrium(9)|kidney(4)|large_intestine(5)|lung(34)|ovary(3)|pancreas(1)|prostate(6)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(3)	76	Ovarian(185;0.249)	Lung NSC(185;4.16e-05)|all_lung(284;4.76e-05)|Renal(390;0.000147)|Breast(348;0.00093)|Colorectal(325;0.00205)|Hepatocellular(190;0.00913)|Ovarian(437;0.00965)|Myeloproliferative disorder(586;0.0255)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0228)|Colorectal(212;3.13e-07)|COAD - Colon adenocarcinoma(227;4.83e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000325)|Kidney(185;0.000877)|KIRC - Kidney renal clear cell carcinoma(229;0.00273)|STAD - Stomach adenocarcinoma(313;0.00766)|READ - Rectum adenocarcinoma(331;0.0549)		GGCTGTTCGTCTCCATCCTCA	0.662																																																1	Substitution - coding silent(1)	endometrium(1)											45.0	48.0	47.0					1																	11580754		1960	4144	6104	SO:0001819	synonymous_variant	57540			AB037758	CCDS41247.1	1p36.22	2010-02-17			ENSG00000204624	ENSG00000204624			29251	protein-coding gene	gene with protein product		611251				15738394	Standard	NM_020780		Approved	KIAA1337, DISP3	uc001ash.4	Q9P2K9	OTTHUMG00000002074	ENST00000294484.6:c.2211C>A	1.37:g.11580754C>A			Q5VTU9|Q9UJD6	Silent	SNP	p.V737	ENST00000294484.6	37	CCDS41247.1	-																																																																																			HMMPfam_Patched		0.662	PTCHD2-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding	protein_coding	OTTHUMT00000005770.2	43	0%	-	XM_052561	1	100%		-	+1	NM_020780.1	validated	41	46.3%	0.993
HIVEP3	59269	genome.wustl.edu	37	1	42048023	42048023	+	Missense_Mutation	SNP	T	T	G			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	T	T					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr1:42048023T>G	ENST00000372583.1	-	4	3331	c.2446A>C	c.(2446-2448)Agt>Cgt	p.S816R	HIVEP3_ENST00000460604.1_5'Flank|HIVEP3_ENST00000247584.5_Missense_Mutation_p.S816R|HIVEP3_ENST00000372584.1_Missense_Mutation_p.S816R|HIVEP3_ENST00000429157.2_Missense_Mutation_p.S816R	NM_024503.4	NP_078779.2	Q5T1R4	ZEP3_HUMAN	human immunodeficiency virus type I enhancer binding protein 3	816	No DNA binding activity or transactivation activity, but complete prevention of TRAF-dependent NF-Kappa-B activation; associates with TRAF2 and JUN. {ECO:0000250}.|Ser-rich.				positive regulation of transcription, DNA-templated (GO:0045893)|skeletal muscle cell differentiation (GO:0035914)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|nucleus (GO:0005634)	DNA binding (GO:0003677)|metal ion binding (GO:0046872)	p.S816R(1)		NS(2)|breast(3)|central_nervous_system(5)|endometrium(13)|kidney(3)|large_intestine(13)|lung(33)|ovary(4)|prostate(5)|skin(2)|stomach(1)|upper_aerodigestive_tract(1)	85	Ovarian(52;0.00769)|all_hematologic(146;0.109)|Acute lymphoblastic leukemia(166;0.155)	Myeloproliferative disorder(586;0.0367)				TCCAAGCCACTCGGCTGCTCG	0.557																																																1	Substitution - Missense(1)	endometrium(1)											53.0	56.0	55.0					1																	42048023		2203	4300	6503	SO:0001583	missense	59269			AF278765	CCDS463.1, CCDS44124.1	1p34	2013-01-08	2001-11-28		ENSG00000127124	ENSG00000127124		"""Zinc fingers, C2H2-type"""	13561	protein-coding gene	gene with protein product	"""kappabinding protein-1"""	606649	"""human immunodeficiency virus type I enhancer-binding protein 3"""			11161801	Standard	NR_038260		Approved	KRC, KBP1, KBP-1, SHN3, FLJ16752, KIAA1555, ZAS3, Schnurri-3, ZNF40C	uc001cha.4	Q5T1R4	OTTHUMG00000006361	ENST00000372583.1:c.2446A>C	1.37:g.42048023T>G	ENSP00000361664:p.Ser816Arg		A7YY91|Q5T1R5|Q9BZS0|Q9HCL7	Missense_Mutation	SNP	p.S816R	ENST00000372583.1	37	CCDS463.1	deleterious(0.473)	.	.	.	.	.	.	.	.	.	.	T	11.07	1.529879	0.27387	.	.	ENSG00000127124	ENST00000372584;ENST00000372583;ENST00000247584;ENST00000429157	T;T;T;T	0.17054	2.3;2.3;2.3;2.3	4.21	-2.42	0.06542	.	0.598400	0.16095	N	0.229885	T	0.15305	0.0369	L	0.43152	1.355	0.09310	N	1	P;P	0.46220	0.874;0.8	P;B	0.44359	0.447;0.261	T	0.12268	-1.0554	10	0.72032	D	0.01	-3.7675	9.641	0.39839	0.0:0.3931:0.0:0.6069	.	816;816	Q5T1R4-2;Q5T1R4	.;ZEP3_HUMAN	R	816	ENSP00000361665:S816R;ENSP00000361664:S816R;ENSP00000247584:S816R;ENSP00000410828:S816R	ENSP00000247584:S816R	S	-	1	0	HIVEP3	41820610	0.666000	0.27475	0.218000	0.23776	0.621000	0.37620	0.689000	0.25437	-0.593000	0.05844	0.379000	0.24179	AGT	NULL		0.557	HIVEP3-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding	protein_coding	OTTHUMT00000016978.1	51	0%	possibly_damaging(0.612)	NM_024503	1	0%		tolerated(0.12)	-1	NM_024503.3	validated	69	18.8%	0.046
GLMN	11146	genome.wustl.edu	37	1	92754482	92754482	+	Silent	SNP	T	T	C			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	T	T					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr1:92754482T>C	ENST00000370360.3	-	6	702	c.621A>G	c.(619-621)gaA>gaG	p.E207E	GLMN_ENST00000534881.1_Silent_p.E207E	NM_053274.2	NP_444504.1	Q92990	GLMN_HUMAN	glomulin, FKBP associated protein	207					muscle cell differentiation (GO:0042692)|negative regulation of protein ubiquitination (GO:0031397)|negative regulation of T cell proliferation (GO:0042130)|neural tube closure (GO:0001843)|positive regulation of cytokine secretion (GO:0050715)|positive regulation of interleukin-2 biosynthetic process (GO:0045086)|positive regulation of phosphorylation (GO:0042327)|regulation of gene expression, epigenetic (GO:0040029)|regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)|vasculogenesis (GO:0001570)	Cul2-RING ubiquitin ligase complex (GO:0031462)|Cul3-RING ubiquitin ligase complex (GO:0031463)|Cul4A-RING E3 ubiquitin ligase complex (GO:0031464)|cullin-RING ubiquitin ligase complex (GO:0031461)|intracellular (GO:0005622)	hepatocyte growth factor receptor binding (GO:0005171)|ubiquitin protein ligase binding (GO:0031625)|ubiquitin-protein transferase inhibitor activity (GO:0055105)	p.E207E(1)		endometrium(5)|kidney(1)|large_intestine(2)|lung(7)|pancreas(1)|skin(1)	17		all_lung(203;0.00827)|Lung NSC(277;0.0295)		all cancers(265;0.00702)|GBM - Glioblastoma multiforme(16;0.0381)|Epithelial(280;0.0989)		ATTTCAGTAATTCATCCTTTA	0.308									Multiple Glomus Tumors (of the Skin), Familial																																							1	Substitution - coding silent(1)	endometrium(1)											71.0	77.0	75.0					1																	92754482		2203	4299	6502	SO:0001819	synonymous_variant	11146	Familial Cancer Database	Multiple Familial Glomangiomas, Hereditary Multiple Glomus Tumors, Familial Multiple Glomangiomatosis, Inherited Cutaneous Venous Anomalies, incl. Familial Multiple Glomangiomyoma	U73704	CCDS738.1	1p22.1	2008-02-05	2004-07-01		ENSG00000174842	ENSG00000174842			14373	protein-coding gene	gene with protein product		601749	"""venous malformation with glomus cells"""	VMGLOM		8955134	Standard	XM_005270400		Approved	FAP48, GLML, GVM, FKBPAP	uc001dor.3	Q92990	OTTHUMG00000010283	ENST00000370360.3:c.621A>G	1.37:g.92754482T>C			Q5VVC3|Q9BVE8	Silent	SNP	p.E207	ENST00000370360.3	37	CCDS738.1	-																																																																																			HMMPfam_FKBP12		0.308	GLMN-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000028358.1	272	0%	-	NM_007070	5	60%		-	-1	NM_053274.2	reviewed	274	32.1%	0.998
ADAM15	8751	genome.wustl.edu	37	1	155034447	155034447	+	Missense_Mutation	SNP	C	C	G			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr1:155034447C>G	ENST00000356955.2	+	21	2521	c.2420C>G	c.(2419-2421)cCg>cGg	p.P807R	EFNA3_ENST00000556931.1_5'Flank|ADAM15_ENST00000271836.6_Intron|ADAM15_ENST00000368410.2_Intron|ADAM15_ENST00000449910.2_Missense_Mutation_p.P806R|ADAM15_ENST00000368413.1_Intron|ADAM15_ENST00000472434.1_3'UTR|ADAM15_ENST00000531455.1_Intron|ADAM15_ENST00000360674.4_Intron|ADAM15_ENST00000355956.2_Intron|EFNA4_ENST00000359751.4_5'Flank|ADAM15_ENST00000368412.3_Intron|EFNA4_ENST00000427683.2_5'Flank|EFNA4_ENST00000368409.3_5'Flank|EFNA3_ENST00000505139.1_5'Flank|ADAM15_ENST00000359280.4_Missense_Mutation_p.P782R	NM_207197.2	NP_997080.1	Q13444	ADA15_HUMAN	ADAM metallopeptidase domain 15	807					angiogenesis (GO:0001525)|cardiac epithelial to mesenchymal transition (GO:0060317)|cell-matrix adhesion (GO:0007160)|collagen catabolic process (GO:0030574)|extracellular matrix disassembly (GO:0022617)|extracellular matrix organization (GO:0030198)|innate immune response (GO:0045087)|integrin-mediated signaling pathway (GO:0007229)|negative regulation of cell growth (GO:0030308)|negative regulation of cell migration (GO:0030336)|negative regulation of cell-matrix adhesion (GO:0001953)|negative regulation of receptor binding (GO:1900121)|protein kinase C signaling (GO:0070528)|tissue regeneration (GO:0042246)	cell junction (GO:0030054)|cell projection (GO:0042995)|cell surface (GO:0009986)|cytoplasmic vesicle (GO:0031410)|extracellular vesicular exosome (GO:0070062)|integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	integrin binding (GO:0005178)|metalloendopeptidase activity (GO:0004222)|metallopeptidase activity (GO:0008237)|SH3 domain binding (GO:0017124)|zinc ion binding (GO:0008270)	p.P807R(1)		NS(1)|central_nervous_system(3)|cervix(1)|endometrium(9)|kidney(1)|large_intestine(7)|lung(8)|ovary(1)|prostate(2)|skin(5)|urinary_tract(1)	39	all_epithelial(22;1.43e-30)|all_lung(78;6.64e-28)|all_hematologic(923;0.0359)|Hepatocellular(266;0.0877)		BRCA - Breast invasive adenocarcinoma(34;0.000434)			GTGAGAAGCCCGAAGGTAACG	0.677											OREG0013848	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)																																				1	Substitution - Missense(1)	endometrium(1)											65.0	70.0	68.0					1																	155034447		2203	4300	6503	SO:0001583	missense	8751			U46005	CCDS1084.1, CCDS1085.1, CCDS1086.1, CCDS1087.1, CCDS1088.1, CCDS44236.1, CCDS58031.1, CCDS58032.1, CCDS60282.1	1q21.3	2008-02-05	2007-06-04		ENSG00000143537	ENSG00000143537		"""ADAM metallopeptidase domain containing"""	193	protein-coding gene	gene with protein product	"""metargidin"""	605548	"""a disintegrin and metalloproteinase domain 15 (metargidin)"""			9516430	Standard	NM_003815		Approved	MDC15	uc001fgr.2	Q13444	OTTHUMG00000013898	ENST00000356955.2:c.2420C>G	1.37:g.155034447C>G	ENSP00000349436:p.Pro807Arg	1767	B3KQU5|B4DLB5|B4DMH8|E9PN65|Q13493|Q53XQ0|Q5SR68|Q5SR69|Q6R267|Q71S61|Q71S62|Q71S63|Q71S64|Q71S65|Q71S66|Q71S67|Q71S68|Q71S69|Q96C78|U3KQL5	Missense_Mutation	SNP	p.P807R	ENST00000356955.2	37	CCDS1087.1	deleterious(0.766)	.	.	.	.	.	.	.	.	.	.	C	16.04	3.009101	0.54361	.	.	ENSG00000143537	ENST00000356955;ENST00000449910;ENST00000359280	T;T;T	0.00824	5.76;5.71;5.65	4.17	3.25	0.37280	.	0.217574	0.23282	N	0.049884	T	0.00754	0.0025	L	0.29908	0.895	0.80722	D	1	D;D;D;P	0.58970	0.984;0.984;0.973;0.95	P;P;P;P	0.55999	0.789;0.789;0.62;0.62	T	0.74087	-0.3778	10	0.52906	T	0.07	.	8.0813	0.30746	0.0:0.8877:0.0:0.1123	.	782;806;807;803	Q13444-5;Q13444-3;Q13444;Q59GF2	.;.;ADA15_HUMAN;.	R	807;806;782	ENSP00000349436:P807R;ENSP00000403843:P806R;ENSP00000352226:P782R	ENSP00000349436:P807R	P	+	2	0	ADAM15	153301071	0.005000	0.15991	0.959000	0.39883	0.934000	0.57294	0.324000	0.19610	0.947000	0.37659	0.639000	0.83563	CCG	NULL		0.677	ADAM15-019	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding	protein_coding	OTTHUMT00000387168.1	40	0%	possibly_damaging(0.937)	NM_003815	231	16.4%		deleterious(0.02)	+1	NM_207197.1	reviewed	54	11.1%	0.974
CD1E	913	genome.wustl.edu	37	1	158324229	158324230	+	Frame_Shift_Ins	INS	-	-	A			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	-	-					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr1:158324229_158324230insA	ENST00000368167.3	+	2	360_361	c.121_122insA	c.(121-123)caafs	p.Q41fs	CD1E_ENST00000444681.2_Intron|CD1E_ENST00000368160.3_Frame_Shift_Ins_p.Q41fs|CD1E_ENST00000368155.3_Frame_Shift_Ins_p.Q41fs|CD1E_ENST00000464822.1_Intron|CD1E_ENST00000452291.2_Intron|CD1E_ENST00000368166.3_Intron|CD1E_ENST00000368165.3_Frame_Shift_Ins_p.Q41fs|CD1E_ENST00000368157.1_Intron|CD1E_ENST00000434258.1_Frame_Shift_Ins_p.Q39fs|CD1E_ENST00000368164.3_Intron|CD1E_ENST00000368163.3_Frame_Shift_Ins_p.Q41fs|CD1E_ENST00000368154.1_Intron|CD1E_ENST00000368161.3_Frame_Shift_Ins_p.Q41fs|CD1E_ENST00000368156.1_Frame_Shift_Ins_p.Q41fs	NM_030893.3	NP_112155.2	P15812	CD1E_HUMAN	CD1e molecule	41					antigen processing and presentation (GO:0019882)|immune response (GO:0006955)	endosome (GO:0005768)|Golgi apparatus (GO:0005794)|integral component of plasma membrane (GO:0005887)|lysosome (GO:0005764)	lipid binding (GO:0008289)			breast(2)|endometrium(2)|kidney(1)|large_intestine(6)|lung(27)|pancreas(1)|prostate(4)|skin(4)|stomach(1)|urinary_tract(1)	49	all_hematologic(112;0.0378)					CCGCATGCTCCAAACTTCCTCC	0.545																																																0																																										SO:0001589	frameshift_variant	913			AJ289111	CCDS41417.1, CCDS41418.1, CCDS41419.1, CCDS41420.1, CCDS41421.1, CCDS41422.1, CCDS53387.1, CCDS53388.1, CCDS53389.1, CCDS53390.1, CCDS53384.1, CCDS53385.1, CCDS53386.1	1q23.1	2014-01-14	2006-03-28		ENSG00000158488	ENSG00000158488		"""CD molecules"", ""Immunoglobulin superfamily / C1-set domain containing"""	1638	protein-coding gene	gene with protein product		188411	"""CD1E antigen, e polypeptide"", ""CD1e antigen"""			10948205	Standard	NM_001042585		Approved		uc001fse.3	P15812	OTTHUMG00000017515	ENST00000368167.3:c.124dupA	1.37:g.158324232_158324232dupA	ENSP00000357149:p.Gln41fs		B4DZV3|E7EP01|Q5TDJ9|Q5TDK3|Q5TDK4|Q5TDK5|Q5TDK6|Q5TDK8|Q5TDL1|Q712E4|Q712E5|Q712E6|Q712E7|Q712E8|Q712E9|Q712F0|Q712F1|Q712F2|Q712F3|Q712F4|Q712F5|Q96TD0|Q96TD1|Q9UMM1|Q9Y5M3	Frame_Shift_Ins	INS	p.T42fs	ENST00000368167.3	37	CCDS41417.1	-																																																																																			superfamily_MHC antigen-recognition domain		0.545	CD1E-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding	protein_coding	OTTHUMT00000046353.3	-	-	-	NM_030893	-	-		-	+1	NM_030893.2	reviewed	-	-	0.226:0.234
IPO9	55705	genome.wustl.edu	37	1	201843466	201843466	+	Silent	SNP	C	C	A	rs375467339		TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr1:201843466C>A	ENST00000361565.4	+	21	2868	c.2799C>A	c.(2797-2799)gcC>gcA	p.A933A		NM_018085.4	NP_060555.2	Q96P70	IPO9_HUMAN	importin 9	933					protein import into nucleus (GO:0006606)	cytoplasm (GO:0005737)|membrane (GO:0016020)|nucleus (GO:0005634)	histone binding (GO:0042393)|protein transporter activity (GO:0008565)	p.A933A(1)		cervix(1)|endometrium(5)|kidney(4)|large_intestine(5)|lung(16)|ovary(2)|prostate(1)|skin(2)|stomach(1)|upper_aerodigestive_tract(1)	38						AGGCTAATGCCGCTCGCCAGG	0.512																																																1	Substitution - coding silent(1)	endometrium(1)											89.0	85.0	86.0					1																	201843466		2203	4300	6503	SO:0001819	synonymous_variant	55705			AF410465	CCDS1415.1	1q31.3	2008-02-05			ENSG00000198700	ENSG00000198700		"""Importins"""	19425	protein-coding gene	gene with protein product						11823430, 10574461	Standard	NM_018085		Approved	Imp9, FLJ10402	uc001gwz.3	Q96P70	OTTHUMG00000035805	ENST00000361565.4:c.2799C>A	1.37:g.201843466C>A			B1ASV5|Q8N1Y1|Q8N3I2|Q8NCG9|Q96SU6|Q9NW01|Q9P0A8|Q9ULM8	Silent	SNP	p.A933	ENST00000361565.4	37	CCDS1415.1	-																																																																																			superfamily_ARM repeat		0.512	IPO9-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000087088.1	134	0%	-	NM_018085	74	47.2%		-	+1	NM_018085.4	validated	157	38.9%	0.546
PPFIA4	8497	genome.wustl.edu	37	1	203023240	203023241	+	Frame_Shift_Ins	INS	-	-	GC	rs10635298	byFrequency	TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	-	-					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr1:203023240_203023241insGC	ENST00000447715.2	+	20	2193_2194	c.1752_1753insGC	c.(1753-1755)ccafs	p.P585fs	PPFIA4_ENST00000599966.1_Intron|PPFIA4_ENST00000295706.4_Intron|PPFIA4_ENST00000272198.6_Intron|PPFIA4_ENST00000414050.2_Intron|PPFIA4_ENST00000367240.2_Intron			O75335	LIPA4_HUMAN	protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4	585					cell-matrix adhesion (GO:0007160)|signal transduction (GO:0007165)	cytoplasm (GO:0005737)|intracellular (GO:0005622)|presynaptic active zone (GO:0048786)				NS(1)|autonomic_ganglia(1)|breast(3)|endometrium(6)|kidney(2)|large_intestine(8)|lung(20)|ovary(4)|prostate(1)|skin(2)|stomach(1)|upper_aerodigestive_tract(1)	50						CAGGCCCGCTGCCAGTGCCGGA	0.569														1102	0.220048	0.2905	0.1772	5008	,	,		21107	0.1081		0.2445	False		,,,				2504	0.2454															0																																										SO:0001589	frameshift_variant	8497			AF034801	CCDS44296.1	1q32.1	2013-01-10			ENSG00000143847	ENSG00000143847		"""Sterile alpha motif (SAM) domain containing"""	9248	protein-coding gene	gene with protein product	"""Liprin-alpha4"""	603145				9624153	Standard	XM_005245553		Approved		uc009xaj.3	O75335	OTTHUMG00000042123	Exception_encountered	1.37:g.203023240_203023241insGC	ENSP00000402576:p.Pro585fs		A2RUJ5|B1APN8|B1N949|B7ZM43|O94971	Frame_Shift_Ins	INS	p.P584fs	ENST00000447715.2	37		-																																																																																			NULL		0.569	PPFIA4-005	NOVEL	basic|appris_candidate	protein_coding	protein_coding	OTTHUMT00000462949.1	-	-	-	NM_015053	-	-		-	+1	ENST00000447715	known	-	-	0.005:0.000
POLR1B	84172	genome.wustl.edu	37	2	113309368	113309368	+	Missense_Mutation	SNP	C	C	A			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr2:113309368C>A	ENST00000263331.5	+	6	1359	c.779C>A	c.(778-780)tCt>tAt	p.S260Y	POLR1B_ENST00000417433.2_Missense_Mutation_p.S204Y|POLR1B_ENST00000541869.1_Missense_Mutation_p.S298Y|POLR1B_ENST00000409894.3_Missense_Mutation_p.S260Y|POLR1B_ENST00000537335.1_Missense_Mutation_p.S49Y	NM_019014.4	NP_061887.2	Q9H9Y6	RPA2_HUMAN	polymerase (RNA) I polypeptide B, 128kDa	260					gene expression (GO:0010467)|termination of RNA polymerase I transcription (GO:0006363)|transcription elongation from RNA polymerase I promoter (GO:0006362)|transcription from RNA polymerase I promoter (GO:0006360)|transcription initiation from RNA polymerase I promoter (GO:0006361)	cytoplasm (GO:0005737)|nucleolus (GO:0005730)|nucleoplasm (GO:0005654)	DNA binding (GO:0003677)|DNA-directed RNA polymerase activity (GO:0003899)|metal ion binding (GO:0046872)|ribonucleoside binding (GO:0032549)	p.S260Y(1)		breast(3)|endometrium(9)|kidney(2)|large_intestine(9)|lung(14)|ovary(1)|prostate(1)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)	42						GTCAGCTTTTCTGATTATCAG	0.318																																					Ovarian(16;256 576 9537 23969 41147)											1	Substitution - Missense(1)	endometrium(1)											84.0	86.0	85.0					2																	113309368		2203	4300	6503	SO:0001583	missense	84172			AK001678	CCDS2097.1, CCDS46395.1, CCDS62988.1, CCDS62989.1, CCDS62990.1	2q13	2013-01-21			ENSG00000125630	ENSG00000125630		"""RNA polymerase subunits"""	20454	protein-coding gene	gene with protein product		602000					Standard	NM_001137604		Approved	Rpo1-2, FLJ21921, FLJ10816, RPA2	uc002thw.2	Q9H9Y6	OTTHUMG00000131314	ENST00000263331.5:c.779C>A	2.37:g.113309368C>A	ENSP00000263331:p.Ser260Tyr		B7Z6Y7|B7Z823|F5GZX4|F8W898|Q2TAM4|Q585T5|Q6ZRR2|Q9H9D3	Missense_Mutation	SNP	p.S260Y	ENST00000263331.5	37	CCDS2097.1	deleterious(0.748)	.	.	.	.	.	.	.	.	.	.	C	23.7	4.445533	0.84101	.	.	ENSG00000125630	ENST00000263331;ENST00000541869;ENST00000409894;ENST00000537335;ENST00000417433	T;T;T;T;T	0.79653	-1.29;-1.29;-1.29;-1.29;-1.29	5.03	5.03	0.67393	RNA polymerase, beta subunit, protrusion (1);RNA polymerase Rpb2, domain 2 (1);	0.172430	0.52532	D	0.000072	D	0.90539	0.7035	M	0.84511	2.7	0.80722	D	1	D;D;D;D	0.76494	0.998;0.999;0.971;0.998	D;D;P;D	0.74348	0.971;0.979;0.762;0.983	D	0.92058	0.5654	10	0.87932	D	0	-24.8358	17.4969	0.87720	0.0:1.0:0.0:0.0	.	298;260;204;260	F5GZX4;F8W898;Q9H9Y6-2;Q9H9Y6	.;.;.;RPA2_HUMAN	Y	260;298;260;49;204	ENSP00000263331:S260Y;ENSP00000444136:S298Y;ENSP00000387143:S260Y;ENSP00000437914:S49Y;ENSP00000405358:S204Y	ENSP00000263331:S260Y	S	+	2	0	POLR1B	113025839	1.000000	0.71417	0.999000	0.59377	0.974000	0.67602	7.750000	0.85110	2.502000	0.84385	0.591000	0.81541	TCT	HMMPfam_RNA_pol_Rpb2_1,superfamily_beta and beta-prime subunits of DNA dependent RNA-polymerase		0.318	POLR1B-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000254083.1	146	0%	possibly_damaging(0.808)	NM_019014	6	66.6%		deleterious(0)	+1	NM_019014.4	validated	151	45%	1.000
GLB1L	79411	genome.wustl.edu	37	2	220107953	220107953	+	Missense_Mutation	SNP	G	G	C			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr2:220107953G>C	ENST00000295759.7	-	3	469	c.156C>G	c.(154-156)agC>agG	p.S52R	STK16_ENST00000409743.1_5'Flank|STK16_ENST00000396738.2_5'Flank|GLB1L_ENST00000497855.1_5'Flank|STK16_ENST00000409638.3_5'Flank|STK16_ENST00000409516.3_5'Flank|GLB1L_ENST00000392089.2_Missense_Mutation_p.S52R|GLB1L_ENST00000409640.1_Missense_Mutation_p.S52R|GLB1L_ENST00000356283.3_Missense_Mutation_p.S52R|STK16_ENST00000409260.1_5'Flank			Q6UWU2	GLB1L_HUMAN	galactosidase, beta 1-like	52					carbohydrate metabolic process (GO:0005975)	extracellular region (GO:0005576)	beta-galactosidase activity (GO:0004565)	p.S52R(1)		breast(1)|endometrium(3)|kidney(2)|large_intestine(5)|lung(7)|ovary(1)|prostate(2)|upper_aerodigestive_tract(1)	22		all_lung(227;1.19e-05)|Lung NSC(271;2.76e-05)|Medulloblastoma(418;0.0208)|Esophageal squamous(248;0.0559)		Epithelial(149;1.3e-11)|all cancers(144;2.07e-10)|LUSC - Lung squamous cell carcinoma(224;0.008)|Lung(261;0.00942)		AGTAGTGCAGGCTGCCAGACA	0.562																																																1	Substitution - Missense(1)	endometrium(1)											66.0	74.0	72.0					2																	220107953		2203	4300	6503	SO:0001583	missense	79411				CCDS2437.1, CCDS74657.1	2q36.1	2008-02-05			ENSG00000163521	ENSG00000163521			28129	protein-coding gene	gene with protein product						12975309	Standard	XM_005246850		Approved	MGC10771	uc002vkm.3	Q6UWU2	OTTHUMG00000133133	ENST00000295759.7:c.156C>G	2.37:g.220107953G>C	ENSP00000295759:p.Ser52Arg		Q96DR0	Missense_Mutation	SNP	p.S52R	ENST00000295759.7	37	CCDS2437.1	-	.	.	.	.	.	.	.	.	.	.	G	15.45	2.838038	0.50951	.	.	ENSG00000163521	ENST00000295759;ENST00000409640;ENST00000392089;ENST00000356283;ENST00000428427	D;D;D;D;D	0.98135	-4.74;-4.74;-4.74;-4.74;-4.74	6.17	3.43	0.39272	Glycoside hydrolase, subgroup, catalytic domain (1);Glycoside hydrolase, superfamily (1);	0.000000	0.85682	D	0.000000	D	0.99070	0.9681	H	0.97315	3.98	0.27403	N	0.954806	D;D	0.89917	1.0;1.0	D;D	0.97110	1.0;1.0	D	0.95840	0.8865	10	0.87932	D	0	-18.2576	10.7665	0.46297	0.1959:0.0:0.8041:0.0	.	52;52	Q6UWU2-2;Q6UWU2	.;GLB1L_HUMAN	R	52	ENSP00000295759:S52R;ENSP00000386354:S52R;ENSP00000375939:S52R;ENSP00000348628:S52R;ENSP00000400738:S52R	ENSP00000295759:S52R	S	-	3	2	GLB1L	219816197	1.000000	0.71417	0.998000	0.56505	0.979000	0.70002	1.230000	0.32612	0.487000	0.27698	0.655000	0.94253	AGC	HMMPfam_Glyco_hydro_35,superfamily_(Trans)glycosidases		0.562	GLB1L-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000256822.2	70	0%	unknown(0)	NM_024506	3	33.3%		-	-1	NM_024506.3	provisional	70	42.9%	1.000
DOCK10	55619	genome.wustl.edu	37	2	225740826	225740826	+	Missense_Mutation	SNP	C	C	T	rs377274433		TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr2:225740826C>T	ENST00000258390.7	-	8	927	c.860G>A	c.(859-861)cGc>cAc	p.R287H	DOCK10_ENST00000409592.3_Missense_Mutation_p.R281H	NM_014689.2	NP_055504.2	Q96BY6	DOC10_HUMAN	dedicator of cytokinesis 10	287	PH. {ECO:0000255|PROSITE- ProRule:PRU00145}.				regulation of cell migration (GO:0030334)|small GTPase mediated signal transduction (GO:0007264)	extracellular vesicular exosome (GO:0070062)|membrane (GO:0016020)	Rho guanyl-nucleotide exchange factor activity (GO:0005089)	p.R287H(1)		NS(1)|breast(3)|cervix(1)|endometrium(6)|kidney(10)|large_intestine(16)|lung(40)|ovary(2)|pancreas(1)|prostate(2)|stomach(1)|upper_aerodigestive_tract(3)|urinary_tract(1)	87		Renal(207;0.0113)|all_lung(227;0.0486)|Lung NSC(271;0.0653)|all_hematologic(139;0.14)		Epithelial(121;2.37e-10)|all cancers(144;2.26e-07)|Lung(261;0.0143)|LUSC - Lung squamous cell carcinoma(224;0.0178)		TTGCAGAATGCGGTTGAGGGT	0.488													C|||	1	0.000199681	0.0008	0.0	5008	,	,		18599	0.0		0.0	False		,,,				2504	0.0															1	Substitution - Missense(1)	endometrium(1)						C	HIS/ARG	0,3808		0,0,1904	95.0	94.0	94.0		860	4.8	1.0	2		94	1,8271		0,1,4135	no	missense	DOCK10	NM_014689.2	29	0,1,6039	TT,TC,CC		0.0121,0.0,0.0083	probably-damaging	287/2187	225740826	1,12079	1904	4136	6040	SO:0001583	missense	55619			AB014594	CCDS46528.1, CCDS74661.1	2q36.3	2013-01-10			ENSG00000135905	ENSG00000135905		"""Pleckstrin homology (PH) domain containing"""	23479	protein-coding gene	gene with protein product	"""zizimin3"""	611518				12432077	Standard	NM_014689		Approved	ZIZ3, KIAA0694	uc010fwz.1	Q96BY6	OTTHUMG00000153428	ENST00000258390.7:c.860G>A	2.37:g.225740826C>T	ENSP00000258390:p.Arg287His		B3FL70|O75178|Q9NW06|Q9NXI8	Missense_Mutation	SNP	p.R287H	ENST00000258390.7	37	CCDS46528.1	deleterious(0.544)	.	.	.	.	.	.	.	.	.	.	C	24.3	4.518875	0.85495	0.0	1.21E-4	ENSG00000135905	ENST00000409592;ENST00000258390	T;T	0.76060	-0.99;-0.99	5.76	4.77	0.60923	Pleckstrin homology-type (1);Pleckstrin homology domain (3);	0.124363	0.53938	D	0.000056	T	0.75729	0.3889	L	0.45581	1.43	0.32883	D	0.510848	D;D;D	0.63046	0.991;0.992;0.985	P;P;P	0.62298	0.9;0.895;0.9	T	0.80061	-0.1540	10	0.66056	D	0.02	.	3.7992	0.08751	0.0:0.668:0.0:0.332	.	287;287;281	Q96BY6;Q96BY6-2;B3FL70	DOC10_HUMAN;.;.	H	281;287	ENSP00000386694:R281H;ENSP00000258390:R287H	ENSP00000258390:R287H	R	-	2	0	DOCK10	225449070	1.000000	0.71417	1.000000	0.80357	0.995000	0.86356	4.298000	0.59067	2.721000	0.93114	0.655000	0.94253	CGC	HMMPfam_PH,HMMSmart_SM00233,superfamily_PH domain-like		0.488	DOCK10-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000331246.1	199	0%	possibly_damaging(0.579)		0	-		tolerated(0.05)	-1	NM_014689.2	validated	184	43.5%	1.000
LRRFIP1	9208	genome.wustl.edu	37	2	238672541	238672541	+	Frame_Shift_Del	DEL	C	C	-			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr2:238672541delC	ENST00000392000.4	+	11	2302	c.2185delC	c.(2185-2187)cccfs	p.P729fs	LRRFIP1_ENST00000308482.9_Intron|LRRFIP1_ENST00000289175.6_Frame_Shift_Del_p.P673fs|LRRFIP1_ENST00000244815.5_Frame_Shift_Del_p.P705fs	NM_001137552.1	NP_001131024.1	Q32MZ4	LRRF1_HUMAN	leucine rich repeat (in FLII) interacting protein 1	729					innate immune response (GO:0045087)|negative regulation of transcription, DNA-templated (GO:0045892)|positive regulation of type I interferon production (GO:0032481)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|cytoskeleton (GO:0005856)|cytosol (GO:0005829)|nucleus (GO:0005634)|plasma membrane (GO:0005886)	DNA binding (GO:0003677)|double-stranded RNA binding (GO:0003725)|protein homodimerization activity (GO:0042803)			NS(1)|breast(4)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(7)|lung(10)|ovary(1)|upper_aerodigestive_tract(1)	29		Breast(86;0.00257)|Renal(207;0.00571)|Ovarian(221;0.17)|all_hematologic(139;0.182)		Epithelial(121;9.75e-23)|OV - Ovarian serous cystadenocarcinoma(60;1.01e-10)|Kidney(56;4.85e-09)|KIRC - Kidney renal clear cell carcinoma(57;1.31e-07)|BRCA - Breast invasive adenocarcinoma(100;0.000151)|Lung(119;0.0137)|LUSC - Lung squamous cell carcinoma(224;0.0325)|COAD - Colon adenocarcinoma(134;0.228)		CTGCACCCTGCCCGAACATGA	0.473																																																0													54.0	54.0	54.0					2																	238672541		2203	4300	6503	SO:0001589	frameshift_variant	9208			AJ223075	CCDS2521.1, CCDS46551.1, CCDS46552.1, CCDS46553.1	2q37.3	2010-09-30			ENSG00000124831	ENSG00000124831			6702	protein-coding gene	gene with protein product	"""GC-binding factor 2"""	603256				9705290, 9525888, 16199883	Standard	NM_004735		Approved	FLAP-1, FLIIAP1, TRIP, GCF-2, HUFI-1	uc002vxe.3	Q32MZ4	OTTHUMG00000133339	ENST00000392000.4:c.2185delC	2.37:g.238672541delC	ENSP00000375857:p.Pro729fs		E9PGZ2|O75766|O75799|Q32MZ5|Q53T49|Q6PKG2|Q9Y607	Frame_Shift_Del	DEL	p.E730fs	ENST00000392000.4	37	CCDS46552.1	-																																																																																			NULL		0.473	LRRFIP1-003	KNOWN	basic|CCDS	protein_coding	protein_coding	OTTHUMT00000317198.1	-	-	-	NM_004735	-	-		-	+1	NM_001137552.1	validated	-	-	0.000
TADA3	10474	genome.wustl.edu	37	3	9831273	9831273	+	Missense_Mutation	SNP	A	A	T			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	A	A					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr3:9831273A>T	ENST00000301964.2	-	4	1042	c.484T>A	c.(484-486)Tgt>Agt	p.C162S	ARPC4_ENST00000397261.3_5'Flank|TADA3_ENST00000492635.1_5'Flank|TADA3_ENST00000440161.1_Missense_Mutation_p.C162S|ARPC4_ENST00000498623.2_5'Flank|ARPC4_ENST00000287613.7_5'Flank|TADA3_ENST00000343450.2_Missense_Mutation_p.C162S	NM_006354.2	NP_006345.1	O75528	TADA3_HUMAN	transcriptional adaptor 3	162					chromatin organization (GO:0006325)|histone H3 acetylation (GO:0043966)|intracellular estrogen receptor signaling pathway (GO:0030520)|mitotic nuclear division (GO:0007067)|positive regulation of gene expression (GO:0010628)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of histone deacetylation (GO:0031063)|regulation of protein phosphorylation (GO:0001932)|regulation of protein stability (GO:0031647)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|regulation of tubulin deacetylation (GO:0090043)|transcription, DNA-templated (GO:0006351)	Ada2/Gcn5/Ada3 transcription activator complex (GO:0005671)|intracellular (GO:0005622)|mitotic spindle (GO:0072686)|nucleus (GO:0005634)|STAGA complex (GO:0030914)|transcription factor TFTC complex (GO:0033276)	ligand-dependent nuclear receptor binding (GO:0016922)|ligand-dependent nuclear receptor transcription coactivator activity (GO:0030374)|protein domain specific binding (GO:0019904)|sequence-specific DNA binding transcription factor activity (GO:0003700)|transcription coactivator activity (GO:0003713)	p.C162S(1)		endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(4)|lung(4)|skin(2)|upper_aerodigestive_tract(1)	16						ATGTCAGCACAGTAGGGCTCC	0.597																																																1	Substitution - Missense(1)	endometrium(1)											60.0	57.0	58.0					3																	9831273		2203	4300	6503	SO:0001583	missense	10474			AF069733	CCDS2583.1, CCDS2584.1	3p25.3	2010-08-13	2009-10-02	2009-10-02	ENSG00000171148	ENSG00000171148			19422	protein-coding gene	gene with protein product		602945	"""transcriptional adaptor 3 (NGG1 homolog, yeast)-like"""	TADA3L		9674425, 11707411	Standard	NM_006354		Approved	FLJ20221, FLJ21329, ADA3, hADA3, NGG1	uc010hcn.2	O75528	OTTHUMG00000128440	ENST00000301964.2:c.484T>A	3.37:g.9831273A>T	ENSP00000307684:p.Cys162Ser		Q6FI83|Q9UFS2	Missense_Mutation	SNP	p.C162S	ENST00000301964.2	37	CCDS2583.1	deleterious(0.715)	.	.	.	.	.	.	.	.	.	.	A	21.3	4.126785	0.77549	.	.	ENSG00000171148	ENST00000301964;ENST00000440161;ENST00000343450	.	.	.	5.5	5.5	0.81552	.	0.085998	0.85682	D	0.000000	T	0.63189	0.2490	M	0.79475	2.455	0.80722	D	1	P	0.49635	0.926	P	0.44597	0.454	T	0.67237	-0.5721	9	0.40728	T	0.16	-29.5808	15.5911	0.76530	1.0:0.0:0.0:0.0	.	162	O75528	TADA3_HUMAN	S	162	.	ENSP00000307684:C162S	C	-	1	0	TADA3	9806273	1.000000	0.71417	1.000000	0.80357	0.988000	0.76386	8.811000	0.91954	2.090000	0.63153	0.533000	0.62120	TGT	NULL		0.597	TADA3-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000250236.1	79	0%	possibly_damaging(0.819)		74	50%		deleterious(0.01)	-1	NM_006354.2	reviewed	62	46.8%	1.000
TRAK1	22906	genome.wustl.edu	37	3	42264472	42264472	+	Missense_Mutation	SNP	G	G	A			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr3:42264472G>A	ENST00000327628.5	+	16	2505	c.2105G>A	c.(2104-2106)aGc>aAc	p.S702N	RNU4-78P_ENST00000410940.1_RNA|TRAK1_ENST00000396175.1_Missense_Mutation_p.S644N|TRAK1_ENST00000487159.1_3'UTR	NM_001042646.2	NP_001036111.1	Q9UPV9	TRAK1_HUMAN	trafficking protein, kinesin binding 1	702					endosome to lysosome transport (GO:0008333)|protein O-linked glycosylation (GO:0006493)|protein targeting (GO:0006605)|regulation of transcription from RNA polymerase II promoter (GO:0006357)	cytoplasm (GO:0005737)|early endosome (GO:0005769)|mitochondrion (GO:0005739)|nucleus (GO:0005634)		p.S681N(1)|p.S644N(1)		central_nervous_system(2)|endometrium(1)|kidney(2)|large_intestine(8)|lung(6)|ovary(1)|upper_aerodigestive_tract(2)	22						GGCAGCACCAGCCACTTGAAA	0.552																																					GBM(44;195 884 22595 31865 41850)											2	Substitution - Missense(2)	endometrium(2)											54.0	66.0	62.0					3																	42264472		2046	4199	6245	SO:0001583	missense	22906				CCDS2695.1, CCDS43072.1, CCDS58826.1, CCDS74922.1	3p22.1	2012-03-05			ENSG00000182606	ENSG00000182606			29947	protein-coding gene	gene with protein product	"""OGT(O Glc NAc transferase) interacting protein 106 KDa"", ""O-linked N-acetylglucosamine transferase interacting protein 106"", ""milton homolog 1 (Drosophila)"""	608112				10470851, 12435728, 16380713, 20230862	Standard	NM_014965		Approved	OIP106, KIAA1042, MILT1	uc003cky.4	Q9UPV9	OTTHUMG00000131795	ENST00000327628.5:c.2105G>A	3.37:g.42264472G>A	ENSP00000328998:p.Ser702Asn		E9PDS2|J3KNT7|Q63HR0|Q659B5|Q96B69	Missense_Mutation	SNP	p.S702N	ENST00000327628.5	37	CCDS43072.1	neutral(0.253)	.	.	.	.	.	.	.	.	.	.	G	13.36	2.214149	0.39102	.	.	ENSG00000182606	ENST00000327628;ENST00000543338;ENST00000396175	T;T	0.10288	2.91;2.89	5.36	5.36	0.76844	.	0.219775	0.45867	D	0.000324	T	0.08537	0.0212	N	0.22421	0.69	0.80722	D	1	B;B	0.06786	0.001;0.001	B;B	0.12156	0.004;0.007	T	0.14448	-1.0472	10	0.46703	T	0.11	.	11.5312	0.50612	0.0818:0.0:0.9182:0.0	.	644;702	C9JC32;Q9UPV9	.;TRAK1_HUMAN	N	702;681;644	ENSP00000328998:S702N;ENSP00000379478:S644N	ENSP00000328998:S702N	S	+	2	0	TRAK1	42239476	1.000000	0.71417	0.973000	0.42090	0.669000	0.39330	4.192000	0.58378	2.521000	0.84997	0.591000	0.81541	AGC	NULL		0.552	TRAK1-004	PUTATIVE	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000343413.1	98	1%	benign(0.005)	NM_014965	33	69.6%		tolerated(0.13)	+1	NM_001042646.1	validated	123	43.1%	0.998
SLITRK3	22865	genome.wustl.edu	37	3	164907829	164907829	+	Missense_Mutation	SNP	G	G	T			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr3:164907829G>T	ENST00000475390.1	-	2	1233	c.790C>A	c.(790-792)Cct>Act	p.P264T	SLITRK3_ENST00000241274.3_Missense_Mutation_p.P264T			O94933	SLIK3_HUMAN	SLIT and NTRK-like family, member 3	264	LRRCT 1.				axonogenesis (GO:0007409)	integral component of membrane (GO:0016021)		p.P264T(1)		NS(1)|breast(2)|central_nervous_system(1)|cervix(1)|endometrium(8)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(14)|lung(66)|ovary(6)|pancreas(1)|prostate(4)|skin(5)|upper_aerodigestive_tract(5)	119						AAGTGGAAAGGGGTCTCACAG	0.468										HNSCC(40;0.11)																																						1	Substitution - Missense(1)	endometrium(1)											127.0	131.0	129.0					3																	164907829		2203	4300	6503	SO:0001583	missense	22865			AB020655	CCDS3197.1	3q26.1	2004-07-28			ENSG00000121871	ENSG00000121871			23501	protein-coding gene	gene with protein product		609679				10048485, 14557068	Standard	NM_014926		Approved	KIAA0848	uc003fek.3	O94933	OTTHUMG00000158072	ENST00000475390.1:c.790C>A	3.37:g.164907829G>T	ENSP00000420091:p.Pro264Thr		Q1RMY6	Missense_Mutation	SNP	p.P264T	ENST00000475390.1	37	CCDS3197.1	deleterious(0.945)	.	.	.	.	.	.	.	.	.	.	G	15.79	2.938647	0.52972	.	.	ENSG00000121871	ENST00000475390;ENST00000241274	T;T	0.70631	-0.5;-0.5	5.85	4.97	0.65823	Cysteine-rich flanking region, C-terminal (1);	0.000000	0.37483	N	0.002077	D	0.90215	0.6941	H	0.98068	4.14	0.58432	D	0.999999	D	0.89917	1.0	D	0.80764	0.994	D	0.94114	0.7373	10	0.87932	D	0	-12.7497	16.9653	0.86284	0.0:0.1278:0.8722:0.0	.	264	O94933	SLIK3_HUMAN	T	264	ENSP00000420091:P264T;ENSP00000241274:P264T	ENSP00000241274:P264T	P	-	1	0	SLITRK3	166390523	1.000000	0.71417	0.995000	0.50966	0.819000	0.46315	9.869000	0.99810	1.460000	0.47911	-0.175000	0.13238	CCT	HMMSmart_LRRCT,superfamily_SSF52058		0.468	SLITRK3-002	KNOWN	alternative_5_UTR|basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000350126.1	109	0%	probably_damaging(1)	NM_014926	0	-		deleterious(0)	-1	NM_014926.2	validated	112	41.1%	1.000
PIK3CA	5290	genome.wustl.edu	37	3	178936082	178936082	+	Missense_Mutation	SNP	G	G	A	rs121913273		TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr3:178936082G>A	ENST00000263967.3	+	10	1781	c.1624G>A	c.(1624-1626)Gaa>Aaa	p.E542K		NM_006218.2	NP_006209.2	P42336	PK3CA_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha	542	PIK helical. {ECO:0000255|PROSITE- ProRule:PRU00878}.		E -> K (in CLOVE, KERSEB, CRC and BC; also found in glioblastoma multiforme and endometrial carcinoma; shows an increase in lipid kinase activity; oncogenic in vivo; occurs in the interface between the PI3K helical domain and the nSH2 (N- terminal SH2) region of the p85 regulatory subunit and may reduce the inhibitory effect of p85; requires interaction with RAS to induce cellular transformation). {ECO:0000269|PubMed:15289301, ECO:0000269|PubMed:15784156, ECO:0000269|PubMed:15924253, ECO:0000269|PubMed:15994075, ECO:0000269|PubMed:16322209, ECO:0000269|PubMed:16353168, ECO:0000269|PubMed:16533766, ECO:0000269|PubMed:17673550, ECO:0000269|PubMed:22658544}.|E -> Q (found in an endometrial carcinoma sample; unknown pathological significance). {ECO:0000269|PubMed:16322209}.|E -> V (in BC; unknown pathological significance). {ECO:0000269|PubMed:16353168}.		angiogenesis (GO:0001525)|blood coagulation (GO:0007596)|cardiac muscle contraction (GO:0060048)|endothelial cell migration (GO:0043542)|epidermal growth factor receptor signaling pathway (GO:0007173)|Fc-epsilon receptor signaling pathway (GO:0038095)|Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096)|fibroblast growth factor receptor signaling pathway (GO:0008543)|glucose metabolic process (GO:0006006)|hypomethylation of CpG island (GO:0044029)|innate immune response (GO:0045087)|insulin receptor signaling pathway (GO:0008286)|insulin receptor signaling pathway via phosphatidylinositol 3-kinase (GO:0038028)|leukocyte migration (GO:0050900)|negative regulation of anoikis (GO:2000811)|negative regulation of fibroblast apoptotic process (GO:2000270)|negative regulation of neuron apoptotic process (GO:0043524)|neurotrophin TRK receptor signaling pathway (GO:0048011)|phosphatidylinositol biosynthetic process (GO:0006661)|phosphatidylinositol phosphorylation (GO:0046854)|phosphatidylinositol-mediated signaling (GO:0048015)|phospholipid metabolic process (GO:0006644)|platelet activation (GO:0030168)|positive regulation of peptidyl-serine phosphorylation (GO:0033138)|protein kinase B signaling (GO:0043491)|regulation of genetic imprinting (GO:2000653)|regulation of multicellular organism growth (GO:0040014)|small molecule metabolic process (GO:0044281)|T cell costimulation (GO:0031295)|T cell receptor signaling pathway (GO:0050852)|vasculature development (GO:0001944)	1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex (GO:0005943)|cytosol (GO:0005829)|lamellipodium (GO:0030027)|phosphatidylinositol 3-kinase complex (GO:0005942)|plasma membrane (GO:0005886)	1-phosphatidylinositol-3-kinase activity (GO:0016303)|1-phosphatidylinositol-4-phosphate 3-kinase activity (GO:0035005)|ATP binding (GO:0005524)|kinase activity (GO:0016301)|phosphatidylinositol 3-kinase activity (GO:0035004)|phosphatidylinositol-4,5-bisphosphate 3-kinase activity (GO:0046934)|protein kinase activator activity (GO:0030295)|protein serine/threonine kinase activity (GO:0004674)	p.E542K(545)|p.E542Q(10)		NS(16)|autonomic_ganglia(4)|biliary_tract(22)|bone(1)|breast(2150)|central_nervous_system(110)|cervix(33)|endometrium(473)|eye(1)|haematopoietic_and_lymphoid_tissue(35)|kidney(14)|large_intestine(1202)|liver(42)|lung(202)|meninges(1)|oesophagus(28)|ovary(235)|pancreas(17)|penis(8)|pituitary(12)|prostate(10)|skin(155)|small_intestine(1)|soft_tissue(18)|stomach(121)|thyroid(80)|upper_aerodigestive_tract(70)|urinary_tract(208)	5269	all_cancers(143;1.19e-17)|Ovarian(172;0.00769)|Breast(254;0.155)		OV - Ovarian serous cystadenocarcinoma(80;9.59e-28)|GBM - Glioblastoma multiforme(14;0.003)|BRCA - Breast invasive adenocarcinoma(182;0.0282)		Caffeine(DB00201)	TCCTCTCTCTGAAATCACTGA	0.333	E542K(BT483_BREAST)|E542K(CAL51_BREAST)|E542K(HGC27_STOMACH)|E542K(IM95_STOMACH)|E542K(JHUEM1_ENDOMETRIUM)|E542K(NCIH1341_LUNG)|E542K(SW948_LARGE_INTESTINE)|E542K(T84_LARGE_INTESTINE)|E542K(VMCUB1_URINARY_TRACT)	57	Mis		"""colorectal, gastric, gliobastoma, breast"""					HNSCC(19;0.045)|TSP Lung(28;0.18)																											Colon(199;1504 1750 3362 26421 31210 32040)		Dom	yes		3	3q26.3	5290	"""phosphoinositide-3-kinase, catalytic, alpha polypeptide"""		"""E, O"""	555	Substitution - Missense(555)	breast(176)|large_intestine(166)|urinary_tract(45)|endometrium(37)|skin(19)|lung(18)|stomach(16)|ovary(16)|thyroid(14)|upper_aerodigestive_tract(9)|central_nervous_system(7)|cervix(6)|liver(6)|oesophagus(5)|penis(4)|kidney(3)|soft_tissue(2)|haematopoietic_and_lymphoid_tissue(2)|prostate(2)|biliary_tract(1)|pituitary(1)											56.0	56.0	56.0					3																	178936082		1809	4069	5878	SO:0001583	missense	5290				CCDS43171.1	3q26.3	2014-09-17	2012-07-13		ENSG00000121879	ENSG00000121879	2.7.1.153		8975	protein-coding gene	gene with protein product		171834	"""phosphoinositide-3-kinase, catalytic, alpha polypeptide"""			1322797	Standard	NM_006218		Approved	PI3K	uc003fjk.3	P42336	OTTHUMG00000157311	ENST00000263967.3:c.1624G>A	3.37:g.178936082G>A	ENSP00000263967:p.Glu542Lys		Q14CW1|Q99762	Missense_Mutation	SNP	p.E542K	ENST00000263967.3	37	CCDS43171.1	deleterious(0.804)	.	.	.	.	.	.	.	.	.	.	G	34	5.360420	0.95877	.	.	ENSG00000121879	ENST00000263967	T	0.62105	0.05	5.78	5.78	0.91487	Phosphoinositide 3-kinase, accessory (PIK) domain (3);Armadillo-type fold (1);	0.000000	0.85682	D	0.000000	T	0.69287	0.3094	L	0.41356	1.27	0.80722	D	1	D	0.65815	0.995	D	0.63192	0.912	T	0.60296	-0.7291	10	0.09843	T	0.71	-23.9623	20.0024	0.97423	0.0:0.0:1.0:0.0	.	542	P42336	PK3CA_HUMAN	K	542	ENSP00000263967:E542K	ENSP00000263967:E542K	E	+	1	0	PIK3CA	180418776	1.000000	0.71417	1.000000	0.80357	0.978000	0.69477	9.476000	0.97823	2.722000	0.93159	0.467000	0.42956	GAA	HMMPfam_PI3Ka,HMMSmart_PI3Ka,superfamily_ARM-type_fold		0.333	PIK3CA-001	KNOWN	basic|appris_principal|exp_conf|CCDS	protein_coding	protein_coding	OTTHUMT00000348409.2	215	0.5%	probably_damaging(0.989)		2	100%		deleterious(0.03)	+1	NM_006218.2	reviewed	133	71.4%	1.000
NAA15	80155	genome.wustl.edu	37	4	140300008	140300008	+	Splice_Site	DEL	G	G	-			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr4:140300008delG	ENST00000296543.5	+	17	2478	c.2155delG	c.(2155-2157)gca>ca	p.A719fs	NAA15_ENST00000398947.1_Splice_Site_p.V719fs	NM_057175.3	NP_476516.1	Q9BXJ9	NAA15_HUMAN	N(alpha)-acetyltransferase 15, NatA auxiliary subunit	719	Interaction with HYPK.				angiogenesis (GO:0001525)|cell differentiation (GO:0030154)|N-terminal protein amino acid acetylation (GO:0006474)|negative regulation of apoptotic process (GO:0043066)|positive regulation of transcription, DNA-templated (GO:0045893)|protein stabilization (GO:0050821)|transcription, DNA-templated (GO:0006351)	cytoplasm (GO:0005737)|membrane (GO:0016020)|NatA complex (GO:0031415)|nucleus (GO:0005634)|transcription factor complex (GO:0005667)	N-acetyltransferase activity (GO:0008080)|poly(A) RNA binding (GO:0044822)|ribosome binding (GO:0043022)			NS(1)|endometrium(3)|large_intestine(7)|liver(2)|lung(8)|ovary(1)|prostate(2)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(2)	29						CTTTAATACTGGTATGTTTTT	0.333																																																0													164.0	142.0	149.0					4																	140300008		1856	4101	5957	SO:0001630	splice_region_variant	80155			AY039242	CCDS43270.1	4q31.1	2010-01-14	2010-01-14	2010-01-14	ENSG00000164134	ENSG00000164134		"""N(alpha)-acetyltransferase subunits"""	30782	protein-coding gene	gene with protein product		608000	"""NMDA receptor regulated 1"""	NARG1		12140756, 11478804, 19660095	Standard	XM_005263236		Approved	TBDN100, NATH, FLJ13340	uc003ihu.1	Q9BXJ9	OTTHUMG00000137363	ENST00000296543.5:c.2155+1G>-	4.37:g.140300008delG			D3DNY6|Q52LG9|Q8IWH4|Q8NEV2|Q9H8P6	Frame_Shift_Del	DEL	p.A719fs	ENST00000296543.5	37	CCDS43270.1	-																																																																																			NULL		0.333	NAA15-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding	protein_coding	OTTHUMT00000267839.2	-	-	-	NM_057175	-	-	Frame_Shift_Del	-	+1	NM_057175.3	validated	-	-	1.000
CTXN3	613212	genome.wustl.edu	37	5	126993261	126993261	+	Missense_Mutation	SNP	C	C	A	rs375454212|rs386692235		TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr5:126993261C>A	ENST00000379445.3	+	3	599	c.48C>A	c.(46-48)aaC>aaA	p.N16K	CTC-548H10.2_ENST00000512352.1_RNA|CTXN3_ENST00000395322.3_Missense_Mutation_p.N16K	NM_001048252.2	NP_001041717.1	Q4LDR2	CTXN3_HUMAN	cortexin 3	16						integral component of membrane (GO:0016021)		p.N16K(1)		endometrium(1)|large_intestine(2)|lung(1)	4		Prostate(80;0.165)	KIRC - Kidney renal clear cell carcinoma(527;0.0268)|Kidney(363;0.0488)	Epithelial(69;0.0128)|COAD - Colon adenocarcinoma(49;0.0234)|OV - Ovarian serous cystadenocarcinoma(64;0.038)		CCCTTGGGAACGAATCAGCAG	0.478																																																1	Substitution - Missense(1)	endometrium(1)											125.0	109.0	114.0					5																	126993261		2203	4300	6503	SO:0001583	missense	613212			AB219764	CCDS34221.1	5q23.2	2006-09-21				ENSG00000205279			31110	protein-coding gene	gene with protein product							Standard	NM_001048252		Approved		uc003kum.4	Q4LDR2		ENST00000379445.3:c.48C>A	5.37:g.126993261C>A	ENSP00000368758:p.Asn16Lys		B2RV32|D3DQ82	Missense_Mutation	SNP	p.N16K	ENST00000379445.3	37	CCDS34221.1	deleterious(0.505)	.	.	.	.	.	.	.	.	.	.	C	11.94	1.788346	0.31593	.	.	ENSG00000205279	ENST00000379445;ENST00000395322	T;T	0.30981	1.51;1.51	4.52	-2.34	0.06704	.	0.154234	0.56097	D	0.000027	T	0.20129	0.0484	.	.	.	0.20975	N	0.999816	B	0.21606	0.058	B	0.22880	0.042	T	0.15578	-1.0432	9	0.42905	T	0.14	-0.7023	11.2494	0.49017	0.0:0.4312:0.0:0.5688	.	16	Q4LDR2	CTXN3_HUMAN	K	16	ENSP00000368758:N16K;ENSP00000378732:N16K	ENSP00000368758:N16K	N	+	3	2	CTXN3	127021160	0.001000	0.12720	0.005000	0.12908	0.033000	0.12548	-0.394000	0.07296	-0.552000	0.06167	0.655000	0.94253	AAC	NULL		0.478	CTXN3-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000372467.1	125	0%	possibly_damaging(0.661)	XM_932841	0	-		tolerated(0.11)	+1	NM_001048252.2	validated	140	47.9%	0.001
PCDHGA4	56111	genome.wustl.edu	37	5	140735922	140735922	+	Silent	SNP	T	T	C			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	T	T					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr5:140735922T>C	ENST00000571252.1	+	1	1155	c.1155T>C	c.(1153-1155)tcT>tcC	p.S385S	PCDHGA3_ENST00000253812.6_Intron|PCDHGA1_ENST00000517417.1_Intron|PCDHGA2_ENST00000394576.2_Intron|PCDHGB1_ENST00000523390.1_Intron	NM_018917.2	NP_061740	Q9Y5G9	PCDG4_HUMAN	protocadherin gamma subfamily A, 4	385	Cadherin 4. {ECO:0000255|PROSITE- ProRule:PRU00043}.				homophilic cell adhesion (GO:0007156)|spermatogenesis (GO:0007283)	integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	calcium ion binding (GO:0005509)			endometrium(1)|kidney(1)|lung(3)	5			KIRC - Kidney renal clear cell carcinoma(527;0.00112)|Kidney(363;0.00191)			tcacatgttctattccagata	0.433																																																0													32.0	31.0	31.0					5																	140735922		1906	4049	5955	SO:0001819	synonymous_variant	56111			AF152511	CCDS58979.1, CCDS58979.2, CCDS75331.1	5q31	2010-01-26						"""Cadherins / Protocadherins : Clustered"""	8702	other	protocadherin		606291				10380929	Standard	NM_018917		Approved	PCDH-GAMMA-A4		Q9Y5G9		ENST00000571252.1:c.1155T>C	5.37:g.140735922T>C			Q9Y5D3	Silent	SNP	p.S385	ENST00000571252.1	37	CCDS58979.1	-																																																																																			HMMPfam_Cadherin,HMMSmart_SM00112,superfamily_Cadherin-like		0.433	PCDHGA4-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000437959.1	74	0%	-	NM_018917	0	-		-	+1	NM_018917.2	reviewed	72	27.8%	0.374
C5orf45	51149	genome.wustl.edu	37	5	179280247	179280247	+	Intron	SNP	C	C	T			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr5:179280247C>T	ENST00000292586.6	-	2	217				C5orf45_ENST00000521333.1_Intron|C5orf45_ENST00000518235.1_Intron|C5orf45_ENST00000523084.1_Intron|C5orf45_ENST00000376931.2_Intron|C5orf45_ENST00000403396.2_Missense_Mutation_p.E68K|C5orf45_ENST00000520698.1_Intron|C5orf45_ENST00000518219.1_Intron	NM_016175.3	NP_057259.2	Q6NTE8	CE045_HUMAN	chromosome 5 open reading frame 45											breast(2)|endometrium(2)|large_intestine(2)|lung(4)|ovary(1)|prostate(1)	12						ACAGGAAGCTCGGAAGCAGGA	0.522																																																0																																										SO:0001627	intron_variant	51149				CCDS34318.1, CCDS34319.1	5q35.3	2008-07-10			ENSG00000161010	ENSG00000161010			30817	protein-coding gene	gene with protein product	"""truncated calcium binding protein"""						Standard	NM_016175		Approved	MGC65027, MGC78537, DKFZp686L2452, LOC51149	uc003mla.3	Q6NTE8	OTTHUMG00000163490	ENST00000292586.6:c.126+130G>A	5.37:g.179280247C>T			B5MD09|E9PAK6|Q7Z3D8|Q9BUC1|Q9UN54	Missense_Mutation	SNP	p.E68K	ENST00000292586.6	37	CCDS34319.1	-	.	.	.	.	.	.	.	.	.	.	C	8.435	0.849572	0.17034	.	.	ENSG00000161010	ENST00000403396	T	0.28255	1.62	3.26	-6.52	0.01872	.	.	.	.	.	T	0.15176	0.0366	.	.	.	0.09310	N	1	B	0.18461	0.028	B	0.08055	0.003	T	0.29181	-1.0020	8	0.87932	D	0	.	0.4788	0.00544	0.225:0.3209:0.1971:0.257	.	68	Q6NTE8-2	.	K	68	ENSP00000384599:E68K	ENSP00000384599:E68K	E	-	1	0	C5orf45	179212853	0.000000	0.05858	0.000000	0.03702	0.000000	0.00434	0.046000	0.14035	-1.607000	0.01589	-0.868000	0.02995	GAG	NULL		0.522	C5orf45-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding	protein_coding	OTTHUMT00000373760.2	23	0%	unknown(0)	NM_016175	0	-		-	-1	ENST00000403396	known	25	24%	0.000
RIMS1	22999	genome.wustl.edu	37	6	73108753	73108753	+	Missense_Mutation	SNP	A	A	T			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	A	A					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr6:73108753A>T	ENST00000521978.1	+	33	4817	c.4817A>T	c.(4816-4818)cAg>cTg	p.Q1606L	RIMS1_ENST00000425662.2_Missense_Mutation_p.Q674L|RIMS1_ENST00000517827.1_Missense_Mutation_p.Q740L|RIMS1_ENST00000401910.3_Missense_Mutation_p.Q926L|RIMS1_ENST00000522291.1_Missense_Mutation_p.Q1205L|RIMS1_ENST00000491071.2_Missense_Mutation_p.Q1395L|RIMS1_ENST00000517960.1_Missense_Mutation_p.Q1389L|RIMS1_ENST00000523963.1_Missense_Mutation_p.Q731L|RIMS1_ENST00000431478.2_3'UTR|RIMS1_ENST00000520567.1_Missense_Mutation_p.Q1256L|RIMS1_ENST00000538414.1_Missense_Mutation_p.Q412L|RIMS1_ENST00000348717.5_Missense_Mutation_p.Q1389L|RIMS1_ENST00000264839.7_Missense_Mutation_p.Q1455L|RIMS1_ENST00000518273.1_Missense_Mutation_p.Q1285L|RIMS1_ENST00000414192.2_Missense_Mutation_p.Q133L	NM_014989.5	NP_055804.2	Q86UR5	RIMS1_HUMAN	regulating synaptic membrane exocytosis 1	1606	C2 2. {ECO:0000255|PROSITE- ProRule:PRU00041}.			Q -> R (in Ref. 4; BAH11906). {ECO:0000305}.	calcium ion-dependent exocytosis (GO:0017156)|calcium ion-dependent exocytosis of neurotransmitter (GO:0048791)|glutamate secretion (GO:0014047)|intracellular protein transport (GO:0006886)|membrane fusion (GO:0061025)|neurotransmitter secretion (GO:0007269)|positive regulation of excitatory postsynaptic membrane potential (GO:2000463)|positive regulation of gene expression (GO:0010628)|positive regulation of inhibitory postsynaptic membrane potential (GO:0097151)|protein complex assembly (GO:0006461)|regulated secretory pathway (GO:0045055)|regulation of catalytic activity (GO:0050790)|regulation of long-term neuronal synaptic plasticity (GO:0048169)|regulation of neurotransmitter secretion (GO:0046928)|response to stimulus (GO:0050896)|secretion (GO:0046903)|synaptic transmission (GO:0007268)|synaptic vesicle exocytosis (GO:0016079)|visual perception (GO:0007601)	cell junction (GO:0030054)|plasma membrane (GO:0005886)|presynaptic active zone (GO:0048786)|presynaptic membrane (GO:0042734)	metal ion binding (GO:0046872)|poly(A) RNA binding (GO:0044822)|Rab GTPase binding (GO:0017137)|small GTPase regulator activity (GO:0005083)	p.Q1606L(1)		NS(1)|breast(2)|central_nervous_system(1)|endometrium(5)|haematopoietic_and_lymphoid_tissue(2)|kidney(5)|large_intestine(25)|liver(4)|lung(35)|ovary(9)|pancreas(3)|prostate(2)|skin(2)|stomach(1)|upper_aerodigestive_tract(4)|urinary_tract(1)	102		all_epithelial(107;0.179)|all_hematologic(105;0.212)				TTGTATCAGCAGTCTCTGGTT	0.378																																																1	Substitution - Missense(1)	endometrium(1)											124.0	122.0	123.0					6																	73108753		1832	4083	5915	SO:0001583	missense	22999			AB002338	CCDS47449.1, CCDS55029.1, CCDS55030.1, CCDS55031.1, CCDS55032.1, CCDS55033.1	6q12-q13	2008-10-16	2002-06-12	2002-06-14	ENSG00000079841	ENSG00000079841			17282	protein-coding gene	gene with protein product	"""Rab3-interacting molecule"""	606629	"""RAB3 interacting protein 2"""	RAB3IP2, CORD7		9205841, 11438518	Standard	NM_001168407		Approved	RIM, KIAA0340, RIM1	uc003pga.4	Q86UR5	OTTHUMG00000015009	ENST00000521978.1:c.4817A>T	6.37:g.73108753A>T	ENSP00000428417:p.Gln1606Leu		A7MBN6|B7Z2M0|B7Z2Q9|B7Z3S3|B7Z6S2|E7EX08|E9PCB7|E9PCZ1|E9PF48|E9PHF5|E9PHR1|O15048|Q5JY21|Q5JY25|Q5SZK1|Q8TDY9|Q8TDZ5|Q9HBA1|Q9HBA2|Q9HBA3|Q9HBA4|Q9HBA5|Q9HBA6	Missense_Mutation	SNP	p.Q1606L	ENST00000521978.1	37	CCDS47449.1	deleterious(0.859)	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	A|A	29.1|29.1	4.973448|4.973448	0.92919|0.92919	.|.	.|.	ENSG00000079841|ENSG00000079841	ENST00000491071;ENST00000350827;ENST00000352008;ENST00000348717;ENST00000349908;ENST00000346609;ENST00000264839;ENST00000517960;ENST00000518273;ENST00000520567;ENST00000522291;ENST00000521978;ENST00000401910;ENST00000523963;ENST00000425662;ENST00000517827;ENST00000370420;ENST00000538414;ENST00000414192|ENST00000522211	T;T;T;T;T;T;T;T;T;T;T;T;T;T;T|.	0.70399|.	-0.48;-0.48;-0.48;-0.48;-0.48;-0.48;-0.48;-0.48;-0.48;-0.48;-0.48;-0.48;-0.48;-0.48;-0.48|.	5.37|5.37	5.37|5.37	0.77165|0.77165	C2 membrane targeting protein (1);C2 calcium-dependent membrane targeting (2);C2 calcium/lipid-binding domain, CaLB (1);|.	0.000000|.	0.64402|.	D|.	0.000012|.	D|D	0.86091|0.86091	0.5850|0.5850	H|H	0.97186|0.97186	3.955|3.955	0.80722|0.80722	D|D	1|1	D;D;D;D;D;D;D;D;D;D;D;D;D|.	0.89917|.	0.977;0.992;0.981;0.998;0.965;1.0;0.982;0.999;0.965;0.982;0.959;0.987;0.983|.	P;D;D;D;P;D;P;D;P;P;D;D;D|.	0.77557|.	0.8;0.941;0.98;0.918;0.812;0.99;0.837;0.969;0.812;0.885;0.92;0.953;0.945|.	D|D	0.90944|0.90944	0.4800|0.4800	10|5	0.87932|.	D|.	0|.	-21.8769|-21.8769	15.6481|15.6481	0.77070|0.77070	1.0:0.0:0.0:0.0|1.0:0.0:0.0:0.0	.|.	230;412;740;731;1455;926;1205;509;1285;1389;682;1395;1606|.	B7Z6K9;B7Z7W2;B7Z3S3;E9PHF5;E9PHR1;E9PF48;E7EX08;Q5JY22;E7ERQ1;E7ENC2;Q5JY21;C9JNW6;Q86UR5|.	.;.;.;.;.;.;.;.;.;.;.;.;RIMS1_HUMAN|.	L|C	1395;1455;1395;1389;1285;1205;1455;1389;1285;1256;1205;1606;926;731;674;740;654;412;133|524	ENSP00000430101:Q1395L;ENSP00000275037:Q1389L;ENSP00000264839:Q1455L;ENSP00000429959:Q1389L;ENSP00000430408:Q1285L;ENSP00000430502:Q1256L;ENSP00000430932:Q1205L;ENSP00000428417:Q1606L;ENSP00000385649:Q926L;ENSP00000428328:Q731L;ENSP00000411235:Q674L;ENSP00000428367:Q740L;ENSP00000359448:Q654L;ENSP00000439730:Q412L;ENSP00000402273:Q133L|.	ENSP00000264839:Q1455L|.	Q|S	+|+	2|1	0|0	RIMS1|RIMS1	73165474|73165474	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.981000|0.981000	0.71138|0.71138	9.212000|9.212000	0.95126|0.95126	2.149000|2.149000	0.67028|0.67028	0.533000|0.533000	0.62120|0.62120	CAG|AGT	HMMPfam_C2,HMMSmart_SM00239,superfamily_C2 domain (Calcium/lipid-binding domain CaLB)		0.378	RIMS1-011	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000374968.1	363	0%	probably_damaging(0.972)		0	-		deleterious(0)	+1	NM_014989.4	reviewed	325	46.8%	1.000
EPB41L2	2037	genome.wustl.edu	37	6	131191021	131191021	+	Silent	SNP	G	G	A			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr6:131191021G>A	ENST00000337057.3	-	15	2470	c.2289C>T	c.(2287-2289)acC>acT	p.T763T	EPB41L2_ENST00000528282.1_Intron|EPB41L2_ENST00000525271.1_Intron|EPB41L2_ENST00000530757.1_Intron|EPB41L2_ENST00000527411.1_Silent_p.T693T|EPB41L2_ENST00000530481.1_Silent_p.T693T|EPB41L2_ENST00000527659.1_Silent_p.T693T|EPB41L2_ENST00000445890.2_Intron|EPB41L2_ENST00000368128.2_Silent_p.T763T|EPB41L2_ENST00000531410.1_Intron|EPB41L2_ENST00000524581.1_Silent_p.T141T|EPB41L2_ENST00000529208.1_Silent_p.T693T|EPB41L2_ENST00000392427.3_Intron|EPB41L2_ENST00000525193.1_Intron	NM_001431.3	NP_001422.1	O43491	E41L2_HUMAN	erythrocyte membrane protein band 4.1-like 2	763					cortical actin cytoskeleton organization (GO:0030866)	extracellular vesicular exosome (GO:0070062)|extrinsic component of membrane (GO:0019898)|focal adhesion (GO:0005925)|plasma membrane (GO:0005886)|spectrin (GO:0008091)	structural molecule activity (GO:0005198)	p.T763T(1)		autonomic_ganglia(1)|central_nervous_system(1)|endometrium(7)|kidney(2)|large_intestine(7)|lung(23)|prostate(1)|skin(2)	44	Breast(56;0.0639)			OV - Ovarian serous cystadenocarcinoma(155;0.0271)|GBM - Glioblastoma multiforme(226;0.0355)		TGGTGCCCTCGGTCACTCGGT	0.592																																																1	Substitution - coding silent(1)	endometrium(1)											127.0	117.0	120.0					6																	131191021		2203	4300	6503	SO:0001819	synonymous_variant	2037			AF027299	CCDS5141.1, CCDS47474.1, CCDS56450.1, CCDS59037.1	6q23	2008-08-29			ENSG00000079819	ENSG00000079819			3379	protein-coding gene	gene with protein product		603237				9598318, 9828140	Standard	NM_001431		Approved	4.1-G	uc003qch.2	O43491	OTTHUMG00000015560	ENST00000337057.3:c.2289C>T	6.37:g.131191021G>A			B4DHI8|E9PPD9|Q5T4F0|Q68DV2	Silent	SNP	p.T763	ENST00000337057.3	37	CCDS5141.1	-	.	.	.	.	.	.	.	.	.	.	G	5.655	0.305556	0.10678	.	.	ENSG00000079819	ENST00000456097	.	.	.	5.6	-5.83	0.02325	.	.	.	.	.	.	.	.	.	.	.	0.09310	N	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	4.1354	0.10169	0.4218:0.3499:0.1399:0.0884	.	.	.	.	X	306	.	.	R	-	1	2	EPB41L2	131232714	0.031000	0.19500	0.095000	0.20976	0.970000	0.65996	-0.090000	0.11163	-0.844000	0.04184	0.462000	0.41574	CGA	NULL		0.592	EPB41L2-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000042204.3	148	0%	-		128	38.2%		-	-1	NM_001431.3	validated	187	38.5%	0.000
TAAR6	319100	genome.wustl.edu	37	6	132891535	132891535	+	Missense_Mutation	SNP	C	C	G			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr6:132891535C>G	ENST00000275198.1	+	1	75	c.75C>G	c.(73-75)atC>atG	p.I25M		NM_175067.1	NP_778237.1	Q96RI8	TAAR6_HUMAN	trace amine associated receptor 6	25					G-protein coupled receptor signaling pathway (GO:0007186)	integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	G-protein coupled receptor activity (GO:0004930)|trace-amine receptor activity (GO:0001594)	p.I25M(1)		cervix(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(7)|liver(2)|lung(19)|ovary(2)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)	41	Breast(56;0.112)			OV - Ovarian serous cystadenocarcinoma(155;0.006)|GBM - Glioblastoma multiforme(226;0.00792)		GTGTGAAAATCCCCTTCTCGC	0.512																																																1	Substitution - Missense(1)	endometrium(1)											142.0	132.0	135.0					6																	132891535		2203	4300	6503	SO:0001583	missense	319100			AF380192	CCDS5155.1	6q23.1	2012-08-08	2005-02-23	2005-02-24	ENSG00000146383	ENSG00000146383		"""GPCR / Class A : Trace amine associated receptors"""	20978	protein-coding gene	gene with protein product		608923	"""trace amine receptor 4"""	TRAR4		11459929, 15718104	Standard	NM_175067		Approved	TA4	uc011eck.2	Q96RI8	OTTHUMG00000015579	ENST00000275198.1:c.75C>G	6.37:g.132891535C>G	ENSP00000275198:p.Ile25Met		Q5VUQ4	Missense_Mutation	SNP	p.I25M	ENST00000275198.1	37	CCDS5155.1	neutral(0.364)	.	.	.	.	.	.	.	.	.	.	C	10.09	1.255400	0.22965	.	.	ENSG00000146383	ENST00000275198;ENST00000539228	T	0.38560	1.13	4.88	-9.75	0.00506	.	0.403171	0.17831	N	0.160543	T	0.04861	0.0131	N	0.03608	-0.345	0.09310	N	1	B	0.02656	0.0	B	0.09377	0.004	T	0.28618	-1.0038	10	0.56958	D	0.05	0.8634	10.1706	0.42908	0.0:0.5199:0.271:0.2091	.	25	Q96RI8	TAAR6_HUMAN	M	25;8	ENSP00000275198:I25M	ENSP00000275198:I25M	I	+	3	3	TAAR6	132933228	0.000000	0.05858	0.000000	0.03702	0.002000	0.02628	-3.752000	0.00375	-2.731000	0.00384	-0.253000	0.11424	ATC	superfamily_SSF81321		0.512	TAAR6-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000042255.1	372	0%	benign(0)	NM_175067	0	-		deleterious(0.03)	+1	NM_175067.1	reviewed	412	41.3%	0.000
PDCD2	5134	genome.wustl.edu	37	6	170892198	170892198	+	Missense_Mutation	SNP	A	A	C			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	A	A					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr6:170892198A>C	ENST00000541970.1	-	3	683	c.605T>G	c.(604-606)aTt>aGt	p.I202S	PDCD2_ENST00000542896.1_Missense_Mutation_p.I202S|PDCD2_ENST00000443345.2_Missense_Mutation_p.I169S|PDCD2_ENST00000537445.1_Missense_Mutation_p.I169S|PDCD2_ENST00000453163.2_Missense_Mutation_p.I202S|PDCD2_ENST00000392090.2_Missense_Mutation_p.I169S	NM_001199462.1|NM_002598.3	NP_001186391.1|NP_002589.2	Q16342	PDCD2_HUMAN	programmed cell death 2	202					apoptotic process (GO:0006915)	cytoplasm (GO:0005737)|extracellular vesicular exosome (GO:0070062)|nucleus (GO:0005634)	DNA binding (GO:0003677)|enzyme binding (GO:0019899)|metal ion binding (GO:0046872)	p.I202S(1)		breast(1)|endometrium(2)|large_intestine(1)|lung(5)	9		Breast(66;5.08e-05)|Ovarian(120;0.125)|Esophageal squamous(34;0.246)		OV - Ovarian serous cystadenocarcinoma(33;6.91e-23)|BRCA - Breast invasive adenocarcinoma(81;4.82e-06)|GBM - Glioblastoma multiforme(31;0.142)		CTCAGGCATAATCTCATCTTC	0.363																																					Colon(60;1476 1726 39478)											1	Substitution - Missense(1)	endometrium(1)											129.0	127.0	128.0					6																	170892198		2203	4300	6503	SO:0001583	missense	5134			AJ420535	CCDS5316.1, CCDS47521.1, CCDS56460.1, CCDS56461.1, CCDS56462.1, CCDS75557.1	6q27	2008-02-05			ENSG00000071994	ENSG00000071994		"""Zinc fingers, MYND-type"""	8762	protein-coding gene	gene with protein product		600866				7606924	Standard	NM_002598		Approved	ZMYND7, RP8	uc003qxw.3	Q16342	OTTHUMG00000016083	ENST00000541970.1:c.605T>G	6.37:g.170892198A>C	ENSP00000439467:p.Ile202Ser		E9PCU7|F5GYS7|Q58HM9|Q58HN0|Q9UH12	Missense_Mutation	SNP	p.I202S	ENST00000541970.1	37	CCDS5316.1	neutral(0.002)	.	.	.	.	.	.	.	.	.	.	.	2.521	-0.310684	0.05458	.	.	ENSG00000071994	ENST00000541970;ENST00000392090;ENST00000542896;ENST00000453163;ENST00000537445;ENST00000443345	.	.	.	4.65	-3.11	0.05299	Programmed cell death protein 2, C-terminal (1);	1.465370	0.03792	N	0.263084	T	0.06508	0.0167	N	0.17082	0.46	0.09310	N	1	B;B;B;B;B;B;B	0.28933	0.146;0.228;0.146;0.146;0.013;0.002;0.007	B;B;B;B;B;B;B	0.30855	0.038;0.121;0.057;0.057;0.009;0.012;0.02	T	0.18209	-1.0344	8	.	.	.	-18.3197	1.9393	0.03343	0.3243:0.3416:0.2199:0.1142	.	151;169;202;169;202;202;169	Q7Z6S7;F5GYS7;E9PCU7;Q58HM9;F5H4V9;Q16342;Q58HN0	.;.;.;.;.;PDCD2_HUMAN;.	S	202;169;202;202;169;169	.	.	I	-	2	0	PDCD2	170734123	0.000000	0.05858	0.000000	0.03702	0.006000	0.05464	0.158000	0.16422	-0.146000	0.11274	0.455000	0.32223	ATT	HMMPfam_PDCD2_C		0.363	PDCD2-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000043269.2	433	0%	benign(0)	NM_002598	99	46.4%		tolerated(0.74)	-1	NM_002598.2	reviewed	463	44.3%	0.000
PDGFA	5154	genome.wustl.edu	37	7	540834	540834	+	Missense_Mutation	SNP	C	C	T			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr7:540834C>T	ENST00000354513.5	-	5	891	c.499G>A	c.(499-501)Gtc>Atc	p.V167I	PDGFA_ENST00000402802.3_Missense_Mutation_p.V167I	NM_002607.5	NP_002598.4	P04085	PDGFA_HUMAN	platelet-derived growth factor alpha polypeptide	167					actin cytoskeleton organization (GO:0030036)|angiogenesis (GO:0001525)|blood coagulation (GO:0007596)|cell activation (GO:0001775)|cell projection assembly (GO:0030031)|cell-cell signaling (GO:0007267)|embryo development (GO:0009790)|epidermal growth factor receptor signaling pathway (GO:0007173)|extracellular matrix organization (GO:0030198)|Fc-epsilon receptor signaling pathway (GO:0038095)|fibroblast growth factor receptor signaling pathway (GO:0008543)|hair follicle development (GO:0001942)|innate immune response (GO:0045087)|inner ear development (GO:0048839)|lung alveolus development (GO:0048286)|negative chemotaxis (GO:0050919)|negative regulation of phosphatidylinositol biosynthetic process (GO:0010512)|negative regulation of platelet activation (GO:0010544)|neurotrophin TRK receptor signaling pathway (GO:0048011)|organ morphogenesis (GO:0009887)|phosphatidylinositol-mediated signaling (GO:0048015)|platelet activation (GO:0030168)|platelet degranulation (GO:0002576)|platelet-derived growth factor receptor signaling pathway (GO:0048008)|positive regulation of cell division (GO:0051781)|positive regulation of cell migration (GO:0030335)|positive regulation of cell proliferation (GO:0008284)|positive regulation of DNA replication (GO:0045740)|positive regulation of ERK1 and ERK2 cascade (GO:0070374)|positive regulation of fibroblast proliferation (GO:0048146)|positive regulation of MAP kinase activity (GO:0043406)|positive regulation of MAPK cascade (GO:0043410)|positive regulation of mesenchymal cell proliferation (GO:0002053)|positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:0035793)|positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)|positive regulation of protein autophosphorylation (GO:0031954)|positive regulation of protein kinase B signaling (GO:0051897)|regulation of actin cytoskeleton organization (GO:0032956)|regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling (GO:0060683)|regulation of peptidyl-tyrosine phosphorylation (GO:0050730)|regulation of smooth muscle cell migration (GO:0014910)|response to drug (GO:0042493)|response to estradiol (GO:0032355)|response to hypoxia (GO:0001666)|response to inorganic substance (GO:0010035)|response to retinoic acid (GO:0032526)|response to wounding (GO:0009611)|skin development (GO:0043588)|transforming growth factor beta receptor signaling pathway (GO:0007179)|wound healing (GO:0042060)	cell surface (GO:0009986)|endoplasmic reticulum lumen (GO:0005788)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|Golgi membrane (GO:0000139)|microvillus (GO:0005902)|platelet alpha granule lumen (GO:0031093)	collagen binding (GO:0005518)|growth factor activity (GO:0008083)|platelet-derived growth factor binding (GO:0048407)|platelet-derived growth factor receptor binding (GO:0005161)|protein heterodimerization activity (GO:0046982)|protein homodimerization activity (GO:0042803)	p.V167I(2)		central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(1)|lung(8)|prostate(2)|skin(1)|upper_aerodigestive_tract(1)	16		Ovarian(82;0.0112)		UCEC - Uterine corpus endometrioid carcinoma (27;0.0178)|Epithelial(4;1.1e-17)|OV - Ovarian serous cystadenocarcinoma(56;1.7e-17)|all cancers(6;4.89e-15)		CTCACCTGGACTTCTTTTAAT	0.552																																																2	Substitution - Missense(2)	endometrium(2)											290.0	270.0	277.0					7																	540834		2203	4296	6499	SO:0001583	missense	5154				CCDS34578.1, CCDS47524.1	7p22	2008-07-18			ENSG00000197461	ENSG00000197461			8799	protein-coding gene	gene with protein product	"""PDGF A-chain"", ""platelet-derived growth factor alpha chain"""	173430				1505216, 2536956	Standard	NM_002607		Approved	PDGF1, PDGF-A	uc003sir.3	P04085	OTTHUMG00000151412	ENST00000354513.5:c.499G>A	7.37:g.540834C>T	ENSP00000346508:p.Val167Ile		B5BU73	Missense_Mutation	SNP	p.V167I	ENST00000354513.5	37	CCDS34578.1	deleterious(0.640)	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	27.5|27.5	4.833942|4.833942	0.91036|0.91036	.|.	.|.	ENSG00000197461|ENSG00000197461	ENST00000400761|ENST00000402802;ENST00000354513	.|T;T	.|0.50277	.|0.76;0.75	4.82|4.82	4.82|4.82	0.62117|0.62117	.|Platelet-derived growth factor (PDGF) (3);	.|0.000000	.|0.85682	.|D	.|0.000000	T|T	0.65943|0.65943	0.2740|0.2740	M|M	0.63428|0.63428	1.95|1.95	0.58432|0.58432	D|D	0.999999|0.999999	.|P;D;D	.|0.67145	.|0.868;0.996;0.966	.|P;D;P	.|0.70227	.|0.744;0.968;0.869	T|T	0.67681|0.67681	-0.5608|-0.5608	5|10	.|0.49607	.|T	.|0.09	-21.8337|-21.8337	17.5015|17.5015	0.87733|0.87733	0.0:1.0:0.0:0.0|0.0:1.0:0.0:0.0	.|.	.|181;167;167	.|Q32M96;P04085-2;P04085	.|.;.;PDGFA_HUMAN	N|I	173|167	.|ENSP00000383889:V167I;ENSP00000346508:V167I	.|ENSP00000346508:V167I	S|V	-|-	2|1	0|0	PDGFA|PDGFA	507360|507360	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.998000|0.998000	0.95712|0.95712	6.602000|6.602000	0.74141|0.74141	2.209000|2.209000	0.71365|0.71365	0.655000|0.655000	0.94253|0.94253	AGT|GTC	HMMPfam_PDGF,HMMSmart_SM00141,superfamily_Cystine-knot cytokines		0.552	PDGFA-002	KNOWN	basic|CCDS	protein_coding	protein_coding	OTTHUMT00000322534.1	287	0%	possibly_damaging(0.896)		20	60%		tolerated(0.1)	-1	NM_002607.5	reviewed	276	34.4%	1.000
PRKAR1B	5575	genome.wustl.edu	37	7	624198	624198	+	Missense_Mutation	SNP	G	G	A			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr7:624198G>A	ENST00000406797.1	-	8	890	c.716C>T	c.(715-717)aCg>aTg	p.T239M	PRKAR1B_ENST00000360274.4_Missense_Mutation_p.T239M|PRKAR1B_ENST00000537384.1_Missense_Mutation_p.T239M|PRKAR1B_ENST00000403562.1_Missense_Mutation_p.T239M|PRKAR1B_ENST00000544935.1_Missense_Mutation_p.T239M	NM_001164761.1	NP_001158233.1	P31321	KAP1_HUMAN	protein kinase, cAMP-dependent, regulatory, type I, beta	239					activation of phospholipase C activity (GO:0007202)|activation of protein kinase A activity (GO:0034199)|blood coagulation (GO:0007596)|cellular response to glucagon stimulus (GO:0071377)|energy reserve metabolic process (GO:0006112)|epidermal growth factor receptor signaling pathway (GO:0007173)|fibroblast growth factor receptor signaling pathway (GO:0008543)|innate immune response (GO:0045087)|learning or memory (GO:0007611)|negative regulation of cAMP-dependent protein kinase activity (GO:2000480)|neurotrophin TRK receptor signaling pathway (GO:0048011)|protein phosphorylation (GO:0006468)|regulation of insulin secretion (GO:0050796)|signal transduction (GO:0007165)|small molecule metabolic process (GO:0044281)|transmembrane transport (GO:0055085)|water transport (GO:0006833)	cAMP-dependent protein kinase complex (GO:0005952)|cytosol (GO:0005829)|plasma membrane (GO:0005886)	cAMP binding (GO:0030552)|cAMP-dependent protein kinase inhibitor activity (GO:0004862)|cAMP-dependent protein kinase regulator activity (GO:0008603)|protein kinase A catalytic subunit binding (GO:0034236)	p.T239M(1)		endometrium(4)|large_intestine(1)|liver(1)|lung(10)|prostate(1)	17		Ovarian(82;0.0779)		UCEC - Uterine corpus endometrioid carcinoma (27;0.0181)|Epithelial(4;5.75e-19)|OV - Ovarian serous cystadenocarcinoma(56;2.01e-18)|all cancers(6;3.96e-16)|BRCA - Breast invasive adenocarcinoma(126;0.152)		TTTCCTCAGCGTGCTGCCCTG	0.527																																																1	Substitution - Missense(1)	endometrium(1)											135.0	98.0	111.0					7																	624198		2202	4296	6498	SO:0001583	missense	5575			M65066	CCDS34579.1	7p22.3	2013-09-19			ENSG00000188191	ENSG00000188191	2.7.11.1		9390	protein-coding gene	gene with protein product		176911				1358799, 3479018	Standard	NM_002735		Approved		uc003siw.2	P31321	OTTHUMG00000151411	ENST00000406797.1:c.716C>T	7.37:g.624198G>A	ENSP00000385749:p.Thr239Met		Q8N422	Missense_Mutation	SNP	p.T239M	ENST00000406797.1	37	CCDS34579.1	deleterious(0.945)	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	G|G	21.9|21.9	4.222378|4.222378	0.79464|0.79464	.|.	.|.	ENSG00000188191|ENSG00000188191	ENST00000400758|ENST00000537384;ENST00000544935;ENST00000406797;ENST00000403562;ENST00000360274;ENST00000340920;ENST00000430040	.|D;D;D;D;D;D	.|0.84442	.|-1.85;-1.85;-1.85;-1.85;-1.85;-1.85	4.96|4.96	4.96|4.96	0.65561|0.65561	.|Cyclic nucleotide-binding-like (1);Cyclic nucleotide-binding domain (2);	.|0.000000	.|0.85682	.|U	.|0.000000	D|D	0.92414|0.92414	0.7592|0.7592	M|M	0.82823|0.82823	2.61|2.61	0.80722|0.80722	D|D	1|1	.|D	.|0.89917	.|1.0	.|D	.|0.66716	.|0.946	D|D	0.93658|0.93658	0.6979|0.6979	5|10	.|0.87932	.|D	.|0	-13.4947|-13.4947	17.0165|17.0165	0.86421|0.86421	0.0:0.0:1.0:0.0|0.0:0.0:1.0:0.0	.|.	.|239	.|P31321	.|KAP1_HUMAN	C|M	100|239;239;239;239;239;4;239	.|ENSP00000440449:T239M;ENSP00000444487:T239M;ENSP00000385749:T239M;ENSP00000385349:T239M;ENSP00000353415:T239M;ENSP00000402648:T239M	.|ENSP00000340984:T4M	R|T	-|-	1|2	0|0	PRKAR1B|PRKAR1B	590724|590724	1.000000|1.000000	0.71417|0.71417	0.991000|0.991000	0.47740|0.47740	0.996000|0.996000	0.88848|0.88848	7.975000|7.975000	0.88055|0.88055	2.296000|2.296000	0.77279|0.77279	0.638000|0.638000	0.83543|0.83543	CGC|ACG	HMMPfam_cNMP_binding,HMMSmart_cNMP,superfamily_cNMP_binding		0.527	PRKAR1B-003	KNOWN	alternative_5_UTR|basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000322525.1	101	0%	probably_damaging(1)		83	48.1%		deleterious(0)	-1	NM_002735.2	validated	89	38.2%	0.999
HEATR2	54919	genome.wustl.edu	37	7	801433	801433	+	Missense_Mutation	SNP	T	T	C			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	T	T					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr7:801433T>C	ENST00000297440.6	+	7	1534	c.1514T>C	c.(1513-1515)gTg>gCg	p.V505A	HEATR2_ENST00000313147.5_Missense_Mutation_p.V505A	NM_017802.3	NP_060272.3	Q86Y56	HEAT2_HUMAN	HEAT repeat containing 2	505						cytoplasm (GO:0005737)		p.V505A(1)		breast(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(4)|lung(3)|ovary(2)|prostate(4)|skin(1)	22		Ovarian(82;0.0112)		UCEC - Uterine corpus endometrioid carcinoma (27;0.0182)|Epithelial(4;5.48e-17)|OV - Ovarian serous cystadenocarcinoma(56;1.95e-16)|all cancers(6;2.98e-14)		CAGGCTCTGGTGTCTGTGTGT	0.617																																																1	Substitution - Missense(1)	endometrium(1)											95.0	68.0	78.0					7																	801433		2203	4300	6503	SO:0001583	missense	54919			AL832914, AK000404, NM_017802, AK056233	CCDS34580.1	7p22.3	2014-05-06	2006-05-19		ENSG00000164818	ENSG00000164818			26013	protein-coding gene	gene with protein product		614864				23040496	Standard	NM_017802		Approved	FLJ20397, FLJ31671, FLJ39381, FLJ25564, CILD18	uc010krz.1	Q86Y56	OTTHUMG00000151416	ENST00000297440.6:c.1514T>C	7.37:g.801433T>C	ENSP00000297440:p.Val505Ala		Q69YL1|Q96FI9|Q9NX75	Missense_Mutation	SNP	p.V505A	ENST00000297440.6	37	CCDS34580.1	neutral(0.388)	.	.	.	.	.	.	.	.	.	.	T	16.62	3.173017	0.57584	.	.	ENSG00000164818	ENST00000297440;ENST00000313147;ENST00000537862	T;T	0.65178	-0.14;-0.14	5.38	5.38	0.77491	Armadillo-like helical (1);Armadillo-type fold (1);	0.686833	0.13759	N	0.364750	T	0.59307	0.2184	L	0.54323	1.7	0.19775	N	0.999953	B;P	0.38395	0.304;0.629	B;B	0.35899	0.106;0.213	T	0.57991	-0.7715	10	0.59425	D	0.04	-21.7203	14.5409	0.67995	0.0:0.0:0.0:1.0	.	505;251	Q86Y56;F5H8D4	HEAT2_HUMAN;.	A	505;505;251	ENSP00000297440:V505A;ENSP00000321451:V505A	ENSP00000297440:V505A	V	+	2	0	HEATR2	767959	0.999000	0.42202	0.007000	0.13788	0.010000	0.07245	4.045000	0.57368	2.040000	0.60383	0.459000	0.35465	GTG	superfamily_ARM repeat		0.617	HEATR2-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000322542.1	66	0%	benign(0.071)	NM_017802	36	52.7%		deleterious(0.02)	+1	NM_017802.3	validated	96	38.5%	0.349
BRAT1	221927	genome.wustl.edu	37	7	2586990	2586990	+	Missense_Mutation	SNP	C	C	T			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr7:2586990C>T	ENST00000340611.4	-	3	506	c.250G>A	c.(250-252)Gca>Aca	p.A84T		NM_152743.3	NP_689956.2	Q6PJG6	BRAT1_HUMAN	BRCA1-associated ATM activator 1	84					response to ionizing radiation (GO:0010212)	membrane (GO:0016020)|nucleus (GO:0005634)		p.A84T(1)		breast(1)|central_nervous_system(1)|endometrium(4)|kidney(2)|large_intestine(3)|lung(7)|ovary(1)|pancreas(1)|skin(2)|urinary_tract(1)	23						TCCTGGGCTGCGAAGGTTCCT	0.627																																																1	Substitution - Missense(1)	endometrium(1)											75.0	68.0	71.0					7																	2586990		2203	4300	6503	SO:0001583	missense	221927			BC015632	CCDS5334.1	7p22.3	2011-03-22	2011-02-28	2011-03-22	ENSG00000106009	ENSG00000106009			21701	protein-coding gene	gene with protein product	"""BRCA1-associated protein required for ATM activation protein 1"""	614506	"""chromosome 7 open reading frame 27"""	C7orf27, BAAT1		16452482	Standard	NM_152743		Approved	MGC22916	uc003smi.3	Q6PJG6	OTTHUMG00000119091	ENST00000340611.4:c.250G>A	7.37:g.2586990C>T	ENSP00000339637:p.Ala84Thr		A4D200|C9JY24|Q8IW85|Q8IZ43|Q8WVR8|Q96IV9|Q9H7J8|Q9UFA3	Missense_Mutation	SNP	p.A84T	ENST00000340611.4	37	CCDS5334.1	deleterious(0.883)	.	.	.	.	.	.	.	.	.	.	C	16.81	3.227027	0.58668	.	.	ENSG00000106009	ENST00000340611	T	0.22945	1.93	5.01	5.01	0.66863	Armadillo-type fold (1);	0.000000	0.85682	D	0.000000	T	0.53174	0.1780	M	0.77616	2.38	0.58432	D	0.999996	D;D	0.89917	1.0;1.0	D;D	0.87578	0.998;0.995	T	0.58896	-0.7555	10	0.87932	D	0	-13.1456	16.0942	0.81110	0.0:1.0:0.0:0.0	.	84;84	Q6PJG6-2;Q6PJG6	.;BRAT1_HUMAN	T	84	ENSP00000339637:A84T	ENSP00000339637:A84T	A	-	1	0	BRAT1	2553516	0.994000	0.37717	0.171000	0.22900	0.121000	0.20230	3.582000	0.53921	2.331000	0.79229	0.650000	0.86243	GCA	superfamily_ARM repeat		0.627	BRAT1-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000239305.2	50	0%	probably_damaging(1)	NM_152743	61	45.9%		deleterious(0.02)	-1	NM_152743.2	provisional	53	37.7%	0.897
CCDC129	223075	genome.wustl.edu	37	7	31592725	31592725	+	Missense_Mutation	SNP	C	C	G	rs550681504	byFrequency	TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr7:31592725C>G	ENST00000407970.3	+	2	125	c.87C>G	c.(85-87)agC>agG	p.S29R	CCDC129_ENST00000482748.1_Intron|CCDC129_ENST00000319386.3_Missense_Mutation_p.S29R|CCDC129_ENST00000451887.2_Missense_Mutation_p.S55R|CCDC129_ENST00000409210.1_5'Flank	NM_001257967.1|NM_194300.3	NP_001244896.1|NP_919276.2	Q6ZRS4	CC129_HUMAN	coiled-coil domain containing 129	29								p.S29R(2)		cervix(1)|endometrium(3)|kidney(3)|large_intestine(6)|lung(31)	44						GCACCAAAAGCGCGTGGGCTC	0.537																																																2	Substitution - Missense(2)	endometrium(2)											92.0	69.0	77.0					7																	31592725		2203	4300	6503	SO:0001583	missense	223075			AK128026	CCDS5435.2, CCDS59050.1, CCDS75577.1	7p14.3	2006-08-21			ENSG00000180347	ENSG00000180347			27363	protein-coding gene	gene with protein product						14702039	Standard	NM_001257967		Approved	FLJ38344	uc011kad.1	Q6ZRS4	OTTHUMG00000128611	ENST00000407970.3:c.87C>G	7.37:g.31592725C>G	ENSP00000384416:p.Ser29Arg		A2RU17|B3KTI9|B4DHB0|B4E2R1|F5H3V5	Missense_Mutation	SNP	p.S29R	ENST00000407970.3	37	CCDS5435.2	-	.	.	.	.	.	.	.	.	.	.	C	0	-2.617188	0.00118	.	.	ENSG00000180347	ENST00000409717;ENST00000456011;ENST00000319386;ENST00000407970;ENST00000454513;ENST00000451887;ENST00000538406	T;T;T;T;T;T	0.42131	0.98;0.99;2.29;2.55;0.98;2.54	5.35	-1.16	0.09678	.	0.800688	0.10883	N	0.623523	T	0.11367	0.0277	N	0.02539	-0.55	0.09310	N	1	B;B;B;B	0.09022	0.002;0.002;0.002;0.002	B;B;B;B	0.08055	0.003;0.003;0.003;0.003	T	0.29027	-1.0025	10	0.02654	T	1	-11.18	1.4011	0.02271	0.1605:0.3182:0.265:0.2563	.	55;39;29;29	F5H3V5;F5H2J8;Q6ZRS4;Q6ZRS4-2	.;.;CC129_HUMAN;.	R	29;29;29;29;29;55;39	ENSP00000387220:S29R;ENSP00000390544:S29R;ENSP00000313062:S29R;ENSP00000384416:S29R;ENSP00000413233:S29R;ENSP00000395835:S55R	ENSP00000313062:S29R	S	+	3	2	CCDC129	31559250	0.000000	0.05858	0.001000	0.08648	0.003000	0.03518	0.020000	0.13466	-0.066000	0.12998	-1.114000	0.02060	AGC	NULL		0.537	CCDC129-002	KNOWN	basic|appris_candidate|CCDS	protein_coding	protein_coding	OTTHUMT00000318975.1	152	0%	benign(0)	NM_194300	3	0%		tolerated(1)	+1	NM_194300.2	validated	151	11.3%	0.000
AKAP9	10142	genome.wustl.edu	37	7	91652174	91652174	+	Missense_Mutation	SNP	A	A	C			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	A	A					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr7:91652174A>C	ENST00000359028.2	+	15	4260	c.4035A>C	c.(4033-4035)aaA>aaC	p.K1345N	AKAP9_ENST00000356239.3_Missense_Mutation_p.K1333N|AKAP9_ENST00000358100.2_Missense_Mutation_p.K1345N			Q99996	AKAP9_HUMAN	A kinase (PRKA) anchor protein 9	1345					G2/M transition of mitotic cell cycle (GO:0000086)|mitotic cell cycle (GO:0000278)|Sertoli cell development (GO:0060009)|signal transduction (GO:0007165)|spermatogenesis (GO:0007283)|synaptic transmission (GO:0007268)|transport (GO:0006810)	centrosome (GO:0005813)|ciliary basal body (GO:0036064)|cytoskeleton (GO:0005856)|cytosol (GO:0005829)|Golgi apparatus (GO:0005794)|intracellular membrane-bounded organelle (GO:0043231)|pericentriolar material (GO:0000242)|voltage-gated potassium channel complex (GO:0008076)	ion channel binding (GO:0044325)|protein complex scaffold (GO:0032947)|receptor binding (GO:0005102)	p.K1345N(1)|p.K1333N(1)		NS(1)|autonomic_ganglia(2)|breast(14)|central_nervous_system(3)|cervix(1)|endometrium(13)|kidney(12)|large_intestine(35)|lung(49)|ovary(8)|prostate(6)|skin(8)|stomach(1)|urinary_tract(2)	155	all_cancers(62;2.46e-09)|all_epithelial(64;4.42e-08)|Breast(17;0.00206)|all_lung(186;0.185)|all_hematologic(106;0.215)|Lung NSC(181;0.249)		STAD - Stomach adenocarcinoma(171;6.16e-05)|Lung(22;0.123)|LUSC - Lung squamous cell carcinoma(200;0.225)			ATCTTGAAAAAACTAAACTTG	0.318			T	BRAF	papillary thyroid																																		Dom	yes		7	7q21-q22	10142	A kinase (PRKA) anchor protein (yotiao) 9		E	2	Substitution - Missense(2)	endometrium(2)											46.0	46.0	46.0					7																	91652174		2203	4300	6503	SO:0001583	missense	10142			AF091711	CCDS5622.1	7q21-q22	2014-09-17	2013-09-25		ENSG00000127914	ENSG00000127914		"""A-kinase anchor proteins"", ""Serine/threonine phosphatases / Protein phosphatase 1, regulatory subunits"""	379	protein-coding gene	gene with protein product	"""A-kinase anchoring protein 450"", ""AKAP9-BRAF fusion protein"", ""AKAP120-like protein"", ""centrosome- and golgi-localized protein kinase N-associated protein"", ""protein kinase A anchoring protein 9"", ""A-kinase anchor protein, 350kDa"", ""protein phosphatase 1, regulatory subunit 45"", ""yotiao"""	604001				9482789, 10390370, 24475373	Standard	NM_147185		Approved	KIAA0803, AKAP350, AKAP450, CG-NAP, YOTIAO, HYPERION, PRKA9, MU-RMS-40.16A, PPP1R45, LQT11	uc003ulg.3	Q99996	OTTHUMG00000131127	ENST00000359028.2:c.4035A>C	7.37:g.91652174A>C	ENSP00000351922:p.Lys1345Asn		A4D1F0|A4D1F2|A4D1F4|O14869|O43355|O94895|Q75N20|Q9UQH3|Q9UQQ4|Q9Y6B8|Q9Y6Y2	Missense_Mutation	SNP	p.K1333N	ENST00000359028.2	37		neutral(0.349)	.	.	.	.	.	.	.	.	.	.	A	0.369	-0.934858	0.02340	.	.	ENSG00000127914	ENST00000356239;ENST00000359028;ENST00000358100;ENST00000413120;ENST00000394565	T;T;T	0.03860	3.79;3.79;3.78	4.41	1.93	0.25924	.	0.000000	0.42053	D	0.000761	T	0.03095	0.0091	L	0.28740	0.885	0.09310	N	1	B;B;B;B	0.12630	0.001;0.006;0.004;0.003	B;B;B;B	0.12156	0.003;0.005;0.007;0.006	T	0.41324	-0.9515	10	0.38643	T	0.18	.	1.0715	0.01623	0.4296:0.1624:0.0932:0.3148	.	1345;1333;1333;1345	Q99996;Q99996-2;Q99996-3;A4D1E4	AKAP9_HUMAN;.;.;.	N	1333;1345;1345;1345;1345	ENSP00000348573:K1333N;ENSP00000351922:K1345N;ENSP00000350813:K1345N	ENSP00000348573:K1333N	K	+	3	2	AKAP9	91490110	0.054000	0.20591	0.012000	0.15200	0.046000	0.14306	0.247000	0.18179	0.275000	0.22094	0.482000	0.46254	AAA	NULL		0.318	AKAP9-202	KNOWN	basic	protein_coding	protein_coding		82	0%	benign(0.002)	NM_005751	2	0%		deleterious(0.04)	+1	NM_005751.4	reviewed	105	40%	0.014
PRRT4	401399	genome.wustl.edu	37	7	127999459	127999459	+	Missense_Mutation	SNP	G	G	A	rs145413607	byFrequency	TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr7:127999459G>A	ENST00000446477.2	-	3	900	c.587C>T	c.(586-588)aCg>aTg	p.T196M	PRRT4_ENST00000435512.1_Missense_Mutation_p.T196M|PRRT4_ENST00000535159.1_Missense_Mutation_p.T196M|PRRT4_ENST00000489835.2_Missense_Mutation_p.T196M	NM_001174164.1	NP_001167635.1	C9JH25	PRRT4_HUMAN	proline-rich transmembrane protein 4	196						integral component of membrane (GO:0016021)		p.T196M(1)		endometrium(4)|prostate(1)	5						CAGGGGCAGCGTTCGATGCCC	0.652													G|||	28	0.00559105	0.0	0.0072	5008	,	,		16449	0.0		0.0199	False		,,,				2504	0.0031															1	Substitution - Missense(1)	endometrium(1)						G	MET/THR,MET/THR	5,1379		0,5,687	19.0	23.0	22.0		587,587	2.8	0.9	7	dbSNP_134	22	55,3127		2,51,1538	yes	missense,missense	PRRT4	NM_001174164.1,NM_001114726.2	81,81	2,56,2225	AA,AG,GG		1.7285,0.3613,1.3141	benign,benign	196/900,196/430	127999459	60,4506	692	1591	2283	SO:0001583	missense	401399			BC063892	CCDS47698.1, CCDS47698.2, CCDS55160.1	7q32.1	2011-10-10			ENSG00000224940	ENSG00000224940		"""Proline-rich transmembrane proteins"""	37280	protein-coding gene	gene with protein product							Standard	NM_001114726		Approved		uc022aky.1	C9JH25	OTTHUMG00000157714	ENST00000446477.2:c.587C>T	7.37:g.127999459G>A	ENSP00000415026:p.Thr196Met		A4D0Z9|C9JVW7	Missense_Mutation	SNP	p.T196M	ENST00000446477.2	37	CCDS55160.1	deleterious(0.905)	19	0.0086996336996337	0	0.0	3	0.008287292817679558	0	0.0	16	0.021108179419525065	G	9.816	1.184515	0.21870	0.003613	0.017285	ENSG00000224940	ENST00000489835;ENST00000446477;ENST00000535159;ENST00000435512;ENST00000489517;ENST00000464607;ENST00000495931	.	.	.	4.97	2.78	0.32641	.	.	.	.	.	T	0.08537	0.0212	N	0.08118	0	0.09310	N	1	B;B	0.32893	0.077;0.389	B;B	0.23716	0.01;0.048	T	0.09250	-1.0683	8	0.87932	D	0	-13.8848	7.9713	0.30130	0.2241:0.0:0.7759:0.0	.	196;196	C9JH25;C9JH25-2	PRRT4_HUMAN;.	M	196	.	ENSP00000410779:T196M	T	-	2	0	PRRT4	127786695	0.137000	0.22531	0.873000	0.34254	0.521000	0.34408	1.775000	0.38584	1.115000	0.41800	0.585000	0.79938	ACG	NULL		0.652	PRRT4-202	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding		19	0%	probably_damaging(1)	NM_001114726	1	100%		deleterious(0.01)	-1	NM_001114726.2	validated	25	36%	0.351
NOL8	55035	genome.wustl.edu	37	9	95063978	95063978	+	Silent	SNP	C	C	T			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr9:95063978C>T	ENST00000535387.1	-	11	2915	c.2916G>A	c.(2914-2916)aaG>aaA	p.K972K	NOL8_ENST00000542053.1_Silent_p.K942K|NOL8_ENST00000442668.2_Silent_p.K1010K|NOL8_ENST00000545558.1_Silent_p.K1010K|NOL8_ENST00000358855.4_Silent_p.K942K					nucleolar protein 8									p.K1010K(1)|p.K1012K(1)		endometrium(3)|kidney(2)|large_intestine(5)|lung(5)|ovary(1)	16						TGCCCTCTTCCTTTTCACTGG	0.448																																																2	Substitution - coding silent(2)	endometrium(2)											77.0	72.0	74.0					9																	95063978		1858	4089	5947	SO:0001819	synonymous_variant	55035			AB109030	CCDS47993.1, CCDS59135.1	9q22.32	2013-02-12	2004-01-12	2004-01-14	ENSG00000198000	ENSG00000198000		"""RNA binding motif (RRM) containing"""	23387	protein-coding gene	gene with protein product		611534	"""chromosome 9 open reading frame 34"""	C9orf34		12477932	Standard	NM_017948		Approved	FLJ20736, Nop132	uc022bjx.1	Q76FK4	OTTHUMG00000020221	ENST00000535387.1:c.2916G>A	9.37:g.95063978C>T				Silent	SNP	p.K1010	ENST00000535387.1	37	CCDS47993.1	-																																																																																			NULL		0.448	NOL8-010	NOVEL	basic|exp_conf|CCDS	protein_coding	protein_coding	OTTHUMT00000053082.2	217	0%	-	NM_017948	9	77.7%		-	-1	NM_017948.5	validated	143	79.7%	0.001
NOTCH1	4851	genome.wustl.edu	37	9	139402446	139402446	+	Silent	SNP	C	C	T			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr9:139402446C>T	ENST00000277541.6	-	21	3546	c.3471G>A	c.(3469-3471)ggG>ggA	p.G1157G		NM_017617.3	NP_060087.3	P46531	NOTC1_HUMAN	notch 1	1157	EGF-like 30. {ECO:0000255|PROSITE- ProRule:PRU00076}.				anagen (GO:0042640)|aortic valve morphogenesis (GO:0003180)|apoptotic process involved in embryonic digit morphogenesis (GO:1902263)|arterial endothelial cell differentiation (GO:0060842)|atrioventricular node development (GO:0003162)|atrioventricular valve morphogenesis (GO:0003181)|auditory receptor cell fate commitment (GO:0009912)|axonogenesis (GO:0007409)|branching morphogenesis of an epithelial tube (GO:0048754)|cardiac atrium morphogenesis (GO:0003209)|cardiac chamber formation (GO:0003207)|cardiac epithelial to mesenchymal transition (GO:0060317)|cardiac left ventricle morphogenesis (GO:0003214)|cardiac muscle cell proliferation (GO:0060038)|cardiac muscle tissue morphogenesis (GO:0055008)|cardiac right atrium morphogenesis (GO:0003213)|cardiac right ventricle formation (GO:0003219)|cardiac septum morphogenesis (GO:0060411)|cardiac vascular smooth muscle cell development (GO:0060948)|cardiac ventricle morphogenesis (GO:0003208)|cell fate specification (GO:0001708)|cell migration involved in endocardial cushion formation (GO:0003273)|cellular response to follicle-stimulating hormone stimulus (GO:0071372)|cellular response to vascular endothelial growth factor stimulus (GO:0035924)|cilium morphogenesis (GO:0060271)|collecting duct development (GO:0072044)|compartment pattern specification (GO:0007386)|coronary artery morphogenesis (GO:0060982)|coronary vein morphogenesis (GO:0003169)|determination of left/right symmetry (GO:0007368)|distal tubule development (GO:0072017)|embryonic hindlimb morphogenesis (GO:0035116)|endocardial cell differentiation (GO:0060956)|endocardial cushion morphogenesis (GO:0003203)|endocardium development (GO:0003157)|endocardium morphogenesis (GO:0003160)|endoderm development (GO:0007492)|epithelial to mesenchymal transition (GO:0001837)|epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198)|forebrain development (GO:0030900)|foregut morphogenesis (GO:0007440)|gene expression (GO:0010467)|glial cell differentiation (GO:0010001)|glomerular mesangial cell development (GO:0072144)|growth involved in heart morphogenesis (GO:0003241)|hair follicle morphogenesis (GO:0031069)|heart development (GO:0007507)|heart looping (GO:0001947)|heart trabecula morphogenesis (GO:0061384)|humoral immune response (GO:0006959)|immune response (GO:0006955)|in utero embryonic development (GO:0001701)|inflammatory response to antigenic stimulus (GO:0002437)|interleukin-4 secretion (GO:0072602)|keratinocyte differentiation (GO:0030216)|left/right axis specification (GO:0070986)|liver development (GO:0001889)|lung development (GO:0030324)|mesenchymal cell development (GO:0014031)|mitral valve formation (GO:0003192)|negative regulation of anoikis (GO:2000811)|negative regulation of BMP signaling pathway (GO:0030514)|negative regulation of calcium ion-dependent exocytosis (GO:0045955)|negative regulation of canonical Wnt signaling pathway (GO:0090090)|negative regulation of catalytic activity (GO:0043086)|negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051)|negative regulation of cell proliferation (GO:0008285)|negative regulation of cell-substrate adhesion (GO:0010812)|negative regulation of endothelial cell chemotaxis (GO:2001027)|negative regulation of glial cell proliferation (GO:0060253)|negative regulation of myoblast differentiation (GO:0045662)|negative regulation of myotube differentiation (GO:0010832)|negative regulation of neurogenesis (GO:0050768)|negative regulation of oligodendrocyte differentiation (GO:0048715)|negative regulation of ossification (GO:0030279)|negative regulation of osteoblast differentiation (GO:0045668)|negative regulation of photoreceptor cell differentiation (GO:0046533)|negative regulation of pro-B cell differentiation (GO:2000974)|negative regulation of stem cell differentiation (GO:2000737)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|neural tube development (GO:0021915)|neuronal stem cell maintenance (GO:0097150)|Notch receptor processing (GO:0007220)|Notch signaling involved in heart development (GO:0061314)|Notch signaling pathway (GO:0007219)|Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003270)|pericardium morphogenesis (GO:0003344)|positive regulation of apoptotic process (GO:0043065)|positive regulation of astrocyte differentiation (GO:0048711)|positive regulation of BMP signaling pathway (GO:0030513)|positive regulation of cardiac muscle cell proliferation (GO:0060045)|positive regulation of cell migration (GO:0030335)|positive regulation of cell proliferation (GO:0008284)|positive regulation of epithelial cell proliferation (GO:0050679)|positive regulation of epithelial to mesenchymal transition (GO:0010718)|positive regulation of JAK-STAT cascade (GO:0046427)|positive regulation of keratinocyte differentiation (GO:0045618)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419)|positive regulation of transcription of Notch receptor target (GO:0007221)|positive regulation of transcription, DNA-templated (GO:0045893)|prostate gland epithelium morphogenesis (GO:0060740)|pulmonary valve morphogenesis (GO:0003184)|regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768)|regulation of extracellular matrix assembly (GO:1901201)|regulation of somitogenesis (GO:0014807)|regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256)|regulation of transcription, DNA-templated (GO:0006355)|response to muramyl dipeptide (GO:0032495)|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development (GO:0060528)|skeletal muscle cell differentiation (GO:0035914)|somatic stem cell division (GO:0048103)|sprouting angiogenesis (GO:0002040)|transcription initiation from RNA polymerase II promoter (GO:0006367)|tube formation (GO:0035148)|vasculogenesis involved in coronary vascular morphogenesis (GO:0060979)|venous endothelial cell differentiation (GO:0060843)|ventricular septum morphogenesis (GO:0060412)|ventricular trabecula myocardium morphogenesis (GO:0003222)	cell surface (GO:0009986)|cytosol (GO:0005829)|endoplasmic reticulum membrane (GO:0005789)|extracellular region (GO:0005576)|Golgi membrane (GO:0000139)|integral component of membrane (GO:0016021)|MAML1-RBP-Jkappa- ICN1 complex (GO:0002193)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|plasma membrane (GO:0005886)|receptor complex (GO:0043235)	calcium ion binding (GO:0005509)|chromatin DNA binding (GO:0031490)|core promoter binding (GO:0001047)|enzyme binding (GO:0019899)|enzyme inhibitor activity (GO:0004857)|receptor activity (GO:0004872)|RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription (GO:0001190)|sequence-specific DNA binding (GO:0043565)|sequence-specific DNA binding transcription factor activity (GO:0003700)	p.G1158G(1)|p.G1157G(1)		breast(16)|central_nervous_system(17)|cervix(2)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1183)|kidney(4)|large_intestine(1)|lung(57)|oesophagus(2)|ovary(3)|pancreas(1)|prostate(3)|skin(21)|upper_aerodigestive_tract(39)|urinary_tract(3)	1359	all_cancers(76;0.223)	Myeloproliferative disorder(178;0.0511)		OV - Ovarian serous cystadenocarcinoma(145;5.34e-06)|Epithelial(140;7.77e-06)		TGCAGGTGGCCCCGTTCTGGC	0.677			"""T, Mis, O"""	TRB@	T-ALL					HNSCC(8;0.001)																													Dom	yes		9	9q34.3	4851	"""Notch homolog 1, translocation-associated (Drosophila) (TAN1)"""		L	2	Substitution - coding silent(2)	endometrium(2)											42.0	50.0	48.0					9																	139402446		2077	4203	6280	SO:0001819	synonymous_variant	4851			AF308602	CCDS43905.1	9q34.3	2013-01-10	2010-06-24		ENSG00000148400	ENSG00000148400		"""Ankyrin repeat domain containing"""	7881	protein-coding gene	gene with protein product		190198	"""Notch (Drosophila) homolog 1 (translocation-associated)"", ""Notch homolog 1, translocation-associated (Drosophila)"""	TAN1		1831692	Standard	NM_017617		Approved		uc004chz.3	P46531	OTTHUMG00000020935	ENST00000277541.6:c.3471G>A	9.37:g.139402446C>T			Q59ED8|Q5SXM3	Silent	SNP	p.G1157	ENST00000277541.6	37	CCDS43905.1	-																																																																																			HMMSmart_EGF_CA,HMMPfam_EGF,superfamily_SSF57196		0.677	NOTCH1-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000055087.1	21	0%	-	NM_017617	9	66.6%		-	-1	NM_017617.3	reviewed	22	86.4%	0.118
DDX50	79009	genome.wustl.edu	37	10	70661146	70661146	+	Silent	SNP	T	T	G	rs565593277		TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	T	T					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr10:70661146T>G	ENST00000373585.3	+	1	113	c.6T>G	c.(4-6)ccT>ccG	p.P2P		NM_024045.1	NP_076950.1	Q9BQ39	DDX50_HUMAN	DEAD (Asp-Glu-Ala-Asp) box polypeptide 50	2						membrane (GO:0016020)|nucleolus (GO:0005730)|plasma membrane (GO:0005886)	ATP binding (GO:0005524)|helicase activity (GO:0004386)|poly(A) RNA binding (GO:0044822)	p.P2P(1)		breast(2)|cervix(1)|endometrium(3)|kidney(4)|large_intestine(5)|liver(2)|lung(6)|ovary(2)|prostate(3)|upper_aerodigestive_tract(1)	29						CAGTAATGCCTGGGAAACTCC	0.657													T|||	1	0.000199681	0.0	0.0	5008	,	,		15892	0.0		0.001	False		,,,				2504	0.0															1	Substitution - coding silent(1)	endometrium(1)											20.0	18.0	18.0					10																	70661146		2180	4268	6448	SO:0001819	synonymous_variant	79009			AF334103	CCDS7283.1	10q22.2	2010-09-30			ENSG00000107625	ENSG00000107625		"""DEAD-boxes"""	17906	protein-coding gene	gene with protein product		610373				11891046	Standard	NM_024045		Approved	GU2, MGC3199, GUB, RH-II/GuB	uc001jou.3	Q9BQ39	OTTHUMG00000018362	ENST00000373585.3:c.6T>G	10.37:g.70661146T>G			Q5VX37|Q8WV76|Q9BWI8	Silent	SNP	p.P2	ENST00000373585.3	37	CCDS7283.1	-																																																																																			NULL		0.657	DDX50-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000048363.1	39	0%	-	NM_024045	14	50%		-	+1	NM_024045.1	reviewed	49	46.9%	0.999
LIPN	643418	genome.wustl.edu	37	10	90537860	90537860	+	Missense_Mutation	SNP	C	C	T			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr10:90537860C>T	ENST00000404459.1	+	9	1058	c.1058C>T	c.(1057-1059)gCc>gTc	p.A353V		NM_001102469.1	NP_001095939.1	Q5VXI9	LIPN_HUMAN	lipase, family member N	353					lipid catabolic process (GO:0016042)	extracellular region (GO:0005576)	hydrolase activity, acting on ester bonds (GO:0016788)	p.A353V(1)		endometrium(1)|kidney(1)|large_intestine(5)|lung(1)|skin(1)	9		Colorectal(252;0.0161)		Colorectal(12;4.83e-05)|COAD - Colon adenocarcinoma(12;6.5e-05)		CAGGATGTGGCCAGGATACTC	0.493																																																1	Substitution - Missense(1)	endometrium(1)											137.0	129.0	131.0					10																	90537860		1969	4141	6110	SO:0001583	missense	643418				CCDS44456.1	10q23.31	2013-09-20	2007-02-27	2007-02-27	ENSG00000204020	ENSG00000204020			23452	protein-coding gene	gene with protein product		613924	"""lipase-like, ab-hydrolase domain containing 4"""	LIPL4			Standard	NM_001102469		Approved	bA186O14.3	uc010qmw.2	Q5VXI9	OTTHUMG00000018694	ENST00000404459.1:c.1058C>T	10.37:g.90537860C>T	ENSP00000383923:p.Ala353Val		A7KIH9	Missense_Mutation	SNP	p.A353V	ENST00000404459.1	37	CCDS44456.1	neutral(0.042)	.	.	.	.	.	.	.	.	.	.	C	13.39	2.221737	0.39300	.	.	ENSG00000204020	ENST00000404459	T	0.60548	0.18	5.21	2.22	0.28083	Alpha/beta hydrolase fold-1 (1);	0.197870	0.35615	N	0.003087	T	0.54319	0.1851	M	0.69463	2.115	0.27308	N	0.957388	B	0.21520	0.057	B	0.24269	0.052	T	0.48681	-0.9014	10	0.30854	T	0.27	-1.1768	13.6018	0.62024	0.3982:0.6018:0.0:0.0	.	353	Q5VXI9	LIPN_HUMAN	V	353	ENSP00000383923:A353V	ENSP00000383923:A353V	A	+	2	0	LIPN	90527840	0.003000	0.15002	0.678000	0.29963	0.905000	0.53344	0.313000	0.19415	0.395000	0.25257	0.643000	0.83706	GCC	HMMPfam_Abhydrolase_1,superfamily_SSF53474		0.493	LIPN-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000049254.2	291	0%	benign(0.001)	XM_926751	0	-		tolerated(0.22)	+1	NM_001102469.1	validated	35	14.3%	0.992
PLCE1	51196	genome.wustl.edu	37	10	96043587	96043587	+	Silent	SNP	T	T	C			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	T	T					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr10:96043587T>C	ENST00000371380.3	+	20	5071	c.4836T>C	c.(4834-4836)aaT>aaC	p.N1612N	PLCE1_ENST00000371385.3_Silent_p.N1304N|PLCE1_ENST00000371375.1_Silent_p.N1304N|PLCE1-AS1_ENST00000425267.3_RNA|PLCE1-AS1_ENST00000440198.1_RNA|PLCE1_ENST00000260766.3_Silent_p.N1612N|PLCE1-AS1_ENST00000596633.1_RNA			Q9P212	PLCE1_HUMAN	phospholipase C, epsilon 1	1612					activation of MAPK activity (GO:0000187)|calcium-mediated signaling (GO:0019722)|cell proliferation (GO:0008283)|cytoskeleton organization (GO:0007010)|diacylglycerol biosynthetic process (GO:0006651)|epidermal growth factor receptor signaling pathway (GO:0007173)|glomerulus development (GO:0032835)|heart development (GO:0007507)|inositol phosphate metabolic process (GO:0043647)|inositol phosphate-mediated signaling (GO:0048016)|lipid catabolic process (GO:0016042)|phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200)|phospholipid metabolic process (GO:0006644)|positive regulation of cytosolic calcium ion concentration (GO:0007204)|positive regulation of GTPase activity (GO:0043547)|protein kinase C-activating G-protein coupled receptor signaling pathway (GO:0007205)|Ras protein signal transduction (GO:0007265)|regulation of cell growth (GO:0001558)|regulation of G-protein coupled receptor protein signaling pathway (GO:0008277)|regulation of protein kinase activity (GO:0045859)|regulation of Ras protein signal transduction (GO:0046578)|regulation of smooth muscle contraction (GO:0006940)|small molecule metabolic process (GO:0044281)	cytoplasm (GO:0005737)|cytosol (GO:0005829)|Golgi apparatus (GO:0005794)|plasma membrane (GO:0005886)	calcium ion binding (GO:0005509)|enzyme binding (GO:0019899)|guanyl-nucleotide exchange factor activity (GO:0005085)|phosphatidylinositol phospholipase C activity (GO:0004435)|phospholipase C activity (GO:0004629)|Ras GTPase binding (GO:0017016)|receptor signaling protein activity (GO:0005057)	p.N1612N(1)|p.N1304N(1)		liver(1)|ovary(2)|skin(4)|upper_aerodigestive_tract(1)	8		Colorectal(252;0.0458)				AATCATGTAATGACAAGCTTC	0.373																																																2	Substitution - coding silent(2)	endometrium(2)											102.0	99.0	100.0					10																	96043587		1857	4081	5938	SO:0001819	synonymous_variant	51196				CCDS41552.1, CCDS53555.1	10q23	2010-02-22			ENSG00000138193	ENSG00000138193	3.1.4.11		17175	protein-coding gene	gene with protein product	"""nephrosis type 3"""	608414				11022047, 11022048	Standard	NM_016341		Approved	KIAA1516, PLCE, NPHS3	uc001kjk.3	Q9P212	OTTHUMG00000018789	ENST00000371380.3:c.4836T>C	10.37:g.96043587T>C			A6NGW0|A6NLA1|A7MBN7|A8K1D7|B9EIJ6|Q1X6H8|Q5VWL4|Q5VWL5|Q9H9X8|Q9HBX6|Q9HC53|Q9UHV3	Silent	SNP	p.N1612	ENST00000371380.3	37	CCDS41552.1	-																																																																																			superfamily_PLC-like phosphodiesterases		0.373	PLCE1-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding	protein_coding	OTTHUMT00000049469.3	249	0%	-	NM_016341	1	100%		-	+1	NM_016341.3	reviewed	139	69.1%	0.204
JAKMIP3	282973	genome.wustl.edu	37	10	133967268	133967268	+	Silent	SNP	C	C	T			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr10:133967268C>T	ENST00000298622.4	+	17	2211	c.2073C>T	c.(2071-2073)ctC>ctT	p.L691L	JAKMIP3_ENST00000477275.1_3'UTR	NM_001105521.2	NP_001098991.1	Q5VZ66	JKIP3_HUMAN	Janus kinase and microtubule interacting protein 3	691						Golgi apparatus (GO:0005794)		p.L691L(1)		breast(1)|cervix(1)|endometrium(4)|kidney(3)|large_intestine(7)|lung(10)|ovary(2)|prostate(1)|upper_aerodigestive_tract(2)	31		all_cancers(35;5.63e-09)|all_epithelial(44;9.25e-07)|Lung NSC(174;0.0108)|all_lung(145;0.0173)|Colorectal(31;0.0721)|all_neural(114;0.0726)|Breast(234;0.0949)|Glioma(114;0.172)|Melanoma(40;0.175)		OV - Ovarian serous cystadenocarcinoma(35;0.000104)|Epithelial(32;0.000142)|all cancers(32;0.000185)|BRCA - Breast invasive adenocarcinoma(275;0.224)		TCCAGTGGCTCCAGCAGATTG	0.622																																																1	Substitution - coding silent(1)	endometrium(1)											118.0	124.0	122.0					10																	133967268		2203	4299	6502	SO:0001819	synonymous_variant	282973			AL832756	CCDS44494.1	10q26.3	2009-04-23	2009-04-23	2008-01-28	ENSG00000188385	ENSG00000188385			23523	protein-coding gene	gene with protein product	"""neuroendocrine long coiled-coil 2"""	611198	"""chromosome 10 open reading frame 39"", ""chromosome 10 open reading frame 14"""	C10orf39, C10orf14		15277531, 17572408	Standard	NM_001105521		Approved	FLJ37857, NECC2, KIAA4091, bA140A10.5	uc001lkx.4	Q5VZ66	OTTHUMG00000150167	ENST00000298622.4:c.2073C>T	10.37:g.133967268C>T			A6PW00|Q69YM6|Q6ZT29	Silent	SNP	p.L691	ENST00000298622.4	37	CCDS44494.1	-																																																																																			NULL		0.622	JAKMIP3-001	KNOWN	NMD_exception|basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000051049.3	73	0%	-	NM_194303	0	-		-	+1	NM_001105521.2	provisional	41	85.4%	0.736
RP5-903G2.2	0	genome.wustl.edu	37	11	67700745	67700745	+	lincRNA	SNP	A	A	G			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	A	A					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr11:67700745A>G	ENST00000527543.1	-	0	910				AC004924.1_ENST00000408626.1_RNA																							ggattttgccattaaaagtaa	0.388																																																0																																												0																															11.37:g.67700745A>G				RNA	SNP	NULL	ENST00000527543.1	37		-																																																																																			-		0.388	RP5-903G2.2-001	KNOWN	basic|exp_conf	lincRNA	lincRNA	OTTHUMT00000394105.1	76	0%	-		0	-		-	+1	ENST00000408626	novel	79	35.4%	0.217
ARHGAP20	57569	genome.wustl.edu	37	11	110477468	110477468	+	Nonsense_Mutation	SNP	C	C	A			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr11:110477468C>A	ENST00000260283.4	-	10	1065	c.781G>T	c.(781-783)Gaa>Taa	p.E261*	ARHGAP20_ENST00000527598.1_Nonsense_Mutation_p.E225*|ARHGAP20_ENST00000533353.1_Nonsense_Mutation_p.E235*|ARHGAP20_ENST00000528829.1_Nonsense_Mutation_p.E225*|ARHGAP20_ENST00000357139.3_Nonsense_Mutation_p.E235*|ARHGAP20_ENST00000524756.1_Nonsense_Mutation_p.E238*	NM_020809.3	NP_065860.2	Q9P2F6	RHG20_HUMAN	Rho GTPase activating protein 20	261	Ras-associating. {ECO:0000255|PROSITE- ProRule:PRU00166}.				regulation of small GTPase mediated signal transduction (GO:0051056)|small GTPase mediated signal transduction (GO:0007264)	cytosol (GO:0005829)	GTPase activator activity (GO:0005096)	p.E261*(1)		breast(1)|central_nervous_system(1)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1)|kidney(8)|large_intestine(18)|lung(13)|ovary(4)|prostate(2)|skin(4)|upper_aerodigestive_tract(1)	60		all_cancers(61;3.26e-12)|all_epithelial(67;6.09e-07)|Melanoma(852;1.46e-05)|all_hematologic(158;0.000484)|Acute lymphoblastic leukemia(157;0.000967)|all_neural(223;0.0199)|Medulloblastoma(222;0.0425)|Breast(348;0.0544)		Epithelial(105;3.05e-06)|BRCA - Breast invasive adenocarcinoma(274;1.24e-05)|all cancers(92;0.000147)|OV - Ovarian serous cystadenocarcinoma(223;0.0475)		TATGGATATTCATGCCCTACA	0.453																																																1	Substitution - Nonsense(1)	endometrium(1)											107.0	109.0	109.0					11																	110477468		2201	4298	6499	SO:0001587	stop_gained	57569			AB037812	CCDS31673.1, CCDS58175.1, CCDS58176.1, CCDS58177.1	11q23.2	2011-06-29			ENSG00000137727	ENSG00000137727		"""Rho GTPase activating proteins"""	18357	protein-coding gene	gene with protein product		609568				14532992	Standard	NM_020809		Approved	KIAA1391	uc001pkz.2	Q9P2F6	OTTHUMG00000166590	ENST00000260283.4:c.781G>T	11.37:g.110477468C>A	ENSP00000260283:p.Glu261*		A8K8C5|B0YIW7|B0YIW8|Q6RJU1|Q6RJU2|Q6RJU3|Q6RJU5|Q8IXS1	Nonsense_Mutation	SNP	p.E261*	ENST00000260283.4	37	CCDS31673.1	-	.	.	.	.	.	.	.	.	.	.	C	40	8.005918	0.98605	.	.	ENSG00000137727	ENST00000260283;ENST00000357139;ENST00000524756;ENST00000528829;ENST00000533353;ENST00000527598	.	.	.	5.37	5.37	0.77165	.	0.047006	0.85682	D	0.000000	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.87932	D	0	.	19.5317	0.95231	0.0:1.0:0.0:0.0	.	.	.	.	X	261;235;238;225;235;225	.	ENSP00000260283:E261X	E	-	1	0	ARHGAP20	109982678	1.000000	0.71417	0.990000	0.47175	0.967000	0.64934	6.543000	0.73874	2.681000	0.91329	0.644000	0.83932	GAA	HMMPfam_RA		0.453	ARHGAP20-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding	protein_coding	OTTHUMT00000390628.1	118	0%	-	NM_020809	0	-		-	-1	NM_020809.2	validated	164	43.9%	1.000
MANSC1	54682	genome.wustl.edu	37	12	12483036	12483036	+	Silent	SNP	G	G	A	rs375526137		TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr12:12483036G>A	ENST00000535902.1	-	4	1784	c.1221C>T	c.(1219-1221)atC>atT	p.I407I	MANSC1_ENST00000545735.1_Silent_p.I326I|MANSC1_ENST00000396349.3_Silent_p.I373I			Q9H8J5	MANS1_HUMAN	MANSC domain containing 1	407						integral component of membrane (GO:0016021)		p.I407I(1)		breast(2)|endometrium(1)|kidney(2)|large_intestine(4)|lung(9)|skin(1)|stomach(4)	23		Prostate(47;0.0865)		BRCA - Breast invasive adenocarcinoma(232;0.185)		ATTCCGAGAGGATTCTACCCA	0.463																																																1	Substitution - coding silent(1)	endometrium(1)						G		0,4406		0,0,2203	88.0	88.0	88.0		1221	2.5	0.0	12		88	1,8599	1.2+/-3.3	0,1,4299	no	coding-synonymous	MANSC1	NM_018050.2		0,1,6502	AA,AG,GG		0.0116,0.0,0.0077		407/432	12483036	1,13005	2203	4300	6503	SO:0001819	synonymous_variant	54682			AK001160	CCDS8648.1	12p13.2	2006-04-12				ENSG00000111261			25505	protein-coding gene	gene with protein product						12975309	Standard	NM_018050		Approved	FLJ10298, LOH12CR3	uc001rai.1	Q9H8J5		ENST00000535902.1:c.1221C>T	12.37:g.12483036G>A			Q8NEC1|Q9NW60	Silent	SNP	p.I407	ENST00000535902.1	37	CCDS8648.1	-																																																																																			NULL		0.463	MANSC1-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000400144.1	137	0%	-	NM_018050	103	20.3%		-	-1	NM_018050.2	validated	172	39.5%	0.019
SLCO1C1	53919	genome.wustl.edu	37	12	20893265	20893265	+	Missense_Mutation	SNP	T	T	A			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	T	T					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr12:20893265T>A	ENST00000266509.2	+	12	2064	c.1696T>A	c.(1696-1698)Tcc>Acc	p.S566T	SLCO1C1_ENST00000545102.1_Missense_Mutation_p.S448T|SLCO1C1_ENST00000381552.1_Missense_Mutation_p.S566T|SLCO1C1_ENST00000545604.1_Missense_Mutation_p.S566T|SLCO1C1_ENST00000540354.1_Missense_Mutation_p.S517T	NM_017435.4	NP_059131.1	Q9NYB5	SO1C1_HUMAN	solute carrier organic anion transporter family, member 1C1	566					sodium-independent organic anion transport (GO:0043252)|transmembrane transport (GO:0055085)	integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	transporter activity (GO:0005215)	p.S566T(2)		NS(1)|cervix(1)|endometrium(4)|kidney(3)|large_intestine(9)|liver(1)|lung(28)|ovary(5)|pancreas(1)|prostate(2)|skin(3)|stomach(1)|upper_aerodigestive_tract(1)	60	Esophageal squamous(101;0.149)				Conjugated Estrogens(DB00286)|Dextrothyroxine(DB00509)|Diclofenac(DB00586)|Digoxin(DB00390)|Dinoprostone(DB00917)|Estradiol(DB00783)|Levothyroxine(DB00451)|Liothyronine(DB00279)|Liotrix(DB01583)|Meclofenamic acid(DB00939)|Methotrexate(DB00563)|Ouabain(DB01092)|Phenytoin(DB00252)|Probenecid(DB01032)	CTATACTTTATCCCTAGGTGG	0.378																																																2	Substitution - Missense(2)	endometrium(2)											186.0	181.0	183.0					12																	20893265		2203	4300	6503	SO:0001583	missense	53919			AF260704	CCDS8683.1, CCDS53757.1, CCDS53758.1, CCDS53759.1	12p12.2	2013-05-22	2003-11-25	2003-11-26	ENSG00000139155	ENSG00000139155		"""Solute carriers"""	13819	protein-coding gene	gene with protein product		613389	"""solute carrier family 21 (organic anion transporter), member 14"""	SLC21A14			Standard	NM_017435		Approved	OATP-F, OATP1C1, OATP1	uc010sii.2	Q9NYB5	OTTHUMG00000168966	ENST00000266509.2:c.1696T>A	12.37:g.20893265T>A	ENSP00000266509:p.Ser566Thr		B7Z251|B7Z3Q3|B7Z8P1|F5GZD6|Q5JPA4	Missense_Mutation	SNP	p.S566T	ENST00000266509.2	37	CCDS8683.1	deleterious(0.845)	.	.	.	.	.	.	.	.	.	.	T	24.4	4.528644	0.85706	.	.	ENSG00000139155	ENST00000545604;ENST00000540354;ENST00000266509;ENST00000381552;ENST00000545102	T;T;T;T;D	0.81499	0.24;0.24;0.24;0.24;-1.5	4.88	4.88	0.63580	Major facilitator superfamily domain, general substrate transporter (1);Major facilitator superfamily domain (1);	0.000000	0.85682	D	0.000000	D	0.88481	0.6448	M	0.77313	2.365	0.58432	D	0.999996	D;P;P;P	0.63046	0.992;0.887;0.887;0.774	D;P;P;P	0.65140	0.932;0.775;0.823;0.627	D	0.89692	0.3898	10	0.59425	D	0.04	.	14.6543	0.68823	0.0:0.0:0.0:1.0	.	448;517;566;566	F5GZD6;B7Z3Q3;Q5JPA4;Q9NYB5	.;.;.;SO1C1_HUMAN	T	566;517;566;566;448	ENSP00000444149:S566T;ENSP00000438665:S517T;ENSP00000266509:S566T;ENSP00000370964:S566T;ENSP00000444527:S448T	ENSP00000266509:S566T	S	+	1	0	SLCO1C1	20784532	1.000000	0.71417	0.968000	0.41197	0.943000	0.58893	7.383000	0.79741	2.045000	0.60652	0.533000	0.62120	TCC	HMMPfam_OATP,superfamily_MFS_gen_substrate_transporter		0.378	SLCO1C1-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000401765.1	350	0%	probably_damaging(0.989)	NM_017435	0	-		deleterious(0.01)	+1	NM_017435.4	reviewed	441	32.9%	1.000
TUBA1A	7846	genome.wustl.edu	37	12	49579493	49579493	+	Missense_Mutation	SNP	A	A	C			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	A	A					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr12:49579493A>C	ENST00000295766.5	-	4	1135	c.656T>G	c.(655-657)aTt>aGt	p.I219S	TUBA1A_ENST00000301071.7_Missense_Mutation_p.I219S|TUBA1A_ENST00000546918.1_3'UTR|TUBA1A_ENST00000550767.1_Missense_Mutation_p.I184S	NM_001270399.1	NP_001257328.1	Q71U36	TBA1A_HUMAN	tubulin, alpha 1a	219					'de novo' posttranslational protein folding (GO:0051084)|cell division (GO:0051301)|cellular protein metabolic process (GO:0044267)|cytoskeleton-dependent intracellular transport (GO:0030705)|G2/M transition of mitotic cell cycle (GO:0000086)|microtubule-based process (GO:0007017)|mitotic cell cycle (GO:0000278)|protein folding (GO:0006457)|protein polymerization (GO:0051258)	cytoplasmic microtubule (GO:0005881)|cytoplasmic ribonucleoprotein granule (GO:0036464)|cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062)|microtubule (GO:0005874)|nucleus (GO:0005634)	GTP binding (GO:0005525)|GTPase activity (GO:0003924)|structural constituent of cytoskeleton (GO:0005200)|structural molecule activity (GO:0005198)	p.I219S(1)		stomach(1)|upper_aerodigestive_tract(1)	2					Albendazole(DB00518)|Mebendazole(DB00643)|Vinblastine(DB00570)	TGGACGCTCAATATCGAGGTT	0.473																																					Pancreas(111;782 2307 24613 44561)|NSCLC(165;1667 2752 9496 39006)|Ovarian(19;24 776 10875 37451)											1	Substitution - Missense(1)	endometrium(1)											130.0	120.0	124.0					12																	49579493		2203	4300	6503	SO:0001583	missense	7846			AF141347	CCDS8781.1, CCDS58226.1, CCDS58227.1	12q13.12	2007-02-07						"""Tubulins"""	20766	protein-coding gene	gene with protein product	"""tubulin, alpha, brain-specific"""	602529				11504633, 3839072	Standard	NM_006009		Approved	TUBA3, B-ALPHA-1, FLJ25113	uc010smg.1	Q71U36	OTTHUMG00000169511	ENST00000295766.5:c.656T>G	12.37:g.49579493A>C	ENSP00000439020:p.Ile219Ser		A8K0B8|G3V1U9|P04687|P05209	Missense_Mutation	SNP	p.I219S	ENST00000295766.5	37	CCDS58227.1	deleterious(0.637)	.	.	.	.	.	.	.	.	.	.	A	14.18	2.459663	0.43736	.	.	ENSG00000167552	ENST00000301071;ENST00000548405;ENST00000295766;ENST00000550767;ENST00000547939	T;T;T;T	0.72051	-0.62;-0.62;-0.62;-0.62	5.01	5.01	0.66863	Tubulin/FtsZ, GTPase domain (4);	0.000000	0.64402	D	0.000001	D	0.87517	0.6197	H	0.95114	3.625	0.80722	D	1	P	0.40000	0.698	P	0.57371	0.819	D	0.90315	0.4340	10	0.87932	D	0	.	13.7215	0.62730	1.0:0.0:0.0:0.0	.	219	Q71U36	TBA1A_HUMAN	S	219;66;219;184;184	ENSP00000301071:I219S;ENSP00000439020:I219S;ENSP00000446637:I184S;ENSP00000450268:I184S	ENSP00000439020:I219S	I	-	2	0	TUBA1A	47865760	1.000000	0.71417	1.000000	0.80357	0.878000	0.50629	8.544000	0.90654	1.886000	0.54624	0.379000	0.24179	ATT	HMMPfam_Tubulin,superfamily_Tubulin nucleotide-binding domain-like		0.473	TUBA1A-002	PUTATIVE	basic|appris_principal|exp_conf|CCDS	protein_coding	protein_coding	OTTHUMT00000404547.2	255	0%	possibly_damaging(0.564)	NM_006009	127	29.9%		deleterious(0)	-1	NM_006009.2	reviewed	292	45.2%	1.000
OR6C65	403282	genome.wustl.edu	37	12	55794637	55794637	+	Missense_Mutation	SNP	G	G	A			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr12:55794637G>A	ENST00000379665.2	+	1	424	c.325G>A	c.(325-327)Gaa>Aaa	p.E109K		NM_001005518.1	NP_001005518.1	A6NJZ3	O6C65_HUMAN	olfactory receptor, family 6, subfamily C, member 65	109						integral component of membrane (GO:0016021)|plasma membrane (GO:0005886)	G-protein coupled receptor activity (GO:0004930)|olfactory receptor activity (GO:0004984)	p.E109K(1)		cervix(1)|endometrium(2)|large_intestine(3)|lung(9)	15						GGGATCAACAGAATTTTTTCT	0.368																																																1	Substitution - Missense(1)	endometrium(1)											86.0	92.0	90.0					12																	55794637		2203	4300	6503	SO:0001583	missense	403282				CCDS31821.1	12q13.2	2013-09-23			ENSG00000205328	ENSG00000205328		"""GPCR / Class A : Olfactory receptors"""	31295	protein-coding gene	gene with protein product							Standard	NM_001005518		Approved		uc010spl.2	A6NJZ3	OTTHUMG00000169955	ENST00000379665.2:c.325G>A	12.37:g.55794637G>A	ENSP00000368986:p.Glu109Lys		B2RNH9	Missense_Mutation	SNP	p.E109K	ENST00000379665.2	37	CCDS31821.1	deleterious(0.779)	.	.	.	.	.	.	.	.	.	.	G	17.57	3.421982	0.62622	.	.	ENSG00000205328	ENST00000379665	T	0.00414	7.52	3.4	3.4	0.38934	GPCR, rhodopsin-like superfamily (1);	0.000000	0.35677	U	0.003045	T	0.00906	0.0030	M	0.92923	3.36	0.30084	N	0.808909	P	0.50528	0.936	P	0.46362	0.514	T	0.05257	-1.0896	10	0.87932	D	0	.	14.9474	0.71042	0.0:0.0:1.0:0.0	.	109	A6NJZ3	O6C65_HUMAN	K	109	ENSP00000368986:E109K	ENSP00000368986:E109K	E	+	1	0	OR6C65	54080904	0.997000	0.39634	0.465000	0.27155	0.873000	0.50193	2.467000	0.45093	1.909000	0.55274	0.424000	0.28305	GAA	HMMPfam_7tm_1,PatternScan_G_PROTEIN_RECEP_F1_1,superfamily_SSF81321		0.368	OR6C65-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000406674.1	130	0%	possibly_damaging(0.925)		0	-		deleterious(0.01)	+1	NM_001005518.1	provisional	121	38%	0.811
MTUS2	23281	genome.wustl.edu	37	13	30071441	30071441	+	Missense_Mutation	SNP	G	G	A			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr13:30071441G>A	ENST00000380808.2	+	6	799	c.583G>A	c.(583-585)Gcc>Acc	p.A195T	MTUS2_ENST00000542829.1_Missense_Mutation_p.A105T|MTUS2_ENST00000431530.3_Missense_Mutation_p.A1226T|MTUS2_ENST00000400542.3_3'UTR	NM_015233.5	NP_056048.1	Q5JR59	MTUS2_HUMAN	microtubule associated tumor suppressor candidate 2	1216						cytoplasm (GO:0005737)|microtubule (GO:0005874)	microtubule binding (GO:0008017)|protein homodimerization activity (GO:0042803)	p.A195T(1)|p.A1226T(1)		NS(1)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(6)|lung(3)|prostate(1)|skin(1)	20						CTTCGAAGAGGCCTTGAGGAA	0.627																																																2	Substitution - Missense(2)	endometrium(2)											34.0	44.0	40.0					13																	30071441		2078	4227	6305	SO:0001583	missense	23281			AB018317	CCDS41874.1, CCDS45022.1	13q12.3	2013-01-17	2009-10-20	2009-10-20	ENSG00000132938	ENSG00000132938			20595	protein-coding gene	gene with protein product	"""+TIP of 150 kDa"", ""cardiac zipper protein"""		"""KIAA0774"""	KIAA0774		19543227	Standard	NM_001033602		Approved	TIP150, CAZIP, ICIS	uc001usl.4	Q5JR59	OTTHUMG00000016657	ENST00000380808.2:c.583G>A	13.37:g.30071441G>A	ENSP00000370186:p.Ala195Thr		A7E292|B4DF81|O94872|Q08E97|Q5JQR3|Q8N5E2	Missense_Mutation	SNP	p.A1226T	ENST00000380808.2	37	CCDS41874.1	deleterious(0.559)	.	.	.	.	.	.	.	.	.	.	G	35	5.563409	0.96527	.	.	ENSG00000132938	ENST00000431530;ENST00000380808;ENST00000542829;ENST00000417109	T;T;T	0.24723	2.61;2.15;1.84	5.17	5.17	0.71159	.	0.000000	0.85682	D	0.000000	T	0.52533	0.1740	M	0.73962	2.25	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.87578	0.997;0.998	T	0.50065	-0.8871	9	.	.	.	.	17.8315	0.88684	0.0:0.0:1.0:0.0	.	195;1216	Q5JR59-3;Q5JR59	.;MTUS2_HUMAN	T	1226;195;105;152	ENSP00000392057:A1226T;ENSP00000370186:A195T;ENSP00000445403:A105T	.	A	+	1	0	MTUS2	28969441	1.000000	0.71417	0.998000	0.56505	0.944000	0.59088	8.895000	0.92512	2.677000	0.91161	0.655000	0.94253	GCC	NULL		0.627	MTUS2-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000044335.2	76	0%	probably_damaging(1)	XM_166270	0	-		tolerated(0.17)	+1	NM_001033602.2	validated	75	26.7%	1.000
FOXO1	2308	genome.wustl.edu	37	13	41133979	41133979	+	Missense_Mutation	SNP	G	G	A	rs149675484		TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr13:41133979G>A	ENST00000379561.5	-	2	2033	c.1649C>T	c.(1648-1650)tCg>tTg	p.S550L	FOXO1_ENST00000473775.1_5'Flank	NM_002015.3	NP_002006.2	Q12778	FOXO1_HUMAN	forkhead box O1	550	Sufficient for interaction with NLK. {ECO:0000250}.				apoptotic process (GO:0006915)|autophagy (GO:0006914)|blood vessel development (GO:0001568)|cellular glucose homeostasis (GO:0001678)|cellular response to cold (GO:0070417)|cellular response to DNA damage stimulus (GO:0006974)|cellular response to hyperoxia (GO:0071455)|cellular response to insulin stimulus (GO:0032869)|cellular response to nitric oxide (GO:0071732)|cellular response to oxidative stress (GO:0034599)|cellular response to starvation (GO:0009267)|endocrine pancreas development (GO:0031018)|epidermal growth factor receptor signaling pathway (GO:0007173)|fat cell differentiation (GO:0045444)|Fc-epsilon receptor signaling pathway (GO:0038095)|fibroblast growth factor receptor signaling pathway (GO:0008543)|innate immune response (GO:0045087)|insulin receptor signaling pathway (GO:0008286)|negative regulation of apoptotic process (GO:0043066)|negative regulation of fat cell differentiation (GO:0045599)|negative regulation of stress-activated MAPK cascade (GO:0032873)|negative regulation of transcription, DNA-templated (GO:0045892)|neurotrophin TRK receptor signaling pathway (GO:0048011)|phosphatidylinositol-mediated signaling (GO:0048015)|positive regulation of apoptotic process (GO:0043065)|positive regulation of autophagy (GO:0010508)|positive regulation of gluconeogenesis (GO:0045722)|positive regulation of protein catabolic process (GO:0045732)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription, DNA-templated (GO:0045893)|protein acetylation (GO:0006473)|regulation of cell proliferation (GO:0042127)|regulation of energy homeostasis (GO:2000505)|regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter (GO:0035947)|temperature homeostasis (GO:0001659)	cytoplasm (GO:0005737)|cytosol (GO:0005829)|mitochondrion (GO:0005739)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)	chromatin binding (GO:0003682)|protein phosphatase 2A binding (GO:0051721)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription (GO:0001078)|sequence-specific DNA binding (GO:0043565)|transcription factor binding transcription factor activity (GO:0000989)|ubiquitin protein ligase binding (GO:0031625)	p.S550L(2)	PAX7/FOXO1(197)|PAX3/FOXO1(749)	central_nervous_system(1)|cervix(1)|endometrium(5)|haematopoietic_and_lymphoid_tissue(7)|kidney(1)|large_intestine(2)|lung(2)|upper_aerodigestive_tract(1)	20		Lung NSC(96;1.18e-05)|Breast(139;0.00394)|Prostate(109;0.0181)|Lung SC(185;0.0262)|Hepatocellular(188;0.194)		all cancers(112;7.32e-09)|Epithelial(112;2.87e-06)|OV - Ovarian serous cystadenocarcinoma(117;6.98e-05)|GBM - Glioblastoma multiforme(144;0.00394)|BRCA - Breast invasive adenocarcinoma(63;0.0815)		GTTCATACCCGAGGTGTGGGG	0.612																																																2	Substitution - Missense(2)	endometrium(2)						G	LEU/SER	0,4406		0,0,2203	123.0	120.0	121.0		1649	5.7	0.9	13	dbSNP_134	121	2,8598	2.2+/-6.3	0,2,4298	yes	missense	FOXO1	NM_002015.3	145	0,2,6501	AA,AG,GG		0.0233,0.0,0.0154	benign	550/656	41133979	2,13004	2203	4300	6503	SO:0001583	missense	2308				CCDS9371.1	13q14.1	2011-08-01	2007-05-02	2007-05-02	ENSG00000150907	ENSG00000150907		"""Forkhead boxes"""	3819	protein-coding gene	gene with protein product		136533	"""forkhead homolog in rhabdomyosarcoma"""	FKHR, FOXO1A		8275086, 15057823	Standard	NM_002015		Approved	FKH1	uc001uxl.4	Q12778	OTTHUMG00000016775	ENST00000379561.5:c.1649C>T	13.37:g.41133979G>A	ENSP00000368880:p.Ser550Leu		O43523|Q5VYC7|Q6NSK6	Missense_Mutation	SNP	p.S550L	ENST00000379561.5	37	CCDS9371.1	neutral(0.277)	.	.	.	.	.	.	.	.	.	.	G	11.76	1.735737	0.30774	0.0	2.33E-4	ENSG00000150907	ENST00000379561	D	0.94417	-3.42	5.65	5.65	0.86999	.	1.090100	0.06854	N	0.797917	D	0.92864	0.7730	L	0.55481	1.735	0.34199	D	0.672967	P	0.40398	0.716	B	0.30251	0.113	D	0.89566	0.3810	10	0.44086	T	0.13	-10.344	18.7201	0.91689	0.0:0.0:1.0:0.0	.	550	Q12778	FOXO1_HUMAN	L	550	ENSP00000368880:S550L	ENSP00000368880:S550L	S	-	2	0	FOXO1	40031979	0.988000	0.35896	0.872000	0.34217	0.381000	0.30169	4.080000	0.57620	2.668000	0.90789	0.655000	0.94253	TCG	NULL		0.612	FOXO1-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000044634.3	157	0%	benign(0.075)	NM_002015	16	25%		tolerated(0.11)	-1	NM_002015.3	reviewed	140	35%	0.815
SPTBN5	51332	genome.wustl.edu	37	15	42149884	42149884	+	Missense_Mutation	SNP	C	C	G			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr15:42149884C>G	ENST00000320955.6	-	50	8478	c.8251G>C	c.(8251-8253)Ggc>Cgc	p.G2751R		NM_016642.2	NP_057726.4	Q9NRC6	SPTN5_HUMAN	spectrin, beta, non-erythrocytic 5	2751					actin cytoskeleton organization (GO:0030036)|actin filament capping (GO:0051693)|axon guidance (GO:0007411)|Golgi organization (GO:0007030)|lysosomal transport (GO:0007041)|protein homooligomerization (GO:0051260)	cytoplasm (GO:0005737)|cytosol (GO:0005829)|extracellular vesicular exosome (GO:0070062)|membrane (GO:0016020)|photoreceptor connecting cilium (GO:0032391)|photoreceptor disc membrane (GO:0097381)|spectrin (GO:0008091)	actin binding (GO:0003779)|dynactin binding (GO:0034452)|dynein intermediate chain binding (GO:0045505)|kinesin binding (GO:0019894)|myosin tail binding (GO:0032029)|protein self-association (GO:0043621)|spectrin binding (GO:0030507)	p.G2751R(1)		NS(1)|breast(1)|central_nervous_system(3)|endometrium(9)|haematopoietic_and_lymphoid_tissue(3)|kidney(4)|large_intestine(6)|lung(18)|ovary(5)|prostate(8)|skin(2)|stomach(1)|upper_aerodigestive_tract(1)	62		all_cancers(109;1.84e-17)|all_epithelial(112;1.12e-15)|Lung NSC(122;7.6e-10)|all_lung(180;4.15e-09)|Melanoma(134;0.0179)|Ovarian(310;0.143)|Colorectal(260;0.173)		all cancers(2;4.33e-34)|Epithelial(2;1.72e-25)|OV - Ovarian serous cystadenocarcinoma(18;8.32e-20)|GBM - Glioblastoma multiforme(94;4.69e-07)|Colorectal(2;0.00104)|COAD - Colon adenocarcinoma(120;0.0405)|READ - Rectum adenocarcinoma(92;0.0908)		GCTGGGTGGCCCCCCTGCAGC	0.612																																																1	Substitution - Missense(1)	endometrium(1)											13.0	17.0	16.0					15																	42149884		2009	4170	6179	SO:0001583	missense	51332			AF233523	CCDS61599.1	15q21	2010-08-17			ENSG00000137877	ENSG00000137877			15680	protein-coding gene	gene with protein product	"""beta V spectrin"""	605916				10764729	Standard	NM_016642		Approved	HUSPECV, BSPECV, HUBSPECV	uc001zos.4	Q9NRC6		ENST00000320955.6:c.8251G>C	15.37:g.42149884C>G	ENSP00000317790:p.Gly2751Arg			Missense_Mutation	SNP	p.G2716R	ENST00000320955.6	37		neutral(0.403)	.	.	.	.	.	.	.	.	.	.	.	5.913	0.352527	0.11182	.	.	ENSG00000137877	ENST00000320955	T	0.54675	0.56	4.72	3.81	0.43845	.	0.706089	0.12250	N	0.485722	T	0.59528	0.2200	M	0.64997	1.995	0.09310	N	1	D	0.54772	0.968	P	0.58331	0.837	T	0.46091	-0.9216	10	0.21014	T	0.42	.	5.8419	0.18639	0.0:0.6545:0.1605:0.185	.	2751	Q9NRC6	SPTN5_HUMAN	R	2751	ENSP00000317790:G2751R	ENSP00000317790:G2751R	G	-	1	0	SPTBN5	39937176	0.000000	0.05858	0.087000	0.20705	0.107000	0.19398	0.401000	0.20948	0.970000	0.38263	0.467000	0.42956	GGC	HMMPfam_Spectrin,HMMSmart_SM00150,superfamily_Spectrin repeat		0.612	SPTBN5-001	KNOWN	basic|appris_principal	protein_coding	protein_coding	OTTHUMT00000420237.1	31	0%	possibly_damaging(0.88)	NM_016642	1	100%		tolerated(0.16)	-1	NM_016642.2	validated	20	85%	0.039
CACNG3	10368	genome.wustl.edu	37	16	24373179	24373179	+	Missense_Mutation	SNP	G	G	A			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr16:24373179G>A	ENST00000005284.3	+	4	2145	c.943G>A	c.(943-945)Gtc>Atc	p.V315I		NM_006539.3	NP_006530.1	O60359	CCG3_HUMAN	calcium channel, voltage-dependent, gamma subunit 3	315					calcium ion transport (GO:0006816)|regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity (GO:2000311)|synaptic transmission (GO:0007268)	alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex (GO:0032281)|endocytic vesicle membrane (GO:0030666)|plasma membrane (GO:0005886)|voltage-gated calcium channel complex (GO:0005891)	voltage-gated calcium channel activity (GO:0005245)	p.V315I(2)		NS(2)|breast(1)|endometrium(4)|kidney(2)|large_intestine(10)|lung(13)|ovary(2)|prostate(4)|skin(2)	40				GBM - Glioblastoma multiforme(48;0.0809)		CACCACGCCCGTCTGAACTGA	0.552																																																2	Substitution - Missense(2)	NS(1)|endometrium(1)											37.0	39.0	38.0					16																	24373179		2197	4300	6497	SO:0001583	missense	10368			AF131911	CCDS10620.1	16p12.1	2008-05-14			ENSG00000006116	ENSG00000006116		"""Calcium channel subunits"""	1407	protein-coding gene	gene with protein product		606403				10221464, 10493829	Standard	NM_006539		Approved		uc002dmf.3	O60359	OTTHUMG00000131651	ENST00000005284.3:c.943G>A	16.37:g.24373179G>A	ENSP00000005284:p.Val315Ile			Missense_Mutation	SNP	p.V315I	ENST00000005284.3	37	CCDS10620.1	deleterious(0.702)	.	.	.	.	.	.	.	.	.	.	g	25.7	4.660745	0.88154	.	.	ENSG00000006116	ENST00000005284	T	0.66099	-0.19	4.93	4.93	0.64822	.	0.000000	0.85682	D	0.000000	T	0.78091	0.4229	M	0.65498	2.005	0.58432	D	0.999999	D	0.89917	1.0	D	0.80764	0.994	T	0.80832	-0.1206	10	0.72032	D	0.01	.	17.8078	0.88607	0.0:0.0:1.0:0.0	.	315	O60359	CCG3_HUMAN	I	315	ENSP00000005284:V315I	ENSP00000005284:V315I	V	+	1	0	CACNG3	24280680	1.000000	0.71417	0.998000	0.56505	0.998000	0.95712	9.472000	0.97709	2.266000	0.75297	0.645000	0.84053	GTC	NULL		0.552	CACNG3-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000254548.1	27	0%	possibly_damaging(0.791)	NM_006539	0	-		deleterious(0.01)	+1	NM_006539.2	reviewed	29	44.8%	1.000
USP6	9098	genome.wustl.edu	37	17	5038539	5038539	+	Silent	SNP	C	C	T			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr17:5038539C>T	ENST00000574788.1	+	16	2735	c.505C>T	c.(505-507)Cta>Tta	p.L169L	USP6_ENST00000304328.5_5'UTR|USP6_ENST00000250066.6_Silent_p.L169L|USP6_ENST00000332776.4_Silent_p.L169L			P35125	UBP6_HUMAN	ubiquitin specific peptidase 6	169	Rab-GAP TBC. {ECO:0000255|PROSITE- ProRule:PRU00163}.				cellular protein modification process (GO:0006464)|protein deubiquitination (GO:0016579)|regulation of vesicle-mediated transport (GO:0060627)|ubiquitin-dependent protein catabolic process (GO:0006511)	cytoplasm (GO:0005737)|lysosome (GO:0005764)|plasma membrane (GO:0005886)|recycling endosome (GO:0055037)	calmodulin binding (GO:0005516)|cysteine-type endopeptidase activity (GO:0004197)|nucleic acid binding (GO:0003676)|Rab GTPase activator activity (GO:0005097)|ubiquitin-specific protease activity (GO:0004843)	p.L169L(2)		breast(2)|central_nervous_system(1)|endometrium(1)|kidney(4)|large_intestine(4)|lung(15)|ovary(1)|prostate(1)|skin(3)|stomach(1)|upper_aerodigestive_tract(1)	34						GCAGAGGGAACTATTCTACAT	0.468			T	"""COL1A1, CDH11, ZNF9, OMD"""	aneurysmal bone cysts																																		Dom	yes		17	17p13	9098	ubiquitin specific peptidase 6 (Tre-2 oncogene)		M	2	Substitution - coding silent(2)	endometrium(2)											134.0	130.0	131.0					17																	5038539		2203	4300	6503	SO:0001819	synonymous_variant	9098			X63547	CCDS11069.2	17p13	2014-06-12	2014-06-12		ENSG00000129204	ENSG00000129204	3.4.19.12	"""Ubiquitin-specific peptidases"""	12629	protein-coding gene	gene with protein product	"""ubiquitin carboxyl-terminal hydrolase 6"", ""TBC1D3 and USP32 fusion"", ""Tre-2 oncogene"""	604334	"""ubiquitin specific protease 6 (Tre-2 oncogene)"", ""TRE oncogene, Smith Magenis syndrome chromosome region"", ""ubiquitin specific peptidase 6 (Tre-2 oncogene)"""	HRP1, TRESMCR		12838346, 1349106	Standard	NM_004505		Approved	Tre-2, TRE17, Tre2	uc002gav.1	P35125	OTTHUMG00000099449	ENST00000574788.1:c.505C>T	17.37:g.5038539C>T			Q15634|Q86WP6|Q8IWT4	Silent	SNP	p.L169	ENST00000574788.1	37	CCDS11069.2	-																																																																																			HMMPfam_TBC,HMMSmart_SM00164,superfamily_Ypt/Rab-GAP domain of gyp1p		0.468	USP6-002	KNOWN	alternative_5_UTR|basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000438990.1	298	0%	-	NM_004505	0	-		-	+1	NM_004505.2	validated	328	85.4%	0.998
TP53	7157	genome.wustl.edu	37	17	7578429	7578429	+	Frame_Shift_Del	DEL	C	C	-			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr17:7578429delC	ENST00000269305.4	-	5	690	c.501delG	c.(499-501)cagfs	p.Q167fs	TP53_ENST00000359597.4_Frame_Shift_Del_p.Q167fs|TP53_ENST00000445888.2_Frame_Shift_Del_p.Q167fs|TP53_ENST00000413465.2_Frame_Shift_Del_p.Q167fs|TP53_ENST00000574684.1_5'UTR|TP53_ENST00000420246.2_Frame_Shift_Del_p.Q167fs|TP53_ENST00000455263.2_Frame_Shift_Del_p.Q167fs	NM_000546.5|NM_001126112.2|NM_001126118.1|NM_001276760.1|NM_001276761.1	NP_000537.3|NP_001119584.1|NP_001119590.1|NP_001263689.1|NP_001263690.1	P04637	P53_HUMAN	tumor protein p53	167	Interaction with AXIN1. {ECO:0000250}.|Interaction with HIPK1. {ECO:0000250}.|Required for interaction with FBXO42.|Required for interaction with ZNF385A.		Q -> H (in sporadic cancers; somatic mutation).|Q -> K (in LFS; germline mutation and in a sporadic cancer; somatic mutation).|Q -> L (in sporadic cancers; somatic mutation).|Q -> R (in sporadic cancers; somatic mutation).|QH -> HD (in a sporadic cancer; somatic mutation).|QH -> YL (in a sporadic cancer; somatic mutation).		apoptotic process (GO:0006915)|B cell lineage commitment (GO:0002326)|base-excision repair (GO:0006284)|blood coagulation (GO:0007596)|cell aging (GO:0007569)|cell cycle arrest (GO:0007050)|cell differentiation (GO:0030154)|cell proliferation (GO:0008283)|cellular protein localization (GO:0034613)|cellular response to DNA damage stimulus (GO:0006974)|cellular response to drug (GO:0035690)|cellular response to glucose starvation (GO:0042149)|cellular response to hypoxia (GO:0071456)|cellular response to ionizing radiation (GO:0071479)|cellular response to UV (GO:0034644)|cerebellum development (GO:0021549)|chromatin assembly (GO:0031497)|determination of adult lifespan (GO:0008340)|DNA damage response, signal transduction by p53 class mediator (GO:0030330)|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)|DNA strand renaturation (GO:0000733)|double-strand break repair (GO:0006302)|embryonic organ development (GO:0048568)|ER overload response (GO:0006983)|gastrulation (GO:0007369)|in utero embryonic development (GO:0001701)|intrinsic apoptotic signaling pathway (GO:0097193)|intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)|mitotic cell cycle arrest (GO:0071850)|mitotic G1 DNA damage checkpoint (GO:0031571)|multicellular organism growth (GO:0035264)|multicellular organismal development (GO:0007275)|necroptotic process (GO:0070266)|negative regulation of apoptotic process (GO:0043066)|negative regulation of cell growth (GO:0030308)|negative regulation of cell proliferation (GO:0008285)|negative regulation of DNA replication (GO:0008156)|negative regulation of fibroblast proliferation (GO:0048147)|negative regulation of helicase activity (GO:0051097)|negative regulation of macromitophagy (GO:1901525)|negative regulation of neuroblast proliferation (GO:0007406)|negative regulation of reactive oxygen species metabolic process (GO:2000378)|negative regulation of transcription from RNA polymerase II promoter (GO:0000122)|negative regulation of transcription, DNA-templated (GO:0045892)|negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)|neuron apoptotic process (GO:0051402)|Notch signaling pathway (GO:0007219)|nucleotide-excision repair (GO:0006289)|oligodendrocyte apoptotic process (GO:0097252)|oxidative stress-induced premature senescence (GO:0090403)|positive regulation of apoptotic process (GO:0043065)|positive regulation of cardiac muscle cell apoptotic process (GO:0010666)|positive regulation of cell aging (GO:0090343)|positive regulation of cell cycle arrest (GO:0071158)|positive regulation of histone deacetylation (GO:0031065)|positive regulation of intrinsic apoptotic signaling pathway (GO:2001244)|positive regulation of mitochondrial membrane permeability (GO:0035794)|positive regulation of neuron apoptotic process (GO:0043525)|positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)|positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740)|positive regulation of protein oligomerization (GO:0032461)|positive regulation of reactive oxygen species metabolic process (GO:2000379)|positive regulation of release of cytochrome c from mitochondria (GO:0090200)|positive regulation of thymocyte apoptotic process (GO:0070245)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription, DNA-templated (GO:0045893)|protein complex assembly (GO:0006461)|protein import into nucleus, translocation (GO:0000060)|protein localization (GO:0008104)|protein tetramerization (GO:0051262)|Ras protein signal transduction (GO:0007265)|regulation of apoptotic process (GO:0042981)|regulation of mitochondrial membrane permeability (GO:0046902)|regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108)|regulation of tissue remodeling (GO:0034103)|regulation of transcription, DNA-templated (GO:0006355)|release of cytochrome c from mitochondria (GO:0001836)|replicative senescence (GO:0090399)|response to antibiotic (GO:0046677)|response to gamma radiation (GO:0010332)|response to ischemia (GO:0002931)|response to salt stress (GO:0009651)|response to X-ray (GO:0010165)|rRNA transcription (GO:0009303)|somitogenesis (GO:0001756)|T cell differentiation in thymus (GO:0033077)|T cell lineage commitment (GO:0002360)|T cell proliferation involved in immune response (GO:0002309)|transforming growth factor beta receptor signaling pathway (GO:0007179)|viral process (GO:0016032)	chromatin (GO:0000785)|cytoplasm (GO:0005737)|cytosol (GO:0005829)|endoplasmic reticulum (GO:0005783)|mitochondrial matrix (GO:0005759)|mitochondrion (GO:0005739)|nuclear chromatin (GO:0000790)|nuclear matrix (GO:0016363)|nucleolus (GO:0005730)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|PML body (GO:0016605)|protein complex (GO:0043234)|replication fork (GO:0005657)	ATP binding (GO:0005524)|chaperone binding (GO:0051087)|chromatin binding (GO:0003682)|copper ion binding (GO:0005507)|damaged DNA binding (GO:0003684)|DNA binding (GO:0003677)|enzyme binding (GO:0019899)|histone acetyltransferase binding (GO:0035035)|histone deacetylase regulator activity (GO:0035033)|identical protein binding (GO:0042802)|p53 binding (GO:0002039)|protease binding (GO:0002020)|protein heterodimerization activity (GO:0046982)|protein kinase binding (GO:0019901)|protein N-terminus binding (GO:0047485)|protein phosphatase 2A binding (GO:0051721)|protein phosphatase binding (GO:0019903)|receptor tyrosine kinase binding (GO:0030971)|RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001077)|RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979)|RNA polymerase II transcription factor binding (GO:0001085)|RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001228)|sequence-specific DNA binding transcription factor activity (GO:0003700)|transcription factor binding (GO:0008134)|transcription regulatory region DNA binding (GO:0044212)|ubiquitin protein ligase binding (GO:0031625)|zinc ion binding (GO:0008270)	p.0?(8)|p.Q167H(3)|p.Q167fs*3(3)|p.Q167Q(3)|p.Q167fs*14(2)|p.V157_C176del20(1)|p.Q167_H168>YL(1)|p.Q167del(1)|p.A159_Q167delAMAIYKQSQ(1)|p.Q167fs*4(1)|p.Y163fs*1(1)|p.Q35fs*3(1)|p.Q167fs*12(1)|p.P151_V173del23(1)|p.Q165_M169delQSQHM(1)|p.S149fs*72(1)|p.Q167_H168>HD(1)|p.Q74fs*3(1)|p.H168fs*5(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)	Acetylsalicylic acid(DB00945)	CCGTCATGTGCTGTGACTGCT	0.642		111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""		Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)																											Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53		"""L, E, M, O"""	33	Deletion - Frameshift(8)|Whole gene deletion(8)|Deletion - In frame(5)|Insertion - Frameshift(4)|Substitution - Missense(3)|Substitution - coding silent(3)|Complex - compound substitution(2)	breast(7)|lung(6)|haematopoietic_and_lymphoid_tissue(4)|bone(4)|stomach(2)|central_nervous_system(2)|oesophagus(2)|prostate(2)|upper_aerodigestive_tract(1)|biliary_tract(1)|salivary_gland(1)|ovary(1)											54.0	54.0	54.0					17																	7578429		2203	4300	6503	SO:0001589	frameshift_variant	7157	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	AF307851	CCDS11118.1, CCDS45605.1, CCDS45606.1, CCDS73963.1, CCDS73964.1, CCDS73965.1, CCDS73966.1, CCDS73967.1, CCDS73968.1, CCDS73969.1, CCDS73970.1, CCDS73971.1	17p13.1	2014-09-17	2008-01-16		ENSG00000141510	ENSG00000141510			11998	protein-coding gene	gene with protein product	"""Li-Fraumeni syndrome"""	191170				6396087, 3456488, 2047879	Standard	NM_001126115		Approved	p53, LFS1	uc002gij.3	P04637	OTTHUMG00000162125	ENST00000269305.4:c.501delG	17.37:g.7578429delC	ENSP00000269305:p.Gln167fs		Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	Frame_Shift_Del	DEL	p.Q167fs	ENST00000269305.4	37	CCDS11118.1	-																																																																																			superfamily_p53-like transcription factors,HMMPfam_P53		0.642	TP53-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000367397.1	-	-	-	NM_000546	-	-		-	-1	NM_000546.4	reviewed	-	-	0.986
DNAH2	146754	genome.wustl.edu	37	17	7678610	7678610	+	Missense_Mutation	SNP	G	G	A			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr17:7678610G>A	ENST00000572933.1	+	30	6231	c.4771G>A	c.(4771-4773)Ggc>Agc	p.G1591S	DNAH2_ENST00000389173.2_Missense_Mutation_p.G1591S			Q9P225	DYH2_HUMAN	dynein, axonemal, heavy chain 2	1591	Stem. {ECO:0000250}.				cilium or flagellum-dependent cell motility (GO:0001539)|metabolic process (GO:0008152)|microtubule-based movement (GO:0007018)	axonemal dynein complex (GO:0005858)|microtubule (GO:0005874)	ATP binding (GO:0005524)|ATPase activity (GO:0016887)|microtubule motor activity (GO:0003777)	p.G1591S(1)		NS(3)|breast(11)|central_nervous_system(1)|cervix(3)|endometrium(18)|haematopoietic_and_lymphoid_tissue(2)|kidney(16)|large_intestine(53)|liver(2)|lung(49)|ovary(7)|prostate(7)|skin(15)|upper_aerodigestive_tract(1)|urinary_tract(1)	189		all_cancers(10;4.66e-07)|Prostate(122;0.081)				CTCGGGCGACGGCGAGTACAT	0.552																																																1	Substitution - Missense(1)	endometrium(1)											94.0	80.0	85.0					17																	7678610		2203	4300	6503	SO:0001583	missense	146754			U83570, AK128517	CCDS32551.1	17p13.1	2007-10-05	2006-09-04			ENSG00000183914		"""Axonemal dyneins"""	2948	protein-coding gene	gene with protein product		603333	"""dynein, axonemal, heavy polypeptide 2"", ""dynein heavy chain domain 3"""	DNHD3		9256245	Standard	XM_005256470		Approved	KIAA1503, FLJ46675	uc002giu.1	Q9P225		ENST00000572933.1:c.4771G>A	17.37:g.7678610G>A	ENSP00000458355:p.Gly1591Ser		A8K992|B5MDX5|O15434|Q6PIH3|Q6ZR42	Missense_Mutation	SNP	p.G1591S	ENST00000572933.1	37	CCDS32551.1	deleterious(0.905)	.	.	.	.	.	.	.	.	.	.	G	23.7	4.444437	0.83993	.	.	ENSG00000183914	ENST00000360606;ENST00000389173	T	0.64803	-0.12	5.43	5.43	0.79202	Dynein heavy chain, domain-2 (1);	0.000000	0.85682	D	0.000000	D	0.83399	0.5246	M	0.90425	3.115	0.80722	D	1	D	0.89917	1.0	D	0.87578	0.998	D	0.86645	0.1894	10	0.72032	D	0.01	.	18.0166	0.89242	0.0:0.0:1.0:0.0	.	1591	Q9P225	DYH2_HUMAN	S	1591	ENSP00000373825:G1591S	ENSP00000353818:G1591S	G	+	1	0	DNAH2	7619335	1.000000	0.71417	0.969000	0.41365	0.265000	0.26407	6.628000	0.74262	2.548000	0.85928	0.637000	0.83480	GGC	HMMPfam_DHC_N2		0.552	DNAH2-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000440241.1	241	0%	probably_damaging(1)	NM_020877	0	-		deleterious(0.01)	+1	NM_020877.2	validated	190	84.7%	1.000
LGALS9B	284194	genome.wustl.edu	37	17	20370782	20370783	+	Start_Codon_Ins	INS	-	-	TC	rs10687699|rs554373055|rs372509656	byFrequency	TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	-	-					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr17:20370782_20370783insTC	ENST00000423676.3	-	0	64_65				LGALS9B_ENST00000324290.5_Start_Codon_Ins			Q3B8N2	LEG9B_HUMAN	lectin, galactoside-binding, soluble, 9B								carbohydrate binding (GO:0030246)	p.M1fs*12(1)		central_nervous_system(1)|endometrium(1)|large_intestine(2)|lung(3)|skin(1)|upper_aerodigestive_tract(2)	10						GCTGAAGGCCATCTCCACCGCC	0.584														831	0.165935	0.2504	0.1326	5008	,	,		9041	0.127		0.1481	False		,,,				2504	0.1339															1	Insertion - Frameshift(1)	central_nervous_system(1)								372,1470		152,68,701						2.5	0.7		dbSNP_130	3	715,5069		234,247,2411	no	frameshift	LGALS9B	NM_001042685.1		386,315,3112	A1A1,A1R,RR		12.3617,20.1954,14.2539				1087,6539				SO:0001582	initiator_codon_variant	284194				CCDS42283.1	17p11.2	2011-08-04			ENSG00000170298	ENSG00000170298		"""Lectins, galactoside-binding"""	24842	protein-coding gene	gene with protein product						11997339	Standard	NM_001042685		Approved		uc002gwz.1	Q3B8N2	OTTHUMG00000130730	ENST00000423676.3:c.0_1dupGA	17.37:g.20370785_20370786dupTC			A6NLF8|A8K2J8	Frame_Shift_Ins	INS	p.M1fs	ENST00000423676.3	37		-																																																																																			NULL		0.584	LGALS9B-001	KNOWN	basic|appris_candidate_longest	protein_coding	protein_coding	OTTHUMT00000253230.2	-	-	-	NM_001042685	-	-		-	-1	NM_001042685.1	validated	-	-	0.878:0.831
HID1	283987	genome.wustl.edu	37	17	72951984	72951984	+	Missense_Mutation	SNP	G	G	C			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr17:72951984G>C	ENST00000425042.2	-	13	1616	c.1539C>G	c.(1537-1539)ttC>ttG	p.F513L		NM_030630.2	NP_085133.1	Q8IV36	HID1_HUMAN	HID1 domain containing	513					intracellular protein transport (GO:0006886)|response to brefeldin A (GO:0031001)	cytoplasm (GO:0005737)|cytoplasmic microtubule (GO:0005881)|extracellular vesicular exosome (GO:0070062)|extrinsic component of Golgi membrane (GO:0090498)|Golgi apparatus (GO:0005794)|Golgi medial cisterna (GO:0005797)|Golgi trans cisterna (GO:0000138)		p.F513L(1)									AGGTGGTGGAGAAGGCCTCCA	0.577																																																1	Substitution - Missense(1)	endometrium(1)											152.0	141.0	145.0					17																	72951984		2203	4300	6503	SO:0001583	missense	283987				CCDS32726.1	17q25.1	2012-10-10	2012-10-10	2012-10-10	ENSG00000167861	ENSG00000167861			15736	protein-coding gene	gene with protein product	"""downregulated in multiple cancer 1"""	605752	"""chromosome 17 open reading frame 28"""	C17orf28		11281419, 21337012	Standard	NM_030630		Approved	DMC1, HID-1	uc002jmj.4	Q8IV36	OTTHUMG00000166490	ENST00000425042.2:c.1539C>G	17.37:g.72951984G>C	ENSP00000413520:p.Phe513Leu		Q8N5L6|Q8TE83|Q9NT34	Missense_Mutation	SNP	p.F513L	ENST00000425042.2	37	CCDS32726.1	deleterious(0.802)	.	.	.	.	.	.	.	.	.	.	G	24.1	4.496549	0.85069	.	.	ENSG00000167861	ENST00000525426;ENST00000425042;ENST00000318565	.	.	.	5.06	4.07	0.47477	.	0.000000	0.85682	D	0.000000	T	0.75443	0.3850	M	0.76838	2.35	0.80722	D	1	D	0.60575	0.988	D	0.66497	0.944	T	0.76887	-0.2793	9	0.51188	T	0.08	-26.6774	11.0341	0.47791	0.1879:0.0:0.8121:0.0	.	513	Q8IV36	CQ028_HUMAN	L	285;513;285	.	ENSP00000317795:F285L	F	-	3	2	C17orf28	70463579	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	2.480000	0.45206	2.345000	0.79718	0.644000	0.83932	TTC	HMMPfam_Hid1		0.577	HID1-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000390011.2	247	0%	possibly_damaging(0.903)	NM_030630	128	99.2%		deleterious(0)	-1	NM_030630.2	validated	291	89.7%	1.000
FHOD3	80206	genome.wustl.edu	37	18	34205670	34205670	+	Missense_Mutation	SNP	C	C	T			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr18:34205670C>T	ENST00000359247.4	+	10	1154	c.1154C>T	c.(1153-1155)gCt>gTt	p.A385V	FHOD3_ENST00000591635.1_Missense_Mutation_p.L60F|FHOD3_ENST00000445677.1_Missense_Mutation_p.A385V|FHOD3_ENST00000590592.1_Missense_Mutation_p.A385V|FHOD3_ENST00000257209.4_Missense_Mutation_p.A385V	NM_001281739.1	NP_001268668.1	Q2V2M9	FHOD3_HUMAN	formin homology 2 domain containing 3	385	GBD/FH3. {ECO:0000255|PROSITE- ProRule:PRU00579}.				actin filament network formation (GO:0051639)|cardiac myofibril assembly (GO:0055003)|negative regulation of actin filament polymerization (GO:0030837)|sarcomere organization (GO:0045214)	striated muscle thin filament (GO:0005865)		p.A385V(1)		NS(1)|breast(5)|central_nervous_system(1)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(25)|liver(2)|lung(29)|ovary(3)|prostate(4)|skin(5)|upper_aerodigestive_tract(1)	90		all_epithelial(2;0.0181)|Colorectal(2;0.0195)				TCCCAGTCAGCTCCCAGCTTC	0.612																																																1	Substitution - Missense(1)	endometrium(1)											116.0	119.0	118.0					18																	34205670		2203	4300	6503	SO:0001583	missense	80206			AK091899	CCDS32816.1, CCDS62418.1, CCDS62419.1	18q12	2007-08-02				ENSG00000134775			26178	protein-coding gene	gene with protein product		609691				11214970	Standard	NM_025135		Approved	FHOS2, KIAA1695, FLJ22297, FLJ22717	uc021uiv.1	Q2V2M9		ENST00000359247.4:c.1154C>T	18.37:g.34205670C>T	ENSP00000352186:p.Ala385Val		A8MQT4|E5F5Q0|Q642I2|Q6ZRQ7|Q86TF9|Q8N3A5|Q9C0G8|Q9H604|Q9H6G7	Missense_Mutation	SNP	p.A385V	ENST00000359247.4	37		neutral(0.042)	.	.	.	.	.	.	.	.	.	.	C	12.12	1.842266	0.32513	.	.	ENSG00000134775	ENST00000257209;ENST00000359247;ENST00000445677	T;T;T	0.19250	2.16;2.16;2.16	5.06	1.07	0.20283	GTPase-binding/formin homology 3 (1);Armadillo-type fold (1);	0.647302	0.15347	N	0.267154	T	0.09774	0.0240	N	0.14661	0.345	0.20489	N	0.999896	B;B;B;B	0.14805	0.001;0.0;0.0;0.011	B;B;B;B	0.19946	0.002;0.002;0.003;0.027	T	0.33343	-0.9872	10	0.23891	T	0.37	.	3.7563	0.08586	0.335:0.4756:0.0:0.1893	.	385;385;385;385	Q2V2M9-2;Q2V2M9;Q2V2M9-3;E5F5Q0	.;FHOD3_HUMAN;.;.	V	385	ENSP00000257209:A385V;ENSP00000352186:A385V;ENSP00000411430:A385V	ENSP00000257209:A385V	A	+	2	0	FHOD3	32459668	0.212000	0.23540	0.012000	0.15200	0.996000	0.88848	0.623000	0.24447	-0.093000	0.12396	0.655000	0.94253	GCT	NULL		0.612	FHOD3-001	PUTATIVE	basic	protein_coding	protein_coding	OTTHUMT00000460884.1	58	0%	benign(0)	XM_371114	0	-		tolerated(0.23)	+1	NM_025135.2	validated	48	14.6%	0.605
SERPINB3	6317	genome.wustl.edu	37	18	61323250	61323250	+	Silent	SNP	A	A	G			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	A	A					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr18:61323250A>G	ENST00000283752.5	-	8	957	c.814T>C	c.(814-816)Ttg>Ctg	p.L272L	SERPINB11_ENST00000489748.1_RNA|SERPINB3_ENST00000332821.8_Silent_p.L220L	NM_006919.2	NP_008850.1	P29508	SPB3_HUMAN	serpin peptidase inhibitor, clade B (ovalbumin), member 3	272					negative regulation of catalytic activity (GO:0043086)|negative regulation of endopeptidase activity (GO:0010951)|negative regulation of peptidase activity (GO:0010466)|negative regulation of proteolysis (GO:0045861)|regulation of proteolysis (GO:0030162)|response to virus (GO:0009615)	cytoplasm (GO:0005737)|extracellular region (GO:0005576)|extracellular space (GO:0005615)|extracellular vesicular exosome (GO:0070062)|nucleus (GO:0005634)|vesicle (GO:0031982)	serine-type endopeptidase inhibitor activity (GO:0004867)|virus receptor activity (GO:0001618)	p.L272L(1)		breast(2)|central_nervous_system(1)|endometrium(4)|kidney(3)|large_intestine(4)|lung(14)|ovary(1)|skin(5)|upper_aerodigestive_tract(2)	36						ATATTCTGCAAACTTGTCCAT	0.398																																																1	Substitution - coding silent(1)	endometrium(1)											115.0	100.0	105.0					18																	61323250		2203	4300	6503	SO:0001819	synonymous_variant	6317			U19568	CCDS11987.1	18q21.3	2014-02-18	2005-08-18		ENSG00000057149	ENSG00000057149		"""Serine (or cysteine) peptidase inhibitors"""	10569	protein-coding gene	gene with protein product		600517	"""serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 3"""	SCC, SCCA1		7724531, 24172014	Standard	NM_006919		Approved	T4-A, HsT1196	uc002lji.3	P29508	OTTHUMG00000060403	ENST00000283752.5:c.814T>C	18.37:g.61323250A>G			A6NDM2|B2RBT5|B3W5Y6|Q53H28|Q53YB5|Q86VF3|Q86W04|Q8IWL4|Q8IXI3|Q96J21|Q9BYF8	Silent	SNP	p.L272	ENST00000283752.5	37	CCDS11987.1	-																																																																																			HMMPfam_Serpin,HMMSmart_SM00093,superfamily_Serpins		0.398	SERPINB3-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000133791.1	253	0%	-	NM_006919	2	0%		-	-1	NM_006919.2	validated	132	68.9%	0.000
FFAR3	2865	genome.wustl.edu	37	19	35850313	35850313	+	Missense_Mutation	SNP	G	G	A			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr19:35850313G>A	ENST00000327809.4	+	2	722	c.521G>A	c.(520-522)cGg>cAg	p.R174Q	FFAR3_ENST00000594310.1_Missense_Mutation_p.R174Q	NM_005304.3	NP_005295.1	O14843	FFAR3_HUMAN	free fatty acid receptor 3	174			R -> W (abolishes activation by propionate). {ECO:0000269|PubMed:19630535}.		adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193)|cellular response to fatty acid (GO:0071398)|G-protein coupled receptor signaling pathway (GO:0007186)|inflammatory response (GO:0006954)|mucosal immune response (GO:0002385)|negative regulation of blood pressure (GO:0045776)|positive regulation of acute inflammatory response to non-antigenic stimulus (GO:0002879)|positive regulation of chemokine production (GO:0032722)|positive regulation of cytokine production involved in immune response (GO:0002720)|positive regulation of glucose import in response to insulin stimulus (GO:2001275)|regulation of hormone biosynthetic process (GO:0046885)|regulation of norepinephrine secretion (GO:0014061)|regulation of peptide hormone secretion (GO:0090276)	integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886)	G-protein coupled receptor activity (GO:0004930)|lipid binding (GO:0008289)	p.R174Q(1)		endometrium(3)|large_intestine(2)|lung(9)|ovary(1)|skin(1)|stomach(1)	17	all_lung(56;9.78e-09)|Lung NSC(56;1.46e-08)|Esophageal squamous(110;0.162)		Epithelial(14;1.29e-19)|OV - Ovarian serous cystadenocarcinoma(14;4.63e-18)|all cancers(14;5.19e-17)|LUSC - Lung squamous cell carcinoma(66;0.0221)			CTGGAGTTCCGGAAGGACCAG	0.602																																					Esophageal Squamous(185;1742 2042 21963 24215 27871)											1	Substitution - Missense(1)	endometrium(1)											81.0	63.0	69.0					19																	35850313		2201	4298	6499	SO:0001583	missense	2865			AF024688	CCDS12459.1	19q13.1	2012-08-08	2006-02-15	2006-02-15	ENSG00000185897	ENSG00000185897		"""GPCR / Class A : Fatty acid receptors"""	4499	protein-coding gene	gene with protein product		603821	"""G protein-coupled receptor 41"""	GPR41		9344866, 22493486	Standard	NM_005304		Approved	FFA3R	uc002nzd.3	O14843	OTTHUMG00000172514	ENST00000327809.4:c.521G>A	19.37:g.35850313G>A	ENSP00000328230:p.Arg174Gln		B2RWM8|Q14CM7	Missense_Mutation	SNP	p.R174Q	ENST00000327809.4	37	CCDS12459.1	neutral(0.008)	.	.	.	.	.	.	.	.	.	.	G	5.200	0.222364	0.09863	.	.	ENSG00000185897	ENST00000327809	T	0.71698	-0.59	5.0	1.12	0.20585	GPCR, rhodopsin-like superfamily (1);	0.730502	0.11431	N	0.564846	T	0.37237	0.0996	N	0.02011	-0.69	0.09310	N	1	B	0.02656	0.0	B	0.04013	0.001	T	0.23797	-1.0178	10	0.14656	T	0.56	-3.6478	4.9872	0.14196	0.2992:0.1466:0.5542:0.0	.	174	O14843	FFAR3_HUMAN	Q	174	ENSP00000328230:R174Q	ENSP00000328230:R174Q	R	+	2	0	FFAR3	40542153	0.000000	0.05858	0.333000	0.25482	0.176000	0.22953	-1.107000	0.03316	0.008000	0.14787	0.305000	0.20034	CGG	HMMPfam_7tm_1,superfamily_SSF81321		0.602	FFAR3-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000418873.2	102	0%	benign(0.058)	NM_005304	0	-		tolerated(0.59)	+1	NM_005304.3	validated	134	20.1%	0.014
ZNF574	64763	genome.wustl.edu	37	19	42585390	42585390	+	Missense_Mutation	SNP	G	G	T			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr19:42585390G>T	ENST00000600245.1	+	2	3287	c.2632G>T	c.(2632-2634)Gtg>Ttg	p.V878L	ZNF574_ENST00000222339.7_Missense_Mutation_p.V968L|ZNF574_ENST00000359044.4_Missense_Mutation_p.V878L|CTB-59C6.3_ENST00000594531.1_RNA			Q6ZN55	ZN574_HUMAN	zinc finger protein 574	878					regulation of transcription, DNA-templated (GO:0006355)|transcription, DNA-templated (GO:0006351)	nucleus (GO:0005634)	DNA binding (GO:0003677)|metal ion binding (GO:0046872)	p.V878L(1)		endometrium(4)|kidney(1)|large_intestine(3)|lung(6)|pancreas(1)|prostate(1)|skin(2)|stomach(1)|upper_aerodigestive_tract(1)	20		Prostate(69;0.059)				GCTACCCCTGGTGGAAGCCAT	0.637																																																1	Substitution - Missense(1)	endometrium(1)											73.0	69.0	70.0					19																	42585390		2203	4300	6503	SO:0001583	missense	64763			AK074788	CCDS12596.1	19q13.2	2013-09-20			ENSG00000105732	ENSG00000105732		"""Zinc fingers, C2H2-type"""	26166	protein-coding gene	gene with protein product						12477932	Standard	NM_022752		Approved	FLJ22059	uc002osm.4	Q6ZN55	OTTHUMG00000182751	ENST00000600245.1:c.2632G>T	19.37:g.42585390G>T	ENSP00000469029:p.Val878Leu		Q6IPE0|Q6ZN10|Q7L5Z5|Q8NCE3|Q9H6N0	Missense_Mutation	SNP	p.V878L	ENST00000600245.1	37	CCDS12596.1	neutral(0.029)	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	G|G	12.11|12.11	1.840433|1.840433	0.32513|0.32513	.|.	.|.	ENSG00000105732|ENSG00000105732	ENST00000222339;ENST00000359044|ENST00000535775	T;T|.	0.05996|.	3.36;3.39|.	4.71|4.71	4.71|4.71	0.59529|0.59529	.|.	0.378226|.	0.21879|.	N|.	0.067774|.	T|T	0.29850|0.29850	0.0746|0.0746	N|N	0.14661|0.14661	0.345|0.345	0.30371|0.30371	N|N	0.782912|0.782912	B;B|.	0.14805|.	0.0;0.011|.	B;B|.	0.16289|.	0.001;0.015|.	T|T	0.23119|0.23119	-1.0197|-1.0197	10|6	0.31617|0.66056	T|D	0.26|0.02	-15.5611|-15.5611	6.6324|6.6324	0.22863|0.22863	0.0952:0.1828:0.722:0.0|0.0952:0.1828:0.722:0.0	.|.	878;967|.	Q6ZN55;Q6ZN55-2|.	ZN574_HUMAN;.|.	L|C	968;878|484	ENSP00000222339:V968L;ENSP00000351939:V878L|.	ENSP00000222339:V968L|ENSP00000445515:W484C	V|W	+|+	1|3	0|0	ZNF574|ZNF574	47277230|47277230	0.706000|0.706000	0.27856|0.27856	1.000000|1.000000	0.80357|0.80357	0.504000|0.504000	0.33889|0.33889	1.398000|1.398000	0.34554|0.34554	2.445000|2.445000	0.82738|0.82738	0.460000|0.460000	0.39030|0.39030	GTG|TGG	NULL		0.637	ZNF574-002	KNOWN	upstream_uORF|basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000463458.1	30	0%	benign(0.014)	NM_022752	68	48.5%		tolerated(0.3)	+1	NM_022752.5	validated	27	37%	1.000
CCDC114	93233	genome.wustl.edu	37	19	48814869	48814869	+	Silent	SNP	G	G	A			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr19:48814869G>A	ENST00000315396.7	-	5	1109	c.427C>T	c.(427-429)Ctg>Ttg	p.L143L		NM_144577.3	NP_653178.3	Q96M63	CC114_HUMAN	coiled-coil domain containing 114	143					outer dynein arm assembly (GO:0036158)	cilium (GO:0005929)|outer dynein arm (GO:0036157)		p.L143L(1)		cervix(2)|endometrium(3)|kidney(1)|large_intestine(5)|lung(5)|ovary(1)|pancreas(1)|prostate(3)|skin(2)|stomach(1)	24		all_epithelial(76;9.64e-05)|all_lung(116;0.000147)|Lung NSC(112;0.000251)|Prostate(7;0.0187)|all_neural(266;0.0228)|Ovarian(192;0.113)		OV - Ovarian serous cystadenocarcinoma(262;0.000134)|all cancers(93;0.000162)|Epithelial(262;0.0134)|GBM - Glioblastoma multiforme(486;0.0143)		AGCAGATCCAGCTCCTCCCGC	0.582																																																1	Substitution - coding silent(1)	endometrium(1)											92.0	78.0	82.0					19																	48814869		692	1591	2283	SO:0001819	synonymous_variant	93233			BC025752	CCDS12714.2	19q13.32	2013-02-22			ENSG00000105479	ENSG00000105479			26560	protein-coding gene	gene with protein product		615038				23261302, 23261303	Standard	NM_144577		Approved	FLJ32926, CILD20	uc002pir.2	Q96M63	OTTHUMG00000156161	ENST00000315396.7:c.427C>T	19.37:g.48814869G>A			Q6ZRL4|Q96M06|Q9UFG8	Silent	SNP	p.L143	ENST00000315396.7	37	CCDS12714.2	-																																																																																			NULL		0.582	CCDC114-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000343207.1	108	0%	-	NM_144577	0	-		-	-1	NM_144577.3	validated	154	46.1%	1.000
JAG1	182	genome.wustl.edu	37	20	10639252	10639252	+	Silent	SNP	G	G	A			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr20:10639252G>A	ENST00000254958.5	-	4	1073	c.558C>T	c.(556-558)acC>acT	p.T186T	JAG1_ENST00000423891.2_Silent_p.T27T	NM_000214.2	NP_000205.1	P78504	JAG1_HUMAN	jagged 1	186	DSL. {ECO:0000255|PROSITE- ProRule:PRU00377}.				angiogenesis (GO:0001525)|aorta morphogenesis (GO:0035909)|auditory receptor cell differentiation (GO:0042491)|blood vessel remodeling (GO:0001974)|cardiac neural crest cell development involved in outflow tract morphogenesis (GO:0061309)|cardiac right ventricle morphogenesis (GO:0003215)|cardiac septum morphogenesis (GO:0060411)|cell fate determination (GO:0001709)|ciliary body morphogenesis (GO:0061073)|distal tubule development (GO:0072017)|endocardial cushion cell development (GO:0061444)|endothelial cell differentiation (GO:0045446)|hemopoiesis (GO:0030097)|keratinocyte differentiation (GO:0030216)|loop of Henle development (GO:0072070)|morphogenesis of an epithelial sheet (GO:0002011)|myoblast differentiation (GO:0045445)|negative regulation of fat cell differentiation (GO:0045599)|negative regulation of neuron differentiation (GO:0045665)|negative regulation of stem cell differentiation (GO:2000737)|nervous system development (GO:0007399)|neuronal stem cell maintenance (GO:0097150)|Notch receptor processing (GO:0007220)|Notch signaling involved in heart development (GO:0061314)|Notch signaling pathway (GO:0007219)|positive regulation of myeloid cell differentiation (GO:0045639)|positive regulation of Notch signaling pathway (GO:0045747)|positive regulation of osteoblast differentiation (GO:0045669)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|pulmonary artery morphogenesis (GO:0061156)|pulmonary valve morphogenesis (GO:0003184)|regulation of cell migration (GO:0030334)|regulation of cell proliferation (GO:0042127)|response to muramyl dipeptide (GO:0032495)|T cell mediated immunity (GO:0002456)	apical part of cell (GO:0045177)|extracellular region (GO:0005576)|integral component of plasma membrane (GO:0005887)|membrane (GO:0016020)|plasma membrane (GO:0005886)	calcium ion binding (GO:0005509)|growth factor activity (GO:0008083)|Notch binding (GO:0005112)|structural molecule activity (GO:0005198)	p.T186T(2)		biliary_tract(1)|breast(2)|central_nervous_system(3)|cervix(1)|endometrium(6)|kidney(3)|large_intestine(10)|lung(14)|ovary(2)|pancreas(1)|urinary_tract(1)	44						AGTCATCACAGGTCACGCGGA	0.522									Alagille Syndrome																																							2	Substitution - coding silent(2)	endometrium(2)											166.0	142.0	150.0					20																	10639252		2203	4300	6503	SO:0001819	synonymous_variant	182	Familial Cancer Database	ALGS1, ALGS2.Alagille-Watson syndrome	U61276	CCDS13112.1	20p12.1-p11.23	2011-05-12	2010-06-24		ENSG00000101384	ENSG00000101384		"""CD molecules"""	6188	protein-coding gene	gene with protein product		601920	"""Alagille syndrome"""	AGS, JAGL1		7697721, 9207788	Standard	NM_000214		Approved	AHD, AWS, HJ1, CD339	uc002wnw.2	P78504	OTTHUMG00000031872	ENST00000254958.5:c.558C>T	20.37:g.10639252G>A			A0AV43|B4DYR1|E9PCF9|O14902|O15122|Q15816	Silent	SNP	p.T186	ENST00000254958.5	37	CCDS13112.1	-																																																																																			HMMPfam_DSL,HMMSmart_DSL		0.522	JAG1-201	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding		230	0%	-	NM_000214	4	25%		-	-1	NM_000214.2	reviewed	247	37.7%	1.000
FOXA2	3170	genome.wustl.edu	37	20	22563132	22563132	+	Nonsense_Mutation	SNP	C	C	A			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr20:22563132C>A	ENST00000377115.4	-	3	911	c.730G>T	c.(730-732)Gag>Tag	p.E244*	FOXA2_ENST00000419308.2_Nonsense_Mutation_p.E250*	NM_153675.2	NP_710141.1	Q9Y261	FOXA2_HUMAN	forkhead box A2	244					adult locomotory behavior (GO:0008344)|cell development (GO:0048468)|cell differentiation in hindbrain (GO:0021533)|cell fate specification (GO:0001708)|chromatin modification (GO:0016568)|connective tissue development (GO:0061448)|dopaminergic neuron differentiation (GO:0071542)|dorsal/ventral neural tube patterning (GO:0021904)|ectoderm formation (GO:0001705)|endocrine pancreas development (GO:0031018)|epithelial tube branching involved in lung morphogenesis (GO:0060441)|in utero embryonic development (GO:0001701)|lung epithelial cell differentiation (GO:0060487)|negative regulation of detection of glucose (GO:2000971)|negative regulation of epithelial to mesenchymal transition (GO:0010719)|negative regulation of glucokinase activity (GO:0033132)|negative regulation of neuron differentiation (GO:0045665)|negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433)|negative regulation of transcription from RNA polymerase II promoter by glucose (GO:0000433)|neuron fate specification (GO:0048665)|positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049)|positive regulation of embryonic development (GO:0040019)|positive regulation of gastrulation (GO:2000543)|positive regulation of neuron differentiation (GO:0045666)|positive regulation of smoothened signaling pathway (GO:0045880)|positive regulation of transcription from RNA polymerase II promoter (GO:0045944)|positive regulation of transcription from RNA polymerase II promoter by glucose (GO:0000432)|positive regulation of transcription from RNA polymerase III promoter (GO:0045945)|positive regulation of transcription, DNA-templated (GO:0045893)|primitive streak formation (GO:0090009)|regulation of blood coagulation (GO:0030193)|regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178)|regulation of steroid metabolic process (GO:0019218)|regulation of transcription from RNA polymerase II promoter (GO:0006357)|regulation of transcription from RNA polymerase II promoter involved in detection of glucose (GO:2000976)|response to interleukin-6 (GO:0070741)|signal transduction involved in regulation of gene expression (GO:0023019)|somite rostral/caudal axis specification (GO:0032525)	cytoplasm (GO:0005737)|nucleus (GO:0005634)	DNA binding (GO:0003677)|RNA polymerase II core promoter proximal region sequence-specific DNA binding (GO:0000978)|RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription (GO:0001205)|sequence-specific DNA binding transcription factor activity (GO:0003700)|transcription regulatory region DNA binding (GO:0044212)	p.E244*(1)		breast(1)|central_nervous_system(3)|endometrium(7)|kidney(2)|large_intestine(1)|lung(3)|ovary(2)|prostate(2)|urinary_tract(1)	22	Lung NSC(19;0.188)					CAGCCGTTCTCGAACATGTTG	0.667																																																1	Substitution - Nonsense(1)	endometrium(1)											18.0	21.0	20.0					20																	22563132		2203	4300	6503	SO:0001587	stop_gained	3170			AF147787	CCDS13147.1, CCDS46585.1	20p11	2008-04-10		2002-09-20	ENSG00000125798	ENSG00000125798		"""Forkhead boxes"""	5022	protein-coding gene	gene with protein product		600288	"""hepatocyte nuclear factor 3, beta"""	HNF3B		9119385, 11875061	Standard	NM_153675		Approved		uc002wsm.3	Q9Y261	OTTHUMG00000032041	ENST00000377115.4:c.730G>T	20.37:g.22563132C>A	ENSP00000366319:p.Glu244*		Q8WUW4|Q96DF7	Nonsense_Mutation	SNP	p.E250*	ENST00000377115.4	37	CCDS13147.1	-	.	.	.	.	.	.	.	.	.	.	C	37	6.578057	0.97680	.	.	ENSG00000125798	ENST00000377115;ENST00000419308;ENST00000319993;ENST00000444877	.	.	.	4.98	4.03	0.46877	.	0.000000	0.64402	U	0.000012	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	0.87932	D	0	.	13.2241	0.59905	0.0:0.9206:0.0:0.0794	.	.	.	.	X	244;244;250;130	.	ENSP00000315955:E250X	E	-	1	0	FOXA2	22511132	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	6.019000	0.70818	1.077000	0.40990	0.574000	0.79327	GAG	HMMPfam_Fork_head,HMMSmart_FH,superfamily_SSF46785		0.667	FOXA2-001	KNOWN	basic|CCDS	protein_coding	protein_coding	OTTHUMT00000078289.1	26	0%	-		54	87%		-	-1	NM_021784.4	reviewed	25	76%	1.000
CYP2D6	1565	genome.wustl.edu	37	22	42523581	42523581	+	Missense_Mutation	SNP	C	C	T	rs542114265		TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chr22:42523581C>T	ENST00000360608.5	-	7	1155	c.1041G>A	c.(1039-1041)atG>atA	p.M347I	NDUFA6-AS1_ENST00000439129.1_RNA|NDUFA6-AS1_ENST00000417327.1_RNA|NDUFA6-AS1_ENST00000451451.1_RNA|NDUFA6-AS1_ENST00000434834.1_RNA|NDUFA6-AS1_ENST00000610250.1_RNA|NDUFA6-AS1_ENST00000600968.1_RNA|CYP2D6_ENST00000389970.3_Missense_Mutation_p.M347I|NDUFA6-AS1_ENST00000595777.1_RNA|NDUFA6-AS1_ENST00000536447.2_RNA|NDUFA6-AS1_ENST00000416037.2_RNA|CYP2D6_ENST00000359033.4_Missense_Mutation_p.M296I	NM_000106.5	NP_000097	P10635	CP2D6_HUMAN	cytochrome P450, family 2, subfamily D, polypeptide 6	347					alkaloid catabolic process (GO:0009822)|alkaloid metabolic process (GO:0009820)|coumarin metabolic process (GO:0009804)|drug catabolic process (GO:0042737)|drug metabolic process (GO:0017144)|heterocycle metabolic process (GO:0046483)|isoquinoline alkaloid metabolic process (GO:0033076)|monoterpenoid metabolic process (GO:0016098)|negative regulation of binding (GO:0051100)|negative regulation of cellular organofluorine metabolic process (GO:0090350)|oxidation-reduction process (GO:0055114)|oxidative demethylation (GO:0070989)|small molecule metabolic process (GO:0044281)|steroid metabolic process (GO:0008202)|xenobiotic metabolic process (GO:0006805)	endoplasmic reticulum (GO:0005783)|endoplasmic reticulum membrane (GO:0005789)|mitochondrion (GO:0005739)	aromatase activity (GO:0070330)|drug binding (GO:0008144)|heme binding (GO:0020037)|iron ion binding (GO:0005506)|monooxygenase activity (GO:0004497)|oxidoreductase activity (GO:0016491)	p.M296I(1)|p.M347I(1)		NS(1)|breast(2)|endometrium(1)|large_intestine(2)|lung(4)|prostate(7)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	21					Abiraterone(DB05812)|Acebutolol(DB01193)|Acetaminophen(DB00316)|Ajmaline(DB01426)|Almotriptan(DB00918)|Alogliptin(DB06203)|Alprenolol(DB00866)|Aminophenazone(DB01424)|Amiodarone(DB01118)|Amitriptyline(DB00321)|Amlodipine(DB00381)|Amodiaquine(DB00613)|Amoxapine(DB00543)|Amphetamine(DB00182)|Amprenavir(DB00701)|Amsacrine(DB00276)|Antipyrine(DB01435)|Aprindine(DB01429)|Arformoterol(DB01274)|Aripiprazole(DB01238)|Artemether(DB06697)|Asenapine(DB06216)|Astemizole(DB00637)|Atomoxetine(DB00289)|Atorvastatin(DB01076)|Azelastine(DB00972)|Benzatropine(DB00245)|Benzyl alcohol(DB06770)|Bepridil(DB01244)|Betaxolol(DB00195)|Bicalutamide(DB01128)|Biperiden(DB00810)|Bisoprolol(DB00612)|Bortezomib(DB00188)|Brompheniramine(DB00835)|Bupivacaine(DB00297)|Buprenorphine(DB00921)|Bupropion(DB01156)|Buspirone(DB00490)|Caffeine(DB00201)|Captopril(DB01197)|Carbinoxamine(DB00748)|Carteolol(DB00521)|Carvedilol(DB01136)|Celecoxib(DB00482)|Cephalexin(DB00567)|Cevimeline(DB00185)|Chlordiazepoxide(DB00475)|Chloroquine(DB00608)|Chlorphenamine(DB01114)|Chlorpromazine(DB00477)|Chlorzoxazone(DB00356)|Cholecalciferol(DB00169)|Ciclesonide(DB01410)|Cilostazol(DB01166)|Cimetidine(DB00501)|Cinacalcet(DB01012)|Cinnarizine(DB00568)|Cisapride(DB00604)|Citalopram(DB00215)|Clemastine(DB00283)|Clevidipine(DB04920)|Clomipramine(DB01242)|Clonidine(DB00575)|Clotrimazole(DB00257)|Clozapine(DB00363)|Cocaine(DB00907)|Codeine(DB00318)|Cyclobenzaprine(DB00924)|Cyclophosphamide(DB00531)|Cyclosporine(DB00091)|Dapagliflozin(DB06292)|Darifenacin(DB00496)|Debrisoquin(DB04840)|Delavirdine(DB00705)|Desipramine(DB01151)|Desloratadine(DB00967)|Dexamethasone(DB01234)|Dexfenfluramine(DB01191)|Dexmedetomidine(DB00633)|Dexmethylphenidate(DB06701)|Dextroamphetamine(DB01576)|Dextromethorphan(DB00514)|Dextropropoxyphene(DB00647)|Dihydrocodeine(DB01551)|Diltiazem(DB00343)|Dimethyl sulfoxide(DB01093)|Diphenhydramine(DB01075)|Dolasetron(DB00757)|Domperidone(DB01184)|Donepezil(DB00843)|Dopamine(DB00988)|Doxazosin(DB00590)|Doxepin(DB01142)|Doxorubicin(DB00997)|Dronedarone(DB04855)|Duloxetine(DB00476)|Efavirenz(DB00625)|Eletriptan(DB00216)|Encainide(DB01228)|Enzalutamide(DB08899)|Epinastine(DB00751)|Erlotinib(DB00530)|Escitalopram(DB01175)|Ethylmorphine(DB01466)|Etoricoxib(DB01628)|Felodipine(DB01023)|Fesoterodine(DB06702)|Fexofenadine(DB00950)|Fingolimod(DB08868)|Flecainide(DB01195)|Flunarizine(DB04841)|Fluoxetine(DB00472)|Fluphenazine(DB00623)|Fluvastatin(DB01095)|Fluvoxamine(DB00176)|Formoterol(DB00983)|Galantamine(DB00674)|Gefitinib(DB00317)|Glutethimide(DB01437)|Granisetron(DB00889)|Halofantrine(DB01218)|Haloperidol(DB00502)|Halothane(DB01159)|Histamine Phosphate(DB00667)|Hydrocodone(DB00956)|Hydromorphone(DB00327)|Hydroxychloroquine(DB01611)|Hydroxyurea(DB01005)|Hydroxyzine(DB00557)|Idarubicin(DB01177)|Iloperidone(DB04946)|Imatinib(DB00619)|Imipramine(DB00458)|Indinavir(DB00224)|Ipratropium bromide(DB00332)|Irbesartan(DB01029)|Isoniazid(DB00951)|Itraconazole(DB01167)|Ketoconazole(DB01026)|L-DOPA(DB01235)|Labetalol(DB00598)|Lansoprazole(DB00448)|Lercanidipine(DB00528)|Levomilnacipran(DB08918)|Lidocaine(DB00281)|Lisuride(DB00589)|Lomustine(DB01206)|Loperamide(DB00836)|Lopinavir(DB01601)|Loratadine(DB00455)|Lorcaserin(DB04871)|Lovastatin(DB00227)|Lumefantrine(DB06708)|Maprotiline(DB00934)|Mefloquine(DB00358)|Mepyramine(DB06691)|Mequitazine(DB01071)|Mesoridazine(DB00933)|Methadone(DB00333)|Methamphetamine(DB01577)|Methazolamide(DB00703)|Methimazole(DB00763)|Methotrimeprazine(DB01403)|Methoxyflurane(DB01028)|Methylnaltrexone(DB06800)|Methylphenidate(DB00422)|Methyprylon(DB01107)|Metoclopramide(DB01233)|Metoprolol(DB00264)|Mexiletine(DB00379)|Mianserin(DB06148)|Miconazole(DB01110)|Midodrine(DB00211)|Mifepristone(DB00834)|Minaprine(DB00805)|Mirabegron(DB08893)|Mirtazapine(DB00370)|Moclobemide(DB01171)|Morphine(DB00295)|Nateglinide(DB00731)|Nebivolol(DB04861)|Nefazodone(DB01149)|Nelfinavir(DB00220)|Nevirapine(DB00238)|Niacin(DB00627)|Nicardipine(DB00622)|Nicergoline(DB00699)|Nicotine(DB00184)|Nifedipine(DB01115)|Nilotinib(DB04868)|Nitrofural(DB00336)|Nortriptyline(DB00540)|Olanzapine(DB00334)|Omeprazole(DB00338)|Ondansetron(DB00904)|Oxamniquine(DB01096)|Oxprenolol(DB01580)|Oxybutynin(DB01062)|Oxycodone(DB00497)|Oxymorphone(DB01192)|Paliperidone(DB01267)|Palonosetron(DB00377)|Paroxetine(DB00715)|Pazopanib(DB06589)|Pentamidine(DB00738)|Pergolide(DB01186)|Perhexiline(DB01074)|Perphenazine(DB00850)|Pethidine(DB00454)|Phenformin(DB00914)|Phentermine(DB00191)|Pimozide(DB01100)|Pindolol(DB00960)|Pioglitazone(DB01132)|Piperazine(DB00592)|Pipotiazine(DB01621)|Ponatinib(DB08901)|Pravastatin(DB00175)|Praziquantel(DB01058)|Primaquine(DB01087)|Procainamide(DB01035)|Prochlorperazine(DB00433)|Progesterone(DB00396)|Proguanil(DB01131)|Promethazine(DB01069)|Propafenone(DB01182)|Propofol(DB00818)|Propranolol(DB00571)|Protriptyline(DB00344)|Pseudoephedrine(DB00852)|Pyrimethamine(DB00205)|Quetiapine(DB01224)|Quinidine(DB00908)|Quinine(DB00468)|Rabeprazole(DB01129)|Ranitidine(DB00863)|Ranolazine(DB00243)|Reboxetine(DB00234)|Remoxipride(DB00409)|Rifapentine(DB01201)|Risperidone(DB00734)|Ritonavir(DB00503)|Rivastigmine(DB00989)|Ropinirole(DB00268)|Ropivacaine(DB00296)|Rosiglitazone(DB00412)|Rotigotine(DB05271)|Saquinavir(DB01232)|Selegiline(DB01037)|Sertindole(DB06144)|Sertraline(DB01104)|Sildenafil(DB00203)|Simvastatin(DB00641)|Sorafenib(DB00398)|Sulfanilamide(DB00259)|Sulfaphenazole(DB06729)|Tamoxifen(DB00675)|Tamsulosin(DB00706)|Tapentadol(DB06204)|Telithromycin(DB00976)|Temsirolimus(DB06287)|Terbinafine(DB00857)|Tetrabenazine(DB04844)|Theophylline(DB00277)|Thioridazine(DB00679)|Thiothixene(DB01623)|Ticlopidine(DB00208)|Timolol(DB00373)|Tiotropium(DB01409)|Tipranavir(DB00932)|Tolterodine(DB01036)|Trabectedin(DB05109)|Tramadol(DB00193)|Tranylcypromine(DB00752)|Trazodone(DB00656)|Trimipramine(DB00726)|Tripelennamine(DB00792)|Triprolidine(DB00427)|Trospium(DB00209)|Vemurafenib(DB08881)|Venlafaxine(DB00285)|Verapamil(DB00661)|Vilazodone(DB06684)|Vinblastine(DB00570)|Vinorelbine(DB00361)|Yohimbine(DB01392)|Zafirlukast(DB00549)|Zalcitabine(DB00943)|Ziprasidone(DB00246)|Zolpidem(DB00425)	CCTGGTCACCCATCTCTGGTC	0.617													C|||	1	0.000199681	0.0	0.0	5008	,	,		25494	0.0		0.0	False		,,,				2504	0.001															2	Substitution - Missense(2)	endometrium(2)											87.0	68.0	74.0					22																	42523581		2203	4298	6501	SO:0001583	missense	1565			M20403	CCDS33657.1, CCDS46721.1	22q13.1	2014-09-17	2003-01-14		ENSG00000100197	ENSG00000100197		"""Cytochrome P450s"""	2625	protein-coding gene	gene with protein product		124030	"""cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolizing), polypeptide 6"", ""cytochrome P450, family 2, subfamily D, polypeptide 7 pseudogene 2"", ""cytochrome P450, subfamily II (debrisoquine, sparteine, etc., -metabolising), polypeptide 7 pseudogene 2"", ""cytochrome P450, family 2, subfamily D, polypeptide 8 pseudogene 2"", ""cytochrome P450, subfamily IID (debrisoquine, sparteine, etc., -metabolising), polypeptide 8 pseudogene 2"""	CYP2DL1, CYP2D7P2, CYP2D7BP, CYP2D8P2, CYP2D7AP		8449513	Standard	NM_000106		Approved	CPD6, P450-DB1, CYP2D, P450C2D	uc003bce.3	P10635	OTTHUMG00000150918	ENST00000360608.5:c.1041G>A	22.37:g.42523581C>T	ENSP00000353820:p.Met347Ile		Q16752|Q2XND6|Q2XND7|Q2XNE0|Q6B012|Q6NXU8	Missense_Mutation	SNP	p.M347I	ENST00000360608.5	37	CCDS46721.1	neutral(0.255)	.	.	.	.	.	.	.	.	.	.	C	15.13	2.742366	0.49151	.	.	ENSG00000100197	ENST00000360608;ENST00000389970;ENST00000413640;ENST00000359033;ENST00000542856	T;T;T	0.68624	-0.34;-0.34;-0.34	4.93	4.93	0.64822	.	0.054006	0.85682	D	0.000000	T	0.68035	0.2957	L	0.43757	1.38	0.53005	D	0.999965	B;P;B	0.35944	0.37;0.529;0.37	B;B;B	0.44163	0.309;0.443;0.309	T	0.70278	-0.4916	10	0.52906	T;T	0.07;0.07	.	17.7329	0.88383	0.0:1.0:0.0:0.0	.	347;296;347	C1ID54;Q6NXU8;Q6NWU0	.;.;.	I	347;347;293;296;296	ENSP00000353820:M347I;ENSP00000374620:M347I;ENSP00000351927:M296I	ENSP00000351927:M296I;ENSP00000351927:M296I	M	-	3	0	CYP2D6	40853525	0.295000	0.24389	0.979000	0.43373	0.522000	0.34438	1.103000	0.31062	2.283000	0.76528	0.555000	0.69702	ATG	HMMPfam_p450,superfamily_Cytochrome_P450		0.617	CYP2D6-001	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding	protein_coding	OTTHUMT00000320525.1	64	0%	benign(0.072)		2	100%		tolerated(0.14)	-1	NM_000106.4	reviewed	63	79.4%	0.936
MAGEB6	158809	genome.wustl.edu	37	X	26213018	26213018	+	Missense_Mutation	SNP	C	C	T			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	C	C					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chrX:26213018C>T	ENST00000379034.1	+	2	1204	c.1055C>T	c.(1054-1056)cCt>cTt	p.P352L		NM_173523.2	NP_775794.2	Q8N7X4	MAGB6_HUMAN	melanoma antigen family B, 6	352	MAGE. {ECO:0000255|PROSITE- ProRule:PRU00127}.							p.P352L(1)		breast(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(2)|liver(1)|lung(18)|ovary(3)|prostate(2)	33						AACAGTGATCCTCCATGCTAT	0.512																																																1	Substitution - Missense(1)	endometrium(1)											70.0	67.0	68.0					X																	26213018		2201	4280	6481	SO:0001583	missense	158809			AF320514	CCDS14217.1	Xp22.12	2009-03-17			ENSG00000176746	ENSG00000176746			23796	protein-coding gene	gene with protein product	"""cancer/testis antigen family 3, member 4"""	300467				10861452	Standard	NM_173523		Approved	FLJ40242, MAGE-B6, MAGEB6A, CT3.4	uc004dbr.3	Q8N7X4	OTTHUMG00000021285	ENST00000379034.1:c.1055C>T	X.37:g.26213018C>T	ENSP00000368320:p.Pro352Leu		Q6GS19|Q9H219	Missense_Mutation	SNP	p.P352L	ENST00000379034.1	37	CCDS14217.1	deleterious(0.873)	.	.	.	.	.	.	.	.	.	.	C	14.83	2.651540	0.47362	.	.	ENSG00000176746	ENST00000379034	T	0.06371	3.31	3.29	3.29	0.37713	.	0.000000	0.85682	U	0.000000	T	0.26702	0.0653	H	0.94423	3.535	0.09310	N	0.999999	D	0.55605	0.972	P	0.58577	0.841	T	0.13980	-1.0489	10	0.87932	D	0	.	9.1984	0.37242	0.0:1.0:0.0:0.0	.	352	Q8N7X4	MAGB6_HUMAN	L	352	ENSP00000368320:P352L	ENSP00000368320:P352L	P	+	2	0	MAGEB6	26122939	0.002000	0.14202	0.031000	0.17742	0.093000	0.18481	0.896000	0.28377	1.907000	0.55213	0.594000	0.82650	CCT	HMMPfam_MAGE		0.512	MAGEB6-001	KNOWN	basic|appris_principal|CCDS	protein_coding	protein_coding	OTTHUMT00000056123.1	341	0%	probably_damaging(0.983)	NM_173523	0	-		deleterious(0)	+1	NM_173523.2	reviewed	317	30%	0.025
WNK3	65267	genome.wustl.edu	37	X	54319596	54319596	+	Missense_Mutation	SNP	G	G	C			TCGA-D1-A17K-01A-11D-A12J-09	TCGA-D1-A17K-10A-01D-A12J-09	G	G					Unknown	Untested	Somatic	Phase_IV	WXS	none	1	dbGAP	Illumina GAIIx	50723947-4ab0-4e78-8b30-204b60c24bfb	2b39f34d-3657-46be-bb34-89ee658b77bd	g.chrX:54319596G>C	ENST00000375159.2	-	8	1857	c.1858C>G	c.(1858-1860)Cta>Gta	p.L620V	WNK3_ENST00000375169.3_Missense_Mutation_p.L620V|WNK3_ENST00000354646.2_Missense_Mutation_p.L620V			Q9BYP7	WNK3_HUMAN	WNK lysine deficient protein kinase 3	620					intracellular signal transduction (GO:0035556)|negative regulation of apoptotic process (GO:0043066)|positive regulation of calcium ion transport (GO:0051928)|positive regulation of establishment of protein localization to plasma membrane (GO:0090004)|positive regulation of ion transmembrane transporter activity (GO:0032414)|positive regulation of peptidyl-threonine phosphorylation (GO:0010800)|positive regulation of rubidium ion transmembrane transporter activity (GO:2000688)|positive regulation of rubidium ion transport (GO:2000682)|positive regulation of sodium ion transmembrane transporter activity (GO:2000651)|positive regulation of sodium ion transport (GO:0010765)|protein autophosphorylation (GO:0046777)|protein phosphorylation (GO:0006468)|regulation of ion homeostasis (GO:2000021)	adherens junction (GO:0005912)|cytoplasm (GO:0005737)|tight junction (GO:0005923)	ATP binding (GO:0005524)|chloride channel inhibitor activity (GO:0019869)|protein kinase activity (GO:0004672)|protein serine/threonine kinase activity (GO:0004674)	p.L620V(1)		autonomic_ganglia(1)|biliary_tract(1)|breast(4)|central_nervous_system(2)|cervix(1)|endometrium(10)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(17)|lung(24)|ovary(4)|pancreas(2)|prostate(4)|skin(2)|upper_aerodigestive_tract(3)|urinary_tract(1)	80						TGTCCTACTAGTTGCTGAGAT	0.358																																																1	Substitution - Missense(1)	endometrium(1)											72.0	62.0	65.0					X																	54319596		2201	4299	6500	SO:0001583	missense	65267			AJ409088	CCDS14357.1, CCDS35302.1	Xp11.22	2008-05-14	2005-01-19	2005-01-22	ENSG00000196632	ENSG00000196632			14543	protein-coding gene	gene with protein product		300358	"""protein kinase, lysine deficient 3"""	PRKWNK3			Standard	NM_020922		Approved		uc004dtc.2	Q9BYP7	OTTHUMG00000021626	ENST00000375159.2:c.1858C>G	X.37:g.54319596G>C	ENSP00000364301:p.Leu620Val		B1AKG2|Q5JRC1|Q6JP76|Q8TCX6|Q9HCK6	Missense_Mutation	SNP	p.L620V	ENST00000375159.2	37	CCDS14357.1	neutral(0.015)	.	.	.	.	.	.	.	.	.	.	G	0.011	-1.710693	0.00712	.	.	ENSG00000196632	ENST00000375169;ENST00000354646;ENST00000375159	T;T;T	0.70749	-0.49;-0.51;-0.51	5.81	2.03	0.26663	.	0.000000	0.43416	D	0.000567	T	0.46367	0.1389	N	0.19112	0.55	0.09310	N	0.999996	B;B	0.09022	0.002;0.001	B;B	0.06405	0.002;0.002	T	0.21109	-1.0255	10	0.09338	T	0.73	-0.0896	5.8341	0.18597	0.2278:0.2491:0.5231:0.0	.	620;620	Q9BYP7-3;Q9BYP7	.;WNK3_HUMAN	V	620	ENSP00000364312:L620V;ENSP00000346667:L620V;ENSP00000364301:L620V	ENSP00000346667:L620V	L	-	1	2	WNK3	54336321	0.341000	0.24801	0.010000	0.14722	0.649000	0.38597	0.604000	0.24164	0.222000	0.20900	0.594000	0.82650	CTA	superfamily_Kinase_like		0.358	WNK3-002	KNOWN	basic|appris_candidate_longest|CCDS	protein_coding	protein_coding	OTTHUMT00000056799.2	264	0%	benign(0.027)	NM_020922	0	-		tolerated(0.42)	-1	NM_020922.4	reviewed	248	10.9%	0.538
